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ABSTRACT 
 
BAHBY BANKS: Process Evaluation of a Multilevel Intervention to Increase Rural, African 
American Participation in HIV/AIDS Clinical Trials  
(Under the direction of Dr. Eugenia Eng) 
 
 
Background:   While African Americans are disproportionately affected by the 
HIV/AIDS epidemic, they continue to be underrepresented in clinical trial research.   This 
underrepresentation has led to a critical gap in research and limited access to state of the art 
treatment for their disease.  To increase African American willingness to participate in 
clinical trials, Project EAST conducted a multilevel intervention that targeted rural service 
providers and their HIV/AIDS clients.  The dissertation study evaluated the implementation 
of the intervention. 
Methods: This study conducted the process evaluation of the intervention. Data 
sources included: (a) session audio recordings, (b) verbatim transcripts from sessions, 
facilitator debriefings, and participant focus group discussions, (c) narrative summaries from 
participant observation, (d) recruitment tracking forms, (e) attendance logs, and (f) 
community advisory board (CAB) meeting transcripts.  All qualitative data were managed 
using ATLAS.ti.  
Findings:  Intervention reach was 84% and 184% for clients and service providers, 
respectively.  Mean dose delivered scores were .88 for patient sessions and .92 for service 
provider sessions.  Attendance for each of the four client groups were .92, .86, .83, and .83, 
respectively and .97 and 1 for the two service provider groups.  Fidelity evaluated via 
 iv
facilitator debriefings was essential for identifying deviations from the curriculum. However, 
implementation checklists proved to be more comprehensive in capturing these deviations as 
they related to the quality and integrity of intervention delivery.  Focus group data indicated 
clients had high satisfaction with: interactive activities, being in a group setting with other 
clients living with HIV/AIDS, facilitator characteristics, and an opportunity to discuss 
concerns and clarifications with a clinical trial expert.  Service providers also indicated high 
satisfaction with: interactive activities, facilitator characteristics, and session content. These 
themes were convergent with facilitator perspectives on participant engagement. 
Conclusions: The findings provide important insights regarding education about and 
accessibility to HIV/AIDS clinical trial opportunities for rural, African Americans and their 
local service providers.  As researchers work to establish best practices in recruitment, 
referral, and enrollment of racial and ethnic minorities in HIV/AIDS clinical trials, 
conducting a process evaluation can yield essential understanding and recommendations for 
comparable educational interventions to be undertaken in rural regions of the United States.    
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CHAPTER 1 
INTRODUCTION 
 
The HIV Epidemic: From Metropolitan Areas to the Rural Southeast  
The HIV/AIDS epidemic in the United States was first noted in the early 1980s 
among homosexual White males in urban areas (Gottlieb, 2006).   However, over the past 
twenty years the demographics of those most affected by this disease has shifted 
dramatically, with African Americans accounting for 52% of new HIV cases diagnosed in 
2008 (Prejean et. al 2011) African Americans have accounted for approximately 12% of the 
total population over the same 20-year period.  In 2007, the rate at which African Americans 
were diagnosed with HIV was 73.7 per 100,000, nearly three times higher than Latinos (25.0 
per 100,000) and nine times higher than Whites (8.2 per 100,000) (Centers for Disease 
Control and Prevention, 2008).  In recent years, the epidemic has shifted from being 
concentrated in urban areas in the United States to rural areas, predominantly in the 
southeastern part of the country.  In 2000, the rate of HIV diagnosis was almost as high in 
rural areas of the Southeast as in urban areas of the same region (Hall, Li, & McKenna, 
2005).  In 2008, 67% of all rural AIDS cases reported in the United States were in the South; 
African Americans accounted for 62% of these cases. 
HIV Treatment and Care  
 Prompt initiation of a regimen to treat HIV is essential in reducing one’s viral load 
and preventing the onset of opportunistic infections brought on as one progresses from HIV 
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to AIDS (Department of Health and Human Services, 2011).  Due to great strides in medical 
research, treatment regimens are evolving and becoming more effective in delaying this 
progression.  Despite these advances, African Americans living with HIV/AIDS tend to seek 
treatment for HIV in later stages of the disease when their physical symptoms are more 
apparent.  Additionally, broader environmental factors within minority rural communities, 
such as poverty, lead to limited availability to medical care and a limited number of service 
providers with specialization in HIV/AIDS care (Nguyen & Whetten, 2003).  This lack of 
access can lead to delays in diagnosis and in seeking medical care when needed (Freeman, 
1993).  
 As is the case with treatment and care, racial and ethnic minorities also have 
experienced limited access to participation in HIV clinical trials.  Early in the course of the 
HIV epidemic, AIDS advocates were instrumental in increasing the accessibility and 
acceptability of clinical trials for homosexual White men (Wachter, 1992).  Pressure from 
patient-activists and clinicians resulted in major changes in the procedures in which research 
protocols were initiated, the site of research trials, criteria for entry into trials, end points for 
trials and the definition of the overall research agenda (El-Sadr & Capps, 1992).  Today, the 
populations most likely to enroll in clinical trials still closely reflect the demographics of 
those enrolled in the beginning of the epidemic rather than the rising trend of new infections 
among racial and ethnic minorities.  Gifford et al. (2002) identified White race, male sex, a 
history of homosexual contact, education beyond high school, an annual income of more than 
$25,000, private health insurance and residence within one mile of a center conducting a trial 
as factors associated with participating in a trial.  Predictors for non-enrollment include non-
Hispanic Black race, greater distance from medical centers conducting trials, lower 
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educational attainment and lack of health insurance.  Clinical trials are time intensive, often 
requiring travel to and from major medical centers in large urban areas.  Travel can be 
burdensome and overwhelming, particularly for trials that require visits several times a 
month over the course of months or years.  In sum, key reasons for why minorities might not 
participate in clinical trials in general (Plummer et al., 2002), and HIV/AIDS trials in 
particular (Sengupta et al., 2000), are similar to the barriers they face for HIV care (Heckman 
et al., 1998a). 
Minority Representation in Clinical Trials 
Appropriate representation of minorities in HIV/AIDS clinical trials is important for 
producing results that are generalizable to the populations most affected by the epidemic.  
Cargill and Stone (2005) reported that in the early years of the epidemic when Retrovir (an 
antiretroviral therapy treatment) was widely prescribed, some African American patients 
experienced hyperpigmentation, or darkening of the nails and skin as a side effect.  As a 
result, the treatments presented service providers and their minority patients with side effects 
that previously were unanticipated.  Further, African Americans are already at high risk for 
some of the health problems that HIV medications are known to complicate, including 
hypertension, diabetes, and cholesterol.  Retrovir also may cause anemia, an important 
concern for African Americans because of the high prevalence of anemia already in this 
population.  Similarly, a higher proportion of African Americans are co-infected with HIV 
and hepatitis C as compared to their White counterparts, making liver problems that HIV 
medication can cause another potential problem that is very serious (Cargill & Stone, 2005).  
 Interventions to increase awareness about HIV/AIDS clinical trials and HIV/AIDS 
clinical trial opportunities among African Americans living with HIVAIDS are limited in the 
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literature.  Of those conducted in the United States, all have been in urban areas at, or in 
close proximity to, a major medical center conducting trials.  No intervention studies to date 
have been conducted with rural African Americans living with HIV/AIDS.  Of the studies 
that exist, the report of “minority” or “people of color” often has been broadly defined--not 
explicitly referencing inclusion of historically under-represented racial and ethnic minorities 
(i.e. African Americans or Latinos), which limits the extent to which findings can be 
generalized to these populations.   
Summary 
In summary, the persistent problem of low participation by African Americans in 
HIV/AIDS clinical trials has three implications for the field of public health.  With regard to 
research, advances in treatment and innovations in care are limited in the extent to which 
their effects can be generalized to the U.S. population.  With regard to public health practice, 
African Americans living with HIV/AIDS have limited access to the newest therapies and 
treatments that may benefit their health and provide an avenue for supplemental treatment 
and care of their disease.  For some patients, particularly those in underserved, rural 
communities, clinical trials may represent their best opportunity for life-extending care.  
Finally, to increase minority participation in HIV/AIDS clinical trials, the field of public 
health needs to pilot interventions that are: (a) informed by socio-behavioral theory to 
elucidate our understanding of pathways through which specific factors contribute to or 
mitigate low participation, and (b) in addition to rigorous outcome evaluations, include 
comprehensive process evaluations to document the intermediate effects from specific 
intervention inputs and activities.   
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Purpose, Specific Aims, and Rationale 
 The purpose of this dissertation is to present the methods and findings from a process 
evaluation of Project Education and Access to Services and Testing (EAST), a multilevel 
intervention that targeted rural, African Americans living with HIV/AIDS and their local 
service providers.   The goal of Project EAST’s intervention was to increase awareness about 
clinical trials and clinical trial opportunities offered at the University of North Carolina at 
Chapel Hill (UNC); to address misconceptions related to HIV/AIDS research; to increase 
service provider willingness to refer eligible African American clients living with HIV/AIDS 
to clinical trials; and to increase African American client willingness to participate in a 
clinical trial.  This study was funded by the National Institutes of Nursing Research (NINR), 
the UNC Clinical and Translational Science Award (CTSA), and the UNC General Clinical 
Research Center (GCRC).  The Project EAST intervention was a collaborative effort among 
UNC Schools of Medicine, Dentistry, Nursing, and Public Health and five community health 
centers in North Carolina.  The parent study was conducted from October 2006 through 
December 201l, with intervention sessions occurring May 2010 through June 2011.  The 
dissertation study will evaluate intervention sessions that took place at two of the five 
community-based clinics from May 2010 through November 2010.   
  To date, there has not been a thorough process evaluation conducted for interventions 
to increase historically underrepresented racial and ethnic minority participation in clinical 
trials broadly, or specific to HIV/AIDS research.  Thus, as a newly developed intervention, it 
was critical for Project EAST to examine its intervention’s context, recruitment, fidelity, 
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dose delivered and dose received to better understand the implications for generalizability in 
comparable populations.  Hence, the specific aims for this dissertation study were to:  
1.   Evaluate the implementation of an educational HIV clinical trial intervention with rural, 
African American people living with HIV/AIDS (PLWHA). 
a. Reach:  (i) To what extent did the intervention reach the intended number 
of participants?  (ii) What proportion of participants completed all 
program sessions?  
b. Context: What larger physical, social, and political factors affected 
implementation of the intervention?  
c. Recruitment: (i) What planned and actual recruitment procedures were 
used? (ii) What were the barriers to recruitment? (iii) What were the 
barriers to maintaining involvement? (iv) Were the set recruitment goals 
of clients met? 
d. Fidelity: To what extent was the intervention implemented as intended?   
e. Dose delivered: (i) To what extent were all of the intervention components 
provided? (ii) To what extent were all intervention materials used? (iii) To 
what extent was all of the intended content covered? (iv) To what extent 
were all of the intended methods, strategies, and activities completed? 
f. Dose received: (i) To what extent were participants present at intervention 
activities?  (ii) How did participants react to specific aspects of the 
intervention? (iii) How satisfied were participants with the intervention?  
 
 
 7
 
2.  Evaluate the implementation of an educational HIV clinical trial intervention with 
rural service providers. 
a. Reach:  (i) To what extent did the intervention reach the intended number 
of participants? (ii) What proportion of participants completed all program 
sessions?  
b.   Context: What larger physical, social, and political factors affected 
implementation of the intervention?  
b.  Recruitment: (i) What planned and actual recruitment procedures were 
used? (ii) What were the barriers to recruitment? (iii) What were the 
barriers to maintaining involvement? (iv) Was the set recruitment goal of 
service providers met? 
a. Fidelity: To what extent was the intervention implemented as intended?   
b. Dose delivered: (i) To what extent were all of the intervention components 
provided? (ii) To what extent were all intervention materials used? (iii) To 
what extent was all of the intended content covered? (iv) To what extent 
were all of the intended methods, strategies, and activities completed? 
c. Dose received: (i) To what extent were participants present at intervention 
activities? (ii) How did participants react to specific aspects of the 
intervention? (iii) How satisfied were participants with the intervention? 
This study was designed to systematically assess intervention implementation using available 
process evaluation data collected on Project EAST.  The goal of this assessment was to 
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measure the extent to which the multilevel intervention was carried out as planned and to 
further explore what factors may have influenced implementation.  
Organization of this Dissertation  
 Chapter 2 reviews several bodies of literature related to racial and ethnic minority 
enrollment in HIV/AIDS clinical trials.  Specifically, it synthesizes current understanding 
about: (a) the HIV/AIDS epidemic in the rural Southeast and North Carolina, (b) history of 
clinical trials research, (c) racial and ethnic minority participation in clinical trials, (d) 
barriers to clinical trial participation, (e) interventions to increase minority participation in 
HIV clinical trial research, (f) service provider involvement in clinical trial research, and (g) 
process evaluation research.  Chapter 3 describes Project EAST’s intervention study as well 
as the theories used to inform the intervention.  Chapter 4 gives an overview of the 
methodology and data sources collected for the process evaluation of the intervention.  
Chapter 5 details the process evaluation findings of the intervention.  Chapter 6 revisits the 
dissertation study aims to determine the extent to which the intervention was implemented as 
designed, describes limitations and strengths of the dissertation study, and details 
implications of the process evaluation findings for public health research and practice.   
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CHAPTER 2 
REVIEW OF THE LITERATURE 
 To provide the context and rationale for this study, this chapter presents a review of 
relevant literature on: (a) the HIV/AIDS epidemic in the rural Southeast and North Carolina, 
(b) history of clinical trials research, (c) racial and ethnic minority participation in clinical 
trials, (d) barriers to clinical trial participation, (e) interventions to increase minority 
participation in HIV clinical trial research, (f) service provider involvement in clinical trial 
research, and (g) process evaluation research. 
The HIV/AIDS Epidemic in the Rural Southeast and North Carolina  
 North Carolina is located on the eastern coast of the United States and is home to 
more than 9.5 million people (U.S. Census Bureau, 2010).  The state has 100 counties with 
the majority of its African Americans residents live in the eastern part of the state.  Twenty 
percent of the total population is African American, nearly double the representation (12%) 
of African Americans in the nation.  Seventy-eight percent of adults older than 25 have a 
high school degree, and 22% have at least a bachelor’s degree.  The median household 
income is $44,772, with a mean of 2.5 people per household.  The primary industries are: 
manufacturing, agriculture, textiles and retail.  Twenty percent of the state’s population lives 
below the federal poverty level. 
 According to the Centers for Disease Control and Prevention, during the past several 
years, the number of individuals with HIV/AIDS in the U.S. South has exceeded  
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those in all other regions despite the paucity of major metropolitan areas in the U.S South 
(Centers for Disease Control and Prevention, 2010).  In North Carolina, the estimated 
number of living HIV/AIDS cases reported in 2008 was 23,356.  The cumulative number of 
HIV disease cases reported in North Carolina was 35,346.  Among the HIV disease cases 
diagnosed in 2007, African Americans represented 62% of the total.  The HIV incidence rate 
for adult/adolescent cases was 78.2 per 100,000 for African Americans; 37.9 per 100,000 for 
Hispanics, and 10.7 per 100,000 for Whites (North Carolina Department of Health and 
Human Services, 2010).   Rural residents were more likely to live in poverty, less likely to 
have health insurance, and less likely to be on antiretroviral therapy as compared to urban 
residents.  Without insurance, rural residents are less likely to seek medical care or mental or 
social services.  Additionally, rural areas had fewer healthcare service providers with HIV 
expertise (Nguyen & Whetten, 2003).   In North Carolina, as is the case for many other states 
in the region, the counties with the highest prevalence of AIDS are rural.  As the HIV/AIDS 
epidemic continues to burgeon in the rural Southeast, interest in prevention and research 
efforts has been growing in this region.  In North Carolina, this research has ranged from 
studies exploring HIV transmission (Adimora et al., 2006), concurrent partnerships (Adimora 
et al., 2004), HIV prevention among adolescents (Coker-Appiah et al., 2009; G. Corbie-
Smith et al., 2010),  access to care for incarcerated populations (Rosen et al., 2004) and the 
needs of African American women with HIV (Black & Miles 2002).  Project EAST was the 
first intervention study to conduct HIV/AIDS clinical trials outreach among rural populations 
in this region.   
The data for the dissertation study came from two community-based clinics in a rural 
community in the eastern part of North Carolina.  Clients resided in one of three contiguous 
 11
counties served by the clinics.  The counties are among those with the highest AIDS case 
rates in the state, with two of the three counties ranking among the top 10 counties in the 
state (25.9 and 20.3 per 100,000, respectively).  The third county was ranked 17th with an 
average rate nearly 1.5 times that of the state.  Table 1 details AIDS trends in these three 
counties from 2007 through 2009. 
 
 
 
 
 
 
 
History of Clinical Trials Research 
 An important breakthrough in the treatment of HIV was the development of 
antiretroviral medications to inhibit replication of the virus, thus preventing clinical 
progression of immunosuppression and development of opportunistic infections. These 
medications have significantly decreased mortality among people living with HIV/AIDS 
(PLWHA) and clinical trial studies have been the backbone of drug development.  Clinical 
trials are defined as studies that are developed to test the effectiveness of an intervention in 
treating or preventing disease (National Institutes of Health, September 20, 2007).  All 
medications must go through at least three phases of clinical trial research prior to approval 
from the United States Food and Drug Administration (FDA).  This process is essentially a 
systematic assessment to determine if drugs are safe and effective.  In Phase I trials, 
researchers test a new medication or treatment with a small number of individuals initially to 
assess the pharmacologic action, metabolism, and safety of the treatment, determine a safe 
 
 Table 1:Project EAST Study County AIDS Rate 
County 
AIDS Case Rate  (per 100,000) RANK 
(among all NC counties) 2007 2008 2009 Average 
A 17.1 26.6 34.2 25.9 2 
B 10.8 12.8 16.0 13.2 17 
C 20.9 15.5 24.5 20.3 4 
North Carolina 9.3 10.1 10.4 9.9 n/a 
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dosage range, and identify side effects.  Participants for Phase I trials may be healthy 
volunteers or people with the disease of interest.  In Phase II trials, the medication or 
treatment is given to a larger group of people with the disease to determine if it is effective 
and to further evaluate its safety.  If these early phase trials suggest preliminary evidence of 
effectiveness, the medication or treatment is then given to larger study populations in a Phase 
III trial to confirm its effectiveness, monitor side effects, compare it to commonly used 
treatments, and collect information that will allow the drug or treatment to be used safely.  
After the medication has proven to be safe and effective, approval is given by the FDA and 
the medication is then available for prescription to the public.  If a medication requires 
additional testing, a Phase IV post-marketing trial may be conducted to gather information on 
the drug’s effect in various populations and to assess side effects associated with long-term 
use (National Institutes of Health, 2007). 
 In response to the growing number of HIV cases and high mortality rate in the earlier 
years of the epidemic, the National Institutes of Health established AIDS Treatment and 
Evaluation Units throughout the United States to conduct clinical trials research on treatment 
medications and regimens.   In 1987, the AIDS Clinical Trials Group (ACTG) was 
established by the National Institute of Allergy and Infectious Diseases (AIDS Clinical Trials 
Group Network, 2010).  ACTGs are composed of, and directed by, leading clinical scientists 
who conduct research on HIV prevention, HIV disease and treatment, HIV-associated 
opportunistic infections, and complications of HIV therapy.  The ultimate goal of the ACTG 
is to identify medications and other treatment options that will result in the successful control 
of HIV as well as the prevention and treatment of HIV-related co-morbidities in infected 
persons.  The UNC AIDS Clinical Trials Unit (ACTU) was established in 1987 and 
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continues to provide access to clinical trials to individuals living in and around North 
Carolina and at partner sites around the globe.   
 Depending on PLWHA characteristics and stage of diagnosis, there are many types of 
HIV clinical trials conducted by the UNC ACTU for which potential participants could be 
eligible.  Studies are available for PLWHA who have never taken an HIV medication, those 
who have an acute or recent HIV infection, individuals who are successfully suppressed or 
those for whom treatment is failing, as well as select studies for women, persons with 
complications of HIV, and pharmacokinetic studies used in the early development of 
medication (UNC AIDS Clinical Trials Unit, 2010).  Although a participant may be eligible 
for more than one HIV/AIDS clinical trial, he or she can usually only participate in one 
antiretroviral drug trial at a time.  PLWHA who are recruited and interested in co-enrolling in 
trials on the treatment of other HIV-related or unrelated conditions are open to do so with 
approval and screening from research primary investigators.  Table 2 details eligibility 
criteria for specific trials.    
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Table 2: Types of HIV Clinical Trials 
Trial Type Eligibility Criteria 
Treatment naïve Participants who have never taken any medication to treat their HIV infection.   
Acute and Recent 
Infection 
Participants who have been infected recently with HIV.  In the days immediately 
after infection, HIV replication is extremely rapid, and the virus copies itself over 
and over again, resulting in an extremely high amount of HIV in the blood. The 
period known as acute HIV infection can be referred to by different names such as 
primary HIV infection, acute retroviral syndrome, and acute HIV syndrome.   
Treatment 
experienced: 
suppressed 
Participants who are/have been on HIV medication and whose viral load is at less 
than 50 copies/mL of blood 
Treatment 
experienced: 
failing 
Participants who are/have been on HIV medication but the regimen no longer 
works (this can occur if the virus is already resistant to the drug the individual is 
taking; failure also can occur if the medication is not taken on a consistent basis). 
Women's studies Female participants, including those who are or would like to get pregnant.  
Pharmacokinetic/ 
Laboratory Studies 
These studies establish the correct dose of medication, to see how the body 
processes the drug, and how the drug affects people of different genders and races.  
Pharmacokinetic studies also look at drug concentration in other compartments 
such as semen or saliva. 
Complication 
studies 
Participants who have complications associated with their HIV.  Examples include 
neurologic, metabolic, and opportunistic infections 
HIV negative Participants who are not infected with the virus (usually partners); useful for 
vaccine development. 
 
Minorities and Clinical Trials 
 While enrollment data of racial and ethnic minorities in HIV clinical trials is limited, 
cancer clinical trials give insight into these trends.  African American enrollment in cancer 
clinical trials declined from 1996-2002 in the United States, accounting for 11% of all 
participants in 1996 to 7.9 % of all participants in 2002.  Numbers are likely to be lower in 
rural areas, as transportation to tertiary care centers limits the extent to which eligible 
participants can attend screening and follow-up appointments.  Data collected by the UNC 
ACTU indicated that North Carolina counties with the lowest participation rate in HIV 
clinical trials have the highest prevalence of HIV/AIDS and are rural and are more than an 
hour’s drive from the ACTU facilities in Chapel Hill.  Furthermore, these underrepresented 
counties were among those with the highest levels of poverty and density of minority 
populations. 
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Unpublished data collected by the UNC Center for AIDS Research (CFAR) indicated 
that 31% of HIV-infected patients attending the UNC Infectious Diseases (ID) Clinic live in 
areas with a population of less than 50,000; 18% live in areas with 50,000.  However, the 
major medical centers where HIV clinical care is available are located in more populated 
counties.  The majority of rural NC PLWHA must travel a significant distance from their 
homes to receive care at the UNC Infectious Disease Clinic: 23% of the patients travel 31-60 
miles and 39% travel 61-120 miles.  In short, HIV-related clinical trials, especially trials of 
initial therapy, are least accessible to PLWHA who reside in the very places from which the 
data indicate are the least represented.  
Barriers to Clinical Trial Participation 
 A major barrier to African American clinical trial participation is mistrust of the 
medical establishment, as the relationship between African Americans in the United States 
and the medical establishment has been challenged by racial discrimination and 
disempowerment (Smith & King, 2009).  Perhaps the most well-known of these is the 
Tuskegee Syphilis Study conducted from 1932-1972 by the U.S. Public Health Service with 
African American sharecroppers in Tuskegee, Alabama (Brandt, 1978).  Over the course of 
this 40-year period, researchers withheld treatment from the syphilitic sharecroppers in the 
study in order to observe the natural progression of the disease--despite treatment becoming 
available eight years after the study was initiated.   While study participants received medical 
examinations, none were told they were infected with syphilis, and outside agencies were 
prevented from supplying treatment to any participants enrolled in the study.  Instead, the 
sharecroppers were told they were being treated for “bad blood”.  The inducements for 
participation included free medicine, burial costs, and transportation to and from the hospital.  
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The residual unrest from the Tuskegee Syphilis Study precipitated a formal apology in 1997 
from President Bill Clinton on behalf of the United States Government. 
 Perhaps a less well known ethical abuse is that of Henrietta Lacks, an African 
American who developed gynecological bleeding and sought treatment at Johns Hopkins 
University, the only local major hospital in the area that offered care for African Americans 
(Lucey, Nelson-Rees, & Hutchins, 2009).  During the surgery (and while she was 
anesthetized), her doctor removed a small piece of her healthy cervix and a small piece of her 
cancerous tissue.   Mrs. Lacks did not give consent for the removal of these tissues, nor was 
she made aware of their removal after the procedure.  Instead, the samples were sent to Dr. 
George Otto Gey, who up to that point was unsuccessful in developing techniques to grow 
cancerous cells outside of the body.  This was important to research at the time, as scientists 
needed cells that would survive long enough outside of the human body to experiment in 
ways that could not be done in the human body.  Mrs. Lacks succumbed to her cervical 
cancer at the age of thirty-one, just a few short months after radiation treatment.  On the very 
day that she died, Dr. Gey announced his discovery of an “immortal” line of cells (Javitt, 
2010).  To maintain the anonymity of the origin of the cells, he used the first two letters of 
Mrs. Lacks’ full name, Henrietta Lacks, thus naming the cells “HeLa” cells.  HeLa cells have 
been the backbone of medical and biological research, with demands from all over the world 
for research including gene mapping, in vitro fertilization, cancer, AIDS and countless other 
research endeavors including the polio vaccine which was widely used in the 1950s.  Federal 
legislation has since been developed to protect patients’ rights, but despite these protections, 
minority trust in medical research continues to influence enrollment in clinical trials (Corbie-
Smith, 1999).   
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Fear of experimentation, lack of knowledge about research, language barriers and 
lack of access to clinical trials have been documented in the literature (Corbie-Smith, 
Thomas, & St. George, 2002; Corbie-Smith et al., 2003; Corbie-Smith, Moody-Ayers, & 
Thrasher, 2004; Powell, Fleming, Walker-McGill, & Lenoir, 2008).  Concerns about stigma 
and disclosure also have been noted to outweigh the potential benefits from participating in 
clinical trials (Black & Miles, 2002).  Compared to their urban counterparts, PLWHA in rural 
areas reported even higher constraints to clinical trials research: longer distances to tertiary 
care medical facilities, lack of personal transportation, and the resultant lost income from 
being away from work (Heckman et al., 1998b; Powell et al., 2008).   Table 3 details 
additional barriers documented in the literature related to trial participation for people living 
with HIV/AIDS.  
 
 
 
 
 
 
 
 
 
 
 
 
In rural communities, physicians and other service providers in community healthcare 
practices may be less likely to refer patients to clinical trials because of lack of awareness of 
what participation entails and the increased time and effort these studies pose for already 
Table 3:  Participant Barriers to Clinical Trial Participation 
Physician/institutional mistrust 
Transportation 
Lack of access to research institution 
Inconvenient / lack of time 
Restrictive criteria 
Language barriers 
Side effects/risks 
Lack of awareness about clinical trials 
Patient fear of experimentation, placebo, guinea pig 
Conspiracy against minorities  
Lack of minority physician participation  
Informed consent (too difficult and only protect doctors/research institutions)  
No benefit for African Americans if treatment is found to be effective 
Negative portrayal of community 
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strained medical practices (Kaluzny et al., 1993).   Other service providers noted additional 
barriers to involvement in clinical trial research include inadequate reimbursement, lack of 
access to a clinical research coordinator, concerns about patient safety, and fear of patient 
being lost to other physicians (Powell et al., 2008).  Additional barriers for service providers 
can be found in Table 4. 
 
 
 
 
 
 
 
 
 
 
 
Innovations in clinical trial education and outreach to rural racial and ethnic 
minorities are of the utmost importance, as this population continues to be disproportionately 
affected by the epidemic, yet underrepresented in clinical trial research.  Project EAST’s 
intervention built upon previous intervention research by educating service providers and 
PLWHA concurrently.  This combined approach at the local level within the rural context 
was a novel approach as it relates to clinical trial education, referral, and participation.   
 
Table 4: Barriers to Physician Involvement in Clinical Trial Research 
Attempted participation but denied 
Lack of awareness of clinical trials opportunities 
Lack of time 
Concerns about patient safety 
Inadequate reimbursement  
Not affiliated with a major academic center  
Lack of access to a clinical research coordinator 
Lack of access to an institutional review board  
Patient was lost to other physicians/ being removed from decision-making process 
Poor communication with people conducting trials  
Lack of experience in recruiting racial/ethnic minorities 
Concern about potential adverse effects  
Patient lacks time  
Patient does not understand the need to participate  
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Interventions to Increase Minority Participation in HIV Clinical Trial Research   
 In response to low enrollment of racial and ethnic minorities in clinical trials research, 
many recruitment efforts have been made to increase their participation.  Unfortunately, these 
efforts in the context of HIV are sparse in the literature.  Cancer research, however, has 
provided an important foundation upon which HIV researchers and practitioners can begin to 
develop targeted enrollment strategies.   A few short decades ago, people affected with 
cancer experienced a stigma similar to that experienced by people living with HIV/AIDS 
today.  Discrimination against and isolation of those with cancer were prevalent, both of 
which were partly attributed to misconceptions about cancer and high mortality rates 
experienced by people afflicted by the disease.  Cancer was once referred to as the “Big C” 
because the word itself was still frightening for most people to say.  However, people with 
HIV have an added value attached to their disease, as much of the stigma they face is as a 
result of others’ perceptions of them being punished for engagement in risky behaviors (e.g., 
intravenous drug use, prostitution, promiscuity).  The challenges that patients faced years ago 
very much resemble the challenges that people living with HIV face today.  One researcher 
states, “Before the appearance of AIDS, cancer was the most dreaded disease (Stahly, 
1988).” 
Yancey and colleagues (2006) noted that from 1984 to 1998, an average of six 
publications per year targeted minority enrollment research.  In the six years that followed 
(1999 to 2005), the number of studies nearly tripled to 18.3/year.  A systematic review of 
research studies to increase minority participation in cancer clinical trials also shed light on 
these efforts (Ford et al., 2008).  The review included qualitative, descriptive and cross-
sectional studies, as well as randomized controlled trials.  Of the 65 studies included in this 
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review, 23 targeted African Americans specifically, and of these, two were randomized 
controlled trials (one prevention (Ford, Havstad, & Davis, 2004) and one treatment with a 
pre- and post-assessment of intervention effects (Sears et al., 2003).   An additional study 
was conducted from 1993 to 1996 with rural cancer patients and their local service providers 
in five counties in North Carolina (Paskett et al., 2002).  The intervention included 
installation of a rapid tumor-reporting system, staffing of a nurse facilitator who kept 
physicians informed of clinical trial opportunities for their patients, distribution of a quarterly 
newsletter and lay health advisors to conduct outreach.  This effort included pre- and post-
assessments through surveys with service providers and hospital record data.  An additional 
two studies (Gross & Krumholz, 2005; Randall-David, Stark, Gierisch, & Torti, 2001) in the 
review targeted rural populations as part of their recruitment efforts, but both were 
descriptive studies.  
An exploration of educational intervention studies to increase the participation of 
minority PLWHA in HIV/AIDS clinical trials yielded a small number of behavioral and 
structural interventions, all of which were conducted in urban areas (Gwadz et al., 2010).  
The first study took place at an urban clinic designed for the initial assessment and triage of 
all newly diagnosed patients presenting with HIV infections and seeking primary care.   The 
intervention consisted of a research associate providing information to each patient for five 
minutes about the purpose, role, and availability of HIV clinical trials (Freedberg et al., 
2001).  During the intervention, the research associate answered general questions the patient 
may have had about clinical trials, and patients who expressed further interest in trials were 
given a pamphlet and contact information for additional questions and concerns.  The 
intervention helped reduce demographic differences in HIV clinical trial enrollment (when 
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compared to a historical cohort at the same clinic).  Race was dichotomized for this study, 
with participants categorized as “White” or “persons of color”; the latter consisted of African 
Americans, Haitians, Africans and non-White Hispanics.  Over the 20-month study period, 
15.3% of persons of color and 13.0% of Whites enrolled in a trial, however no significant 
differences were found in participation rates between the two groups  (p=.71).    
 The Harlem AIDS Treatment Group, a Community Program for Clinical Research on 
AIDS (CPCRA) center developed a multilevel outreach program that also was carried out in 
an urban clinic setting (El-Sadr & Capps, 1992).  The focus of the study was to increase 
recruitment, enrollment, and adherence to study protocols among PLWHA of color and 
women.  The program included informational materials about HIV/AIDS clinical trials, 
outreach workers who made home visits when needed, transportation for patients for study 
visits, social work services for referrals to necessary ancillary services (e.g., mental health, 
housing), and peer support groups to assist patients with adherence to study protocols.   
Findings for this study were not published. 
 An additional study conducted in Los Angeles consisted of a PLWHA meeting 
individually with a research assistant to discuss the meaning, role, and availability of HIV 
clinical trials at a local clinic in the city (Volkmann, Claiborne, & Currier, 2009).  
Participants also were given brochures with brief descriptions of currently available clinical 
trials and information on who to contact for more information about the trials. After meeting 
with the research assistant, subjects completed a survey to determine their willingness to 
participate in an HIV clinical trial.  Fifty-six percent of the study participants had enrolled 
previously in a clinical trial, and 50% of these individuals were enrolled in a trial at the time 
of the baseline interview.   After completion of the brief educational intervention, 105 
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participants (94%) indicated they would be willing to be contacted about a clinical trial for 
which they might be eligible. Participant demographics were not reported in this study, 
except for gender, and there was a stark imbalance (male participants [n=106, 92%)]; female 
participants [n= 9, 8%].) 
 The ACT2 Project consisted of a peer-driven intervention (PDI) strategy, which was 
developed to increase participation of PLWHA of color in HIV/AIDS clinical trials (Gwadz 
et al., 2010; Gwadz et al., 2011).   The intervention, the ACT2 Project, was a randomized 
controlled trial designed to target barriers at the levels of individuals, their social networks 
and also social and structural impediments associated with healthcare service providers and 
ACT settings.   The ACT2 intervention was grounded in the theory of normative regulation 
and social cognitive theory and used motivational interviewing for intervention participants.   
The primary outcome for the study was screening and the secondary outcome was enrollment 
in a trial.   
The ACT2 intervention was comprised of three group sessions (5.5 hours total), three 
peer-education experiences, and a 30-minute individual session conducted at the ACTU.  
Participants in the control arm received a time-matched and attention-matched health 
education intervention.   Of the 580 participants enrolled in the study, 56% were African 
American and 32% were Latino/Hispanic.   Intervention dose was assessed in this study by 
calculating the number of sessions attended (range 0–2), whether the health education contact 
was completed (yes/no), and total intervention dose (range 0–3). Study results indicated that 
screening was much more likely in the peer-driven intervention than in the control arm 
(adjusted odds ratio=55.0; p<.001); about half of the participants in the intervention arm 
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(46%) were screened compared with 1.6% of controls (Gwadz et al., 2011).  Approximately 
92% of the participants received a full dose of the intervention.    
 Of the previous studies conducted to increase racial and ethnic minority participation 
in HIV/AIDS clinical trials research, none were conducted in rural communities where the 
HIV epidemic is increasing at alarming rates. Additionally, none of the studies mentioned the 
engagement or involvement of a community advisory board (CAB).  While one of the above-
mentioned studies used a theoretical approach to inform intervention development, the 
intervention did not include service providers, one of the most trusted sources for many 
PLWHA seeking treatment and care.  Additionally, these studies lacked a multiple-pronged 
approach to assess the extent to which the intervention was carried out as planned (i.e. reach, 
context, dose delivered, dose received, fidelity and recruitment).    
Provider Involvement in Clinical Trial Research 
 The importance of service provider involvement in the referral process of potential 
trial participants has been documented in the literature (Powell et al., 2008).  Studies on 
minority recruitment in cancer as well as in HIV/AIDS clinical research have reported that 
service providers feel less prepared to discuss clinical trials with minority patients and 
therefore are less likely to inform minority patients about these opportunities.  Further, 
Durlak and Dupre (2008) note that the four service provider characteristics most consistently 
related to implementation of an innovation, or intervention, involve perceptions related to the 
need for, and potential benefits of the innovation, self-efficacy, and skill proficiency.   They 
found that service providers who recognized a specific need for the innovation, believed the 
innovation will produce desired benefits, felt more confident in their ability to do what is 
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expected (self-efficacy), and had the requisite skills were more likely to implement a 
program at higher levels of dosage or fidelity (Durlak & Dupre, 2008). 
To identify community views about increasing participation in HIV clinical trials in 
rural North Carolina, Project EAST staff conducted focus groups with service providers prior 
to intervention development.  Participants in these groups emphasized the importance of 
educating local service providers, as PLWHA were most likely to consult with these 
individuals when considering clinical trial participation.  They further stated that outreach 
should include a variety of healthcare professionals (physicians, physician assistants, nurses, 
nurse practitioners, pharmacists, health educators, case managers and social workers) and 
should include a clear understanding of what clinical trials entail, what to expect if their 
client is enrolled, and consistent feedback and education around recruitment for ongoing 
studies to increase awareness and confidence in the research process.  This mirrors the 
framework provided by Durlak and Dupre (2008) by addressing perceptions, self-efficacy, 
and skill proficiency as it relates to clinical trial participation.  
Process Evaluation Research 
Process evaluation is used to monitor and document program implementation and can 
aid in understanding the relationship between specific program elements and program 
outcomes (Saunders, Evans, & Joshi, 2005).  The importance of process evaluation was 
conceptualized as early as the 1960s, as sociologist Suchman (1967) wrote: 
An evaluation study may limit its data collection and analysis simply to determining 
whether or not a program is successful. . . . However, an analysis of process can have 
both administrative and scientific significance, particularly where the evaluation 
indicates that a program is not working as expected. Locating the cause of the failure 
may result in modifying the program so that it will work, instead of its being 
discarded as a complete failure  
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Across a variety of disciplines, there has been an increasing interest in process evaluation 
research to assist researchers in understanding the mechanisms by which program 
components are expected to influence behavior change (Linnan & Steckler, 2002; Saunders 
et al., 2005).  Process evaluations have been conducted to target a variety of health behaviors, 
including: smoking, nutrition/diet, breastfeeding, cancer prevention and education, physical 
activity, diabetes, depression, fruit and vegetable consumption, HIV/AIDS prevention, and 
prevention clinical trials.  Only a few of these studies were conducted in rural areas with 
African Americans–none with HIV or clinical trials among this population. 
 The increased attention to process evaluation research is due, in great part, to 
researcher awareness of the importance of understanding what specifically contributes to a 
program’s success or failure.  Program evaluation assists researchers in making a very 
important distinction between implementation failure and intervention failure (Harachi, 
Abbott, Catalano, Haggerty, & Fleming, 1999).  This is to say, a program could be deemed 
ineffective if there were no significant effects associated with its outcome, but that could 
have been due to poor program design, poor or incomplete program implementation and/or 
failure to reach sufficient numbers of the target audience (Flay, 1986; Saunders, Evans, & 
Joshi, 2005).   Process evaluation helps to avoid Type III error, drawing incorrect 
conclusions about the effectiveness of an intervention that was not properly implemented 
(Basch, Sliepcevich, Gold, Duncan, & Kolbe, 1985).  Several studies have questioned 
reported ineffective outcome results of studies that lacked thorough assessments of the 
degree to which the program was implemented as intended (Rezmovic, 1982).    Linnan and 
Steckler (2002) recommend a minimum of six process evaluation concepts: context, reach, 
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recruitment, dose delivered, dose received and fidelity, each of which was assessed for the 
dissertation study.   
Context refers to the aspects of the larger social, political, and economic environment 
that may influence intervention implementation. Reach refers to the proportion of intended 
target audience that participates in the intervention; it is often measured by attendance and is 
a characteristic of the target audience. Dose delivered is the number or amount of intended 
units of each intervention or each component delivered or provided.  Dose delivered is a 
function of efforts of the intervention service providers.  Dose received refers to the extent to 
which participants actively engage with, interact with, are receptive to, and/or use materials 
or recommended resources. It also assesses the extent of engagement of participants with the 
intervention. Fidelity is the extent to which the intervention was delivered as planned.  It 
represents the quality and integrity of the intervention as conceived by the developers and is 
a function of the intervention service providers.  Recruitment details the procedures used to 
approach and attract participants.  Each of the aforementioned components can be assessed 
qualitatively or quantitatively.  A thorough process evaluation helps researchers to better 
understand how challenges, adaptations and contextual issues affect internal and external 
threats to validity to study design and implementation (Cook, Campbell, & Day, 1979; 
Glasgow, 2009).  This has been a critical gap in public health research, and limits the extent 
to which research can interpret and translate findings to comparable populations.   
Summary 
  Previous efforts to increase racial and ethnic minority participation in HIV clinical 
trials have been very limited in the literature.  Of the programs developed to date, none have 
targeted rural populations in general or rural, racial and ethnic minorities specifically.  
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Interventions conducted in urban settings have demonstrated successes in increased screening 
among minorities (Gwadz et al., 2011), however there are not clear indicators to understand 
how or why the interventions were successful.  This coupled with a need for researchers and 
practitioners to fully understand challenges, adaptations, and contextual issues as they relate 
to rural, African American PLWHA and their local service providers, demonstrates the need 
for this dissertation study. 
The multilevel approach of Project EAST’s intervention was novel, as previous HIV 
clinical trial efforts did include service providers as part of their outreach efforts.  As this is 
the first study of its kind, it is important to understand how the program was implemented.  
Therefore, the primary aim of the dissertation study was use to evaluate implementation of 
Project EAST’s educational HIV/AIDS clinical trial intervention.    
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CHAPTER 3 
PROJECT EDUCATION AND ACCESS TO SERVICES AND TESTING (EAST) 
The parent study, Project EAST, consisted of three phases focused on: (a) defining 
community and individual factors that influence willingness of rural, racial and ethnic 
minorities to participate in HIV/AIDS clinical trials; (b) refining a theory-based, culturally 
responsive outreach strategy to increase referral to, and enrollment in clinical trials and 
evaluate the acceptability of components of this outreach from the perspective of community 
members, service providers, and people living with HIV/AIDS (PLWHA); and (c) 
determining the feasibility of the outreach sessions to increase service provider willingness to 
refer eligible PLWHA to open HIV/AIDS clinical trials and increase eligible PLWHA 
willingness to participate in HIV/AIDS clinical trials.  
The principal investigator of Project EAST, Dr. Giselle Corbie-Smith, is a professor 
of social medicine with expertise in community-based research and has published extensively 
on barriers to clinical trial research among minority populations (Corbie-Smith, Moody-
Ayers, & Thrasher, 2004; Corbie-Smith, Thomas, & St. George, 2002; Corbie-Smith et al., 
2003). The research team consisted of investigators from the University of North Carolina at 
Chapel Hill Schools of Medicine, Dentistry, Nursing and Public Health with wide-ranging 
expertise in health disparities research, clinical trials coordination and administration, rural 
population outreach and education, and community-based research.  The author of this 
dissertation study served for three years as a research assistant with Project EAST and two 
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years as project coordinator an additional two years.   
Gaining Entrée: The Community Advisory Board (CAB) 
Given the legacy of mistrust in minority communities of medical research (Braunstein 
et al., 2008; Corbie-Smith, Thomas, & St. George, 2002) and the sensitive nature of HIV, 
guidance from a community advisory board (CAB) was critical for community buy-in, 
recruitment for the study, implementation of the intervention (Fouad et al., 2000; Michaels & 
Seifer, 2007; Seifer, Michaels, & Collins, 2010) and dissemination of findings (Fouad et al., 
2001; Michaels & Seifer, 2007). Partnerships that include the establishment and engagement 
of a CAB can enable researchers to engage minority communities with high rates of HIV but 
not currently accessing clinical trials, build on trusting community relationships to improve 
minority participation in these areas, and provide a vehicle to develop and provide outreach 
to HIV clients and their local service providers around research participation.  Moreover, the 
National Institute of Allergy and Infectious Diseases (NIAID), which requires researchers in 
its clinical trials network program to include community members as part of their efforts, has 
incorporated these principles since the 1980s and has provided a framework for other types 
of clinical trials research (Community Recommendations Working Group of Community 
Partners, 2009). The Project EAST CAB was charged with providing overall guidance to the 
study team by aiding in the refinement and translation of all research materials, participating 
in the development of the focus group and interview guides for formative data collection, 
advising on qualitative data interpretation, and assisted with recruitment of HIV advocates 
and peer outreach workers prior to implementation of the intervention.  
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Intervention Theoretical Foundation  
   Based on findings from interviews conducted with clients and focus groups 
conducted with service providers and community leaders during formative data collection, 
the research team guided intervention development using the intervention mapping approach 
(Bartholomew, Parcel,  & Kok 1998). Constructs from the theory of reasoned action (TRA) 
and social cognitive theory (SCT), in addition to the social support (SS) framework were 
found to be relevant for understanding the mechanisms through which the intervention could 
influence referral to, and participation in, HIV/AIDS clinical trials among study participants.  
Theory of Reasoned Action.  The theory of reasoned action (TRA) was conceptualized by 
Ajzen and Fishbein in 1975 and has been used to explain a variety of health behaviors.  This 
theory asserts that a person’s intention is the strongest predictor for a given behavior, and is a 
direct result of one’s attitude and subjective norms about the behavior (Ajzen & Fishbein, 
1980).  While this theory has not been used for explaining HIV clinical trial participation, it 
has been applied in a national study evaluating the efficacy of HIV prevention counseling in 
changing high-risk sexual behaviors and preventing new sexually transmitted diseases and 
HIV (Fishbein et al., 2001; Fishbein, Hennessy, Yzer, & Douglas, 2003; Kamb et al., 1998).  
TRA also has been used to explain service provider referral behaviors for emergency 
contraception (Sable, Schwartz, Kelly, Lisbon, & Hall, 2006). 
Social Cognitive Theory.  Social cognitive theory (SCT) is one of the most frequently used 
and robust health behavior change theories (Glanz, Rimer, & Viswanath, 2008).  It explores 
the interactions of people and their environments, as well as psychosocial determinants of 
health behavior.  The relationship of these three components is referred to as a reciprocal 
determinism, whereby each domain interacts reciprocally by influencing another (Bandura, 
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1986).   It is important to note however, that the strength of influence of each concept may 
differ and is not necessarily equal.  SCT is very complex and consists of several constructs, 
two of which were used for the development of the educational intervention: self-efficacy 
and outcome expectations.  Self-efficacy is defined as one’s confidence to perform a 
particular behavior.   This construct has been described by Bandura as the most important 
prerequisite for behavior change (Bandura, 1977).  Outcome expectations are defined as the 
anticipatory outcomes of a behavior.   In other words, a person learns that certain outcomes 
occur in a given situation and expects them to occur when that situation presents itself again.   
Social Support.  Social support is defined as the provision of aids and services from 
individuals within a person’s social network (Heaney & Israel, 1997).  The four types of 
social support include: emotional, appraisal, informational, and instrumental.  Emotional 
support is the most commonly recognized form of social support and includes empathy, 
concern, caring, love, and trust.  Appraisal support involves transmission of information in 
the form of affirmation, feedback and social comparison. Informational support includes 
advice, suggestions, or directives that assist the person to respond to personal or situational 
demands.  Instrumental support is the most concrete direct form of social support, 
encompassing help in the form of tangible aid (money, time, childcare, transportation).  This 
framework has not been applied in the context of HIV clinical trial participation, but of the 
interventions targeting trial participation, two have included a peer component as a part of 
the dissemination of information about clinical trials. Evaluation of the HIV clinical trial 
interventions with peer components did not include assessments focused the type of support; 
rather dichotomous values were calculated to indicate whether the intervention participant 
received peer services or not (Volkmann et al., 2009).  
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Series Layout 
 The intervention was designed so that service provider and client series could be 
implemented in a staggered, concurrent layout (see Figure 1).  The goal was to complete half 
of the service provider series prior to implementation of the client series, thus affording 
service providers an opportunity to become familiar with concepts in the event that their 
client had questions regarding trial participation.  This staggered, concurrent layout allowed 
comparable content to be covered for service provider and clients, through a variety of 
theory-based methods and strategies (Bartholomew et al., 1998).   The intervention was 
developed to reach six rural service providers and 40 of their racial and ethnic minority 
clients living with HIV/AIDS.   To ensure effective group interaction and meet the 
recruitment goal of 40 clients, the intervention rolled out in three consecutive groups, with 
12-15 clients in each group.  Figure 1 depicts the layout of one service provider group and 
the first client group, as intended.  Subsequent client groups were scheduled to occur 
sequentially, with a one to two week interval between groups to allow research staff to 
regroup and prepare between groups. 
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 Client Series.  The client series consisted of six sessions that took place at a location 
that was accessible for all participants, including local libraries or community centers.  The 
series was implemented over the course of three weeks, with two sessions implemented one 
day per week (See Figure 1).  Each session ranged between 60 and 90 minutes.  Each client 
received $75.00 worth of Wal-Mart gifts cards for completing the series (including baseline 
and immediate-post survey completion) and a $25.00 Wal-Mart gift card for completion of a 
six-month follow-up survey.  Additionally, $10.00 gasoline cards were provided for 
participants who used a personal vehicle for transportation and needed assistance with 
transportation costs.    
 Each session’s materials were informed by review of the literature on participation in 
clinical trial research in general and participation in HIV clinical trials in particular.  
Formative data from client, service provider, and community leader interviews in the parent 
study guided intervention development.  The intervention mapping (IM) approach informed 
this process (Bartholomew et al., 1998). The client series provided information about the
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conduct of clinical research, information about ongoing HIV/AIDS trials for which clients 
may be eligible, informed consent, participant rights, what to expect as part of their 
participation in a clinical trial and how to get support as part of their decision-making 
process, as well as other components raised in the client interviews the formative phases of 
the study (Table 5).  All session materials, activities, and evaluation tools were guided by the 
results of the qualitative data from the first phase of the study and by the intervention 
mapping (IM) process.  More detail is provided in Appendix A as to what activities were 
developed to cover the aforementioned content.  If questions arose during the session that 
were not covered as part of the curriculum content, facilitators were instructed to place them 
in the “parking lot,” a flip chart used to document participant questions.  Questions from the 
“parking lot” were then e-mailed to two co-investigators on the study who also were 
physicians at the UNC ACTU.   The session facilitator then shared the co-investigators’ 
responses to these questions to clients attending the subsequent session.  After completion of 
their series, clients received postcards every six weeks that reviewed and emphasized 
important concepts from session materials and presentations.   
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Table 5: Client Intervention Series  
Session 1 
Provide basic information on clinical trials.  Participants will learn what clinical trials 
are, their purpose and function, the various phases of clinical trials, characteristics of 
randomized clinical trial research, such as: randomization, blinding and the importance 
of minority participation in clinical trials. Additionally, clients will learn how research 
fits into HIV care. 
Session 2 
Provide information about the different types of clinical trials.   Participants will learn 
more about the referral process through an interactive exercise. Participants will also be 
equipped with necessary tools and skills for asking questions about clinical trials. 
Session 3 
Provide information about ethical issues related to clinical trials, including how 
participant rights are protected.  Additionally, participants will identify ways to 
overcome common barriers associated with clinical trial participation.   
Session 4 
Focus on the importance of seeking support as part of the decision-making process.  
Emphasis was placed on enhancing existing social networks or creating new networks.  
Participants will learn about communication as it relates to seeking support for trial 
participation.  
Session 5 
Provide an opportunity to locate clinical trial opportunities and identify referral sources.   
Additionally, participants will learn how to effectively communicate with their service 
provider about clinical trial opportunities and to seek out and connect to clinical trial 
resources. 
Session 6 
Culmination of information from previous sessions to help participants understand key 
aspects of clinical trials.  Additionally, participants will have an opportunity to 
communication with a referral source, an ACTU physician. 
 
Service Provider Series.  The service provider series consisted of four 60-70 minute sessions.  
Like clients, each session’s materials were informed by review of the literature on 
participation in clinical trial research in general and specific to HIV, as well as formative data 
from the parent study.  All session materials, activities, and evaluation tools were guided by 
formative data from the first phase of the study (clients, service providers, and community 
leaders) and by the intervention mapping (IM) process.  In keeping with EAST co-
investigator experience and existing literature, shorter, intense sessions were developed for 
service providers (as compared to client sessions).    
Content included information about the conduct of clinical research, information 
about ongoing HIV/AIDS trials for which their patients may be eligible, the role of the 
service provider and how their relationships with HIV-positive clients may influence trial 
participation, what to expect if their client or patient participates in a clinical trial and how to 
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support them in their decision.  Service provider sessions also had a “parking lot” to 
document questions that facilitators may not have been able to answer during the session.   
The session facilitator then shared the co-investigators’ responses to these questions to 
service providers attending the subsequent session.  Table 6 details session specific content 
for service providers; more detail is provided in Appendix B regarding activities that were 
developed for each service provider session.   Each service provider received $75.00 for 
completing the series (including baseline and immediate-post survey completion) and $25.00 
for completion of a six-month follow-up survey.  As service provider sessions took place in 
the facility in which they were employed, transportation costs were not applicable for this 
group. 
 
 
 
Table 6: Service Provider Intervention Series 
Session 1 
Provide basic information on clinical trials.  Participants will learn what clinical trials are, 
their purpose and function, the various phases of clinical trials, and characteristics of 
randomized clinical trial research, such as: randomization and blinding.  Will also provide 
information about ethical issues related to clinical trials, including how participant rights 
are protected.  Additionally, service providers will learn how research fits into HIV care 
and how to support their clients in a neutral, balanced way as part of the decision making 
process.  Finally, the session will service providers understand the importance of minority 
participation in clinical trials.   
Session 2 
Inform service providers of their role of communicating with clients in a balanced and 
neutral way Also, service providers will be provided with necessary tools and skills for 
addressing questions about clinical trials. 
Session 3 
Provide an opportunity for service providers to locate clinical trial opportunities and 
identify referral sources. It also covered the importance of establishing networks locally 
and at major medical centers to help enroll clients in clinical trials. Service providers 
were encouraged to think about where and how they can become a resource to each other 
and to their clients.   
Session 4 
Culmination of information from previous sessions to help service providers understand 
key aspects of clinical trials, effectively communicate with clients about clinical trial 
opportunities, seek out and connect to clinical trial referral resources, and to support their 
clients through the decision-making process. Strong emphasis was placed on skills and 
demonstration in this session. 
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Logic Model  
 A logic model is a pictorial representation of how an intervention is expected to work, 
as well as the theory and assumptions underlying the intervention (McLaughlin & Jordan, 
1999).  These models have been widely used in public health research across a variety of 
behavioral interventions (Hawkins, Clinton-Sherrod, Irvin, Hart, & Russell, 2009; Helitzer, 
Willging, Hathorn, & Benally, 2009; Kaplan, Calman, Golub, Ruddock, & Billings, 2006; 
Livingood, Winterbauer, McCaskill, & Wood, 2007; Price, Alkema, & Frank, 2009).  A logic 
model consists of five components: inputs, activities, outputs, short-term and long-term 
outcomes and impacts (W.K. Kellogg Foundation, 2001).  Inputs include the human, 
financial, organizational, and community resources that a program has available to direct 
toward development of intervention activities.  Activities are the components of the 
intervention, or program (e.g., lectures, role-plays, videos).  Outputs refer to the direct 
products of program activities and may include types, levels, and targets of services to be 
delivered by the program.  These could include the number of people taking part in the 
intervention or the number of sessions offered.  Outcomes are specific changes in program 
participants’ behavior, knowledge, skills, status, and level of functioning.  Short-term 
outcomes are typically attainable within one to three years, while long-term outcomes are 
attainable within four to six years.  Impacts are the fundamental intended or unintended 
change occurring in organizations, communities or systems as a result of program activities 
within seven to 10 years. Due to the long duration of impact assessments, evaluation often 
occurs after the conclusion of project funding (W.K. Kellogg Foundation, 2001).  The logic 
model for Project EAST can be found in Figure 2.  
 
  
Figure 2: Project EAST Logic Model 
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The inputs for Project EAST detail the individuals (staff, volunteers, community 
partners and members of the community advisory board) and resources (research, travel, 
money, materials) that supported the development of intervention activities.  Activities 
for clients and service providers included: brainstorming, group discussions, role-plays, 
skits, small group work, lectures, video, newsletters, and homework assignments.  
Outputs detailed the number of outreach sessions held, the number of attendees and the 
cumulative total numbers of hours from all sessions for each group.  Short and long-term 
outcomes are presented in more detail in the logic model.  These outcomes will not be 
discussed for the purposes of the dissertation study, as the assessment of the expected 
behavior changes are part of the outcome evaluation for the parent study. 
 Session Facilitators.   Facilitators consisted of a combination of paid and unpaid 
staff on the research team.  All completed the required human research ethics training 
through the University of North Carolina at Chapel Hill, as well as a three-day training 
comprised of an overview of the intervention study (including the structure and content 
of the client and service provider series), group management skills, and community-based 
research ethics.  At the onset of the facilitator training, all trainees were provided with 
curricula covering the entire intervention study (provider and client series) including 
PowerPoint presentations, handouts, role-play keys with relevant probes, copies of all 
posters used, materials needed, and preparation for the session.   Additionally, facilitators 
were provided with background information about the theoretical foundation of the 
intervention in order to assist with understanding the theoretical objectives that were to 
be met as part of their session.  Each trainee was expected to learn all of the modules for 
both the provider and client series in order to understand how all of the session content 
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syncs together.   After the culmination of the training, each trainee was responsible for 
facilitation of a mock session of their choice and feedback was provided by other trainees 
and the Project EAST research staff leading the training.   The research staff then 
provided individualized feedback for each trainee in a private setting to further detail 
mastery of facilitation skills and session content.   If trainees did not demonstrate 
sufficient mastery, they were offered remediation prior to entry in the field.   
Selection of Study Sites 
 Two regional clinics were identified as potential study sites based on county level 
HIV demographics, service provider composition, number of HIV-positive clients, and 
the clinic’s distance from major medical academic centers.  Like most predominantly 
rural areas, residents in the study counties were generally poorer, had higher 
unemployment rates and were less educated compared to their urban counterparts.  Site 
recruitment began by contacting administration at two community clinics servicing 
clients in Project EAST six-county region.  The project coordinator provided an overview 
of the parent study, the intervention study (including the service provider series and client 
series), and also assisted with determining organizational capacity to: a) assist with 
recruitment and retention of service providers and clients and b) assist with transportation 
for clients (if needed).  Sites were offered an organizational incentive to cover costs 
associated with recruitment of participants, securing meeting space, and tracking of 
participants over the course of the six-month pilot.  After confirmation of interest to 
participate in the study, and administrative approval to participate as a site, the project 
coordinator sent an introduction letter to the site administrator to further explain the 
intervention study with their service providers and clients.  
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At the onset of implementation of the service provider series, one clinic had to 
withdraw due to severe financial and staffing constraints.   Due to recruitment challenges 
at the remaining clinic, a partnering clinic was added to meet the recruitment goal at this 
study site.  More information about this modification can be found in Chapter 5.  Table 6 
profiles each of the participating clinic’s distance from regional major academic medical 
centers (UNC ACTU, Duke University AIDS Research and Treatment Center (DART) 
and East Carolina University (ECU)) as well as the number of HIV service providers and 
HIV-positive clients at each clinic.  Clinic names were not used for the dissertation study, 
as to ensure their anonymity.   They were referred to as “original” or “partnering” site for 
narrative, descriptive purposes, or and Site A or Site B for data management and analyses 
in order to make a clear, simple distinction between the two sites.     
 
Table 7: Intervention Study Site Profiles 
 
Site 
Proximity to 
major 
academic 
health centers 
Status # of  HIV 
Service 
providers 
# of 
HIV+ 
clients 
served 
Original 
Clinic 
UNC: 80.4 
miles (86 min) 
 
Duke: 79.7 
miles (81 min) 
 
ECU: 33.1 
miles (38 min) 
 
Public, non-
profit 
2 (MD and 
a PA)  
402 
(2010) 
Partnering 
Clinic 
UNC: 104 
miles (106 min) 
 
Duke: 103 
miles (101 min) 
 
ECU: 24.9 
miles (97 min) 
 
Public, non-
profit 
(HIV: 1 
NP)  
45 
(2010) 
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Intervention Study Sample Population and Setting 
The study population for the intervention study consisted of clients receiving HIV/AIDS 
care from service providers at two primary healthcare clinics in three contiguous counties 
of North Carolina.  This section will detail eligibility criteria, recruitment procedures, and 
informed consent procedures for clients and providers, respectively.  All consent 
procedures and documents were approved by the Institutional Review Board at the 
University of North Carolina at Chapel Hill. 
Of note, “service provider” was defined broadly, so as to include clinicians and 
non-clinicians (e.g., physicians, nurses, nurse practitioners, pharmacists, case managers, 
social workers, or health educators) as part of recruitment efforts.  Per the 
recommendations of Project EAST CAB members, and formative focus group and 
interview data for the parent study, non-clinicians were strongly suggested to participate 
in the series as they felt case managers and other non-clinicians had a considerable 
amount of interaction with clients living with HIV, and were among the most trusted 
individuals for many of these rural clients.  
Client Eligibility Criteria.  Clients for the intervention study had to receive HIV 
services from the clinic serving as a study site, be African American or Latino, HIV-
positive and English-speaking.   Additionally, each client had to be at least 18 years old 
and have sufficient cognitive functioning to allow informed consent.  
 Client Recruitment.  Recruitment of clients began with identifying an existing 
HIV support at the original study site.  With the guidance of the CAB, Project EAST staff 
was introduced to the leader of this group, an HIV-positive African American male, who 
later served as the site recruiter for all client series.  Having obtained a Certificate of 
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Confidentiality from the National Institutes of Health, the Project EAST research team 
did not collect any identifying information from clients participating in the series.  The 
research assistant made the site recruiter aware of this certificate and explained how 
clients would be tracked over time: alphanumeric identification numbers (IDs).  Each 
client would generate his/her own alphanumeric identification number at the onset of the 
series (e.g., “GLH45”), which was used for all surveys for the study.  Additionally, each 
client was encouraged to give a pseudonym in order to encourage interaction with other 
clients and with the session facilitator.  For example, clients could give names ranging 
from “Sunshine” to “Mr. Z”.  Because session content was built-upon material covered in 
preceding sessions, clients were also made aware that they could not join the series after 
the first session was complete. 
After confirming a start date for the series with the Project EAST research 
assistant, the site recruiter was provided with recruitment flyers and given directives as to 
how to complete recruitment tracking forms as he recruited participants.  The tracking 
form detailed the total number of clients recruited, the number who agreed to participate 
in the client series, the number who declined participation in the series, and the number 
who ultimately participated in the series (see Appendix C).  Participants who declined 
participation in the study were asked why and assured that their decision would in no way 
influence their future care.   Prior to the first session in the client series, the site recruiter 
totaled the number of individuals declining participation and reported reasons for non-
participation.  Participants who were absent for any individual session were also asked 
reasons for non-participation by the site recruiter; the Project EAST research assistant 
documented these reasons.  To stay abreast of recruitment efforts and to assess any 
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challenges related to recruitment efforts, the Project EAST research assistant met weekly 
via conference call with the site recruiter.  
 Client Informed Consent.  Prior to implementation of the first session in the client 
series, a member of the research study team obtained verbal informed consent from all 
participants.  The team member emphasized that agreeing to participate in this part of the 
study did not mean that they were agreeing to be in any clinical trial and they would not 
receive any treatment as part of their participation in the sessions.  Verbal consent was 
obtained from all clients prior to beginning the series. 
 Service Provider Eligibility Criteria.  The site administrator was asked to identify 
six service providers that provided a considerable amount of direct services to African 
American or Latino clients living with HIV/AIDS.   Eligibility criteria for service 
providers also required that providers were clinical or non-clinical employee at the study 
site (physicians, nurses, nurse practitioners, pharmacists, case managers, social workers, 
and health educators) and English-speaking. 
 Service Provider Recruitment. Providers were selected by the site administrator 
based on the number of clients each served, as well as daily interactions with eligible 
clients.  Service providers recruited for the sessions were given information about the 
intervention study via e-mail from the site administrator, as well as dates for the each of 
the scheduled sessions.  Because session content was built-upon material covered in 
preceding sessions, service providers were also made aware that they could not join the 
series after the first session was complete. 
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 Service Provider Informed Consent.   Prior to implementation of service provider 
series, a member of the Project EAST research study team obtained written informed 
consent from all providers     
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CHAPTER 4 
       METHODS 
This chapter describes the methods and procedures used to assess the extent to 
which intervention components for service providers and clients were implemented as 
planned.  It answers research questions for Aim 1 (Evaluate the implementation of an 
educational HIV clinical trial intervention with rural, African American people living 
with HIV/AIDS (PLWHA) and Aim 2 (Evaluate the implementation of an educational 
HIV clinical trial intervention with rural service providers) of this dissertation study.  
Chapter 4 details the data collection methods, data sources (accompanied by information 
on the management, organization and analysis of each source), as well as processes taken 
to strengthen the validity of study findings.    
Data Sources and Collection Methods 
Process evaluation, particularly in the context of complex interventions, requires 
multiple modes of data collection to assess the extent to which the intervention was 
implemented as planned.  Further, multiple methodological approaches strengthen the 
validity of study findings by reducing facilitator subjectivity in interpretation of findings 
(Linnan & Steckler 2002).  As such, this dissertation study used a variety of methods: 
observation, interviews, focus group discussions, memoing, and document review.   A 
total of 2,338 pages of data and 38 hours of audio were analyzed across data sources for 
the dissertation study.  Data sources included: (a) recruitment tracking forms and 
attendance logs, (b) session audio recordings and verbatim transcripts, (b) observational 
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data, (c) facilitator debriefing interviews, (d) participant focus group discussions, (f) CAB 
meeting transcripts, and (g) satisfaction surveys.  A detailed overview of process 
evaluation concepts, data sources, tools, timing and analysis can be found in Table 8.  
The next section will describe each data source, its management and organization, timing 
of data collection, and analysis beginning with session audio recordings and transcripts. 
Recruitment Tracking Forms and Attendance Logs 
 The recruitment tracking form answer the questions regarding recruitment: What 
were the barriers to recruiting participants for the intervention?   What planned and 
actual procedures were used to encourage continued involvement of individuals, groups, 
and organizations?  What were the barriers to recruiting individuals, groups, and 
organizations? What were the barriers to maintaining involvement of individuals, groups, 
and organizations?  Tracking forms were used in concert with attendance logs to assess 
the reach of the intervention study, thus answering the question: What is the proportion 
of the intended target audience that participates in the intervention?     
The tracking form completed by the site recruiter detailed the number of clients 
recruited to participate in the client series, as well as the number of those who agreed or 
declined to participate in the client series (See Appendix C).  Space was also provided for 
the site recruiter to document reasons for client refusal to participate.   The site recruiter 
and a member of the Project EAST team met weekly to discuss recruitment updates for 
each group and barriers to recruitment.   Given that service providers were identified and 
selected by administrators at their respective site, the tracking form was not applicable for 
these participants.  Once enrolled in the intervention study, clients and service providers 
were required to sign in at the beginning of each session in their series.  To maintain 
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client confidentiality, each client was asked to provide “signatures” consisting their self-
generated alphanumeric IDs (three letters and two numbers).   As two consecutive 
sessions were held per day for clients, two sign-in sheets were completed on each of these 
days.   The principal investigator of this dissertation study developed an attendance log 
that was a compilation of sign-in sheets from all service providers and clients in the 
intervention study.   To determine to proportion of those recruited attending each session, 
the total number of participants present were divided by the total number of those who 
agreed to participate in the series (as identified on the recruitment tracking form). 
Management and Organization 
Recruitment tracking forms and sign-in sheets were labeled with the group type 
(client or service provider), session number, and date prior to session implementation.  
Once completed, each form was scanned electronically and saved on a secure, password 
protected server.   The attendance logs created for service providers and clients also were 
saved on the secure server. 
Analysis 
To determine the proportion of intended participants enrolling in the intervention 
series, the total number of participants beginning their respective series across all groups 
divided by the recruitment goal for all clients.  For example, if a total of 36 clients began 
the client series (9 in each group), then 90% of the intended number of clients 
participated in the intervention series.  Recall, the recruitment goal for clients was 40, 
therefore 36 total clients divided by 40 intended participants equals .90 or 90% of the 
intended goal was reached.   
Attendance logs were created from sign-in sheets distributed at each session.  
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These further explored retention of those enrolled in the intervention study All service 
provider and client IDs were compiled into one document and attendance for each session 
was marked as “1” for present and “0” for absent.  Proportions were used to determine 
the percentage of sessions attended by each participant (number of sessions attended/ 
number of sessions offered x 100%).  For example, if a service provider attended three 
out of four sessions, he attended 75% of the sessions offered (3/4 x 100 = 75).   Reasons 
for client or service provider dropout after beginning the series were documented by the 
site recruiter and relayed to research staff during weekly recruitment meetings.      
Session Audio Recordings and Verbatim Transcripts  
 Digital audio recordings and transcripts of sessions served as data sources for 
implementation checklists, tools developed by the principal investigator of this 
dissertation study to assess whether tasks associated with each session activity were 
completed as designed (See Appendix D).  This tool also has been used in other studies to 
assess intervention implementation in HIV clinical trials research (Ferguson et al., 2009).  
Checklists also provided space for the principal investigator to note any variations in 
intervention delivery.  These data provided a structured means to answer the following 
questions related to dose delivered and fidelity: To what extent were all of the intended 
components of the intervention provided to participants? To what extent were the 
intended content, methods, strategies, and activities used?   Was the intervention 
implemented as planned?  
Management and Organization 
All sessions were recorded using digital recorders, typically two with each being 
placed at opposite ends of the meeting space to capture dialogue, comments and 
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questions during the session, and facilitator delivery of session content.   After 
completion of all sessions for a group, the research assistant uploaded audio files from 
the digital recorders to a secure password-protected server for the parent study.  Audio 
files were saved and labeled with an archival ID that included: a) group number, b) study 
site location (abbreviated “AA” for the original study site or “BB” for the partnering site), 
c) the group type (abbreviated as “SP” or “CL”), and session numbers separated by 
periods.  For example, an audio file from sessions 3 and 4 with the second group of 
clients at the original study site would be identified as, “2AACL3.4.FL”.  After session 
audio files were labeled and saved on the secure server, they were ready to be transcribed.   
An experienced transcriptionist, using the Project EAST transcription protocol 
with strict confidentiality guidelines, transcribed session audio files verbatim.  The final 
hard copy transcripts were redacted of any identifying information as part of the 
transcription process.  After completion, the transcriptionist saved the electronic version 
of the transcript on the secure server and alerted the Project EAST research assistant. 
These transcripts were then printed, labeled to mirror audio file IDs, and then stored in a 
locked file cabinet in the principal investigator’s office.  Each session transcript was 
verified through a four-step process: three independent listens, and a finalization.  
The verification process consisted of identification and correction of text that was 
transcribed incorrectly, or audio the transcriptionist could not decipher (thus labeled 
“ inaudible”).  Like the transcriptionist, each reviewer was required to follow the Project 
EAST transcription protocol.  The first verification, or “listen”, of the transcript text was 
conducted by the professional transcriptionist immediately after transcription.  After the 
file was placed on the secure sever, and the Project EAST research assistant alerted of file 
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completion, the transcript was saved in a corresponding folder with additional data for the 
group.   The second verification, or “listen”, was conducted by the research assistant or a 
project intern.  If any discrepancies or errors were identified, edits were made on the hard 
copy of the transcript.  If any additional discrepancies or errors remained after the second 
listen, a third reviewer (the project coordinator or the principal investigator of the parent 
study) would resolve these prior to finalization of the transcript.  During this final step all 
previous edits from the hard copy were made on the electronic version of the transcript 
and saved on a secure server.   The final version included a header that detailed the 
finalization date with the word “FINALIZED” following the original file name (for 
example “2AACL3.4.FL—FINALIZED 10/23/11”.  The finalized transcript was printed 
and placed with the original file in the locked file cabinet. 
  Implementation checklist data were entered electronically, labeled with an ID 
corresponding with session transcript ID, and saved on the secure server by the principal 
investigator of this dissertation study.  Additional space was provided for comments, or 
memos, related to implementation fidelity (see Appendix D).  For example, if the 
facilitator of the session completed a task (as indicated by a “1” on the implementation 
checklist) but did not follow the specific directives the per the session curriculum, this 
variation was documented in the space next to the corresponding task (e.g., “The 
facilitator skimmed the handout very briefly—only read four of the seven types of HIV 
clinical trials”).  In reality, the handout was distributed and the facilitator did read it, thus 
the task was complete and would be scored as such (see “Analysis” below for more 
detail).  Reading a fraction of the handout however, is not the manner in which the 
curriculum directed the facilitator to read the handout.  Fidelity data captured as part of 
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the completion of the implementation checklists were then organized into matrices to 
further explore patterns related to facilitator characteristics, possible intervention 
discrepancies or broader contextual influences on implementation. 
Analysis 
 Session audio files were used a data source for the completion of implementation 
checklists.  The principal investigator of the dissertation used digital software to access 
and listen to these files while completing implementation checklists.  Session transcripts 
supplemented session audio files by serving as a source to resolve any discrepant issues 
with inter-rater reliability scores    
 Tasks were scored on the implementation checklist as “1” if they were completed 
and “0” if they were not completed.   The dose delivered score was then obtained by 
adding the individual scores of the tasks completed in the session and dividing this value 
by the total number of tasks slated to take place in the session.  For example, if the 
session facilitator completed 13 of the 19 tasks required for a particular session, his dose 
delivered score would be .68 (13/19= .68).  Dose delivered scores over .85 indicated high 
dose delivered for the session (Miles & Huberman, 1999).  To assess reliability in scoring 
of the implementation checklists, every fifth checklist was also scored by a doctoral 
student who was part of intervention development and implementation, as well as 
research project staff training.   Inter-rater reliability scores were obtained by determining 
the number of items in agreement between the principal investigator and doctoral student 
divided by the total number of tasks in the session.  Discrepancies found to be a result of 
rater error were categorized as such; discrepancies due to ambiguity or unclear directives 
in the curriculum were categorized as scripting errors.  
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Observational Data 
Observational data were used to assess dose delivered, dose received, and fidelity.  
This data supplemented other data sources by providing information that could not be 
captured otherwise, specifically non-verbal indicators of participant engagement or 
facilitator/participant interaction.  These data were collected by a combination of paid 
and unpaid staff on the research team.  All observers completed the required human 
research ethics training through the University of North Carolina at Chapel Hill, as well 
as four-day training comprised of an overview of the intervention study (including the 
structure and content of the client and service provider series), process evaluation 
methods, group management skills, community-based research ethics, basics of process 
evaluation, measurement, and observation/note-taking basics.  All observers completed a 
one-hour, hands-on field observation exercise in which each trainee had an opportunity to 
expand their observation notes into a narrative summary and receive feedback from 
project staff. 
During each client or service provider session, two members of the research team 
served as observers.  A structured guide that included a layout out of the room and space 
to document issues for each session activity was provided to each observer prior to 
implementation of each session.   Observers documented verbal and non-verbal indicators 
of participant engagement, interruptions (if any), and the length of session activities.  
This handwritten data was expanded into a narrative form within 48 hours of the session, 
and was saved electronically on a secure server.  Narrative summaries also served as a 
very important source to determine whether all session materials were used, particularly 
if the information was not acknowledged or stated by the session facilitator or the 
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participants during the session, or as part of their respective follow-up discussions (i.e., 
facilitator debriefing interview or participant focus group discussion).  For example, the 
observer may note the “Clinical Trial Definition” poster was not displayed during the 
session and the data was not captured elsewhere, this critical information could be 
omitted from process and outcome analyses.   
Management and Organization 
 Structured observation guides were labeled to correspond with the session ID (i.e. 
“2AACL3.4”) and were scanned electronically.  Narrative summaries of these data were 
typed and saved using the same ID from the structured observation guide, with the 
addition of an “.EX” suffix to identify them as expanded notes from the structured guide.   
All observational data was saved on a secure server in a file corresponding with the 
session ID. 
Analysis 
 Handwritten notes and expanded narrative summaries from each session were 
read prior to the analysis of interviews and focus group discussions to gain contextual 
information about the session.  Brief memos were written by the principal investigator 
and documented while completing the checklist.   
Facilitator Debriefing Interviews 
 Facilitator debriefing interviews were conducted at the end of each session by one 
of the session observers.  A pretested debriefing interview guide with relevant probes was 
used to guide the discussion (see Appendix E).  The interviews gave the facilitator an 
opportunity to discuss overall thoughts about the session, barriers to session 
implementation, and suggestions for modifications to the session content.   If the 
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completion of a task was unknown through listening to session audio (e.g. perhaps the 
digital recorders were turned on late, and the status of introductory tasks were unknown), 
facilitator debriefing interviews served as an additional source to determine the dose 
delivered or fidelity of the session.  Unlike implementation checklists, debriefing 
interviews provided contextual information regarding intervention delivery, as facilitators 
were able to provide rationale for the modification or omission of session tasks or 
activities.  These data were also a critical part of understanding whether theory-based 
objectives were met as part of the intervention delivery, as well as the receipt of and 
satisfaction with session content by participants.  
Management and Organization 
  Like session transcripts, each debriefing interview transcript detailed the site 
location (abbreviated using two letters (for example, AA or BB), group type (abbreviated 
as “SP” or “CL”), group number, and session number.   Debriefing files had a suffix to 
further identify the type of file (“.FL” indicating a facilitator debriefing).  For example, a 
facilitator debriefing from sessions 3 and 4 with client group # 2 would be identified as, 
“2AAPL.3.4.FL”.  Debriefing interview transcripts were verified through a four-step 
verification process identical to that of session transcripts (see “Management and 
Organization” for verbatim session transcripts).  Exchange of debriefing audio files and 
electronic transcripts between EAST research staff and the transcriptionist took place on 
a secure server.  Hard copies of debriefing interview transcripts were filed with the 
corresponding session and focus group discussion transcripts in a locked file cabinet in 
the project coordinator’s office. 
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Analysis 
Qualitative themes for debriefing interviews were developed through a deductive 
approach in which codes were developed from the debriefing interview guides.  These 
themes were compiled into a codebook that detailed the code mnemonic, a brief 
definition and a full description of inclusion and exclusion criteria (see Appendix F).  The 
principal investigator of this dissertation study independently reviewed each transcript, 
and developed and applied codes to the text.  If new codes emerged during analysis of 
transcript data, they were added to the codebook and applied to subsequent transcripts. 
Coded interview data was organized into visual displays to facilitate interpretation and 
analysis, and to further explore convergence or divergence of themes within and across 
groups (Miles & Huberman, 1999).  
Participant Focus Group Discussions 
 All session participants (clients and service providers) took part in focus group 
discussions as part of their participation in the intervention study.  These data assessed 
dose received, as they answer the questions: To what extent were participants present at 
session activities engaged in the activities? How did participants react to specific aspects 
of the session? How satisfied were the participants with the session?   Using a pretested 
focus group discussion guide for each group (see Appendices G and H), one of the 
session observers moderated the group discussion to explore participant expectations 
prior to participation in the series, motivators for participation in the series, satisfaction 
with session content, recommendations for improvement and future application of skills 
learned during the series.   
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 Client focus group discussions were conducted at the end of each day (3 days 
total) and covered content for the two sessions implemented earlier in the day.  For 
example, the focus group held the first day of the clients series consisted of questions 
about sessions 1 and 2; the second day consisted of questions about sessions 3 and 4, etc.  
If the ACTU expert session (session 6) occurred during clients’ lunch hour, two separate 
group discussions took place: one immediately before the expert arrived (session 5) and 
one immediately after the expert ended the discussion (session 6). Therefore, a minimum 
of three and a maximum of four focus group discussions were held for each client group.   
 Due to feasibility and time constraints, service providers were not able to 
participate in focus group discussions at the end of each session.  Instead, one focus 
group discussion was held after the completion of the entire service provider series was 
complete.  The discussion was moderated by one of the Project EAST co-investigators, 
and lasted approximately 60 minutes.  All group discussions were audio-recorded and 
professionally transcribed for analysis and verified through a four-step process (see 
“Management and Organization” for verbatim session transcripts). Figures 2 and 3 detail 
data collected for service providers and clients, respectively. 
Management and Organization 
  Each focus group discussion transcript detailed the site location (abbreviated 
using two letters (“AA” or “BB”), group type (abbreviated as “SP” or “CL”), group ID 
number, and session number.  Debriefing and group discussion files had a suffix to 
further identify the type of file (“.PD” indicating a participant discussion).  For example, 
a client focus group discussion from sessions 1 and 2 with the third group of clients the 
original study site would be identified as, “3BBCL.1.2.PD”.  Exchange of audio files and 
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electronic transcripts between EAST research staff and the transcriptionist took place on 
a secure server.  Hard copies of focus group discussion transcripts were filed with the 
corresponding session and facilitator-debriefing interview transcripts in a locked file 
cabinet in the project coordinator’s office. 
Analysis 
  Coding of participant focus group discussions occurred in the in the same fashion 
as facilitator debriefing data.  Deductive codes were generated from the FG discussion 
guides and inductive codes emerged from the data.   See Appendix I for the focus group 
discussion codebook for providers and clients. 
CAB Meeting Transcripts/Team Meeting Minutes 
 CAB transcripts and team meeting minutes were analyzed to capture contextual 
issues occurring over the course of the intervention implementation.  These data answer 
the question: What are the external factors directly or indirectly affecting the intervention?  
A total of 12 CAB meetings were held over the course of the parent study.  Each meeting 
was considered to be a source of data; therefore each meeting was audio-recorded and 
transcribed verbatim.  Project EAST team meetings occurred every other week with 
research project staff at UNC, including the principal investigator, co-investigators, 
project manager, project coordinator, and research assistants.  During these meetings, 
staff discussed maintaining the integrity of the intervention, problem solving, making 
collaborative decisions about issues involved in the intervention, and providing support to 
prevent stress and burnout.  Minutes were taken at each team meeting. 
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Management and Organization 
CAB meeting transcripts were verified through a four-step process identical to 
that of session transcripts (see “Management and Organization” for verbatim session 
transcripts).  Exchange of CAB audio files and electronic transcripts between EAST 
research staff and the transcriptionist took place on a secure server.  The transcripts were 
then printed, labeled with the CAB meeting date (e.g., “CAB Meeting 10.15.09”), filed in 
a folder designated for CAB meeting data in a locked in a file cabinet in the project 
coordinator’s office.  and then stored in a locked file cabinet in the principal 
investigator’s office.  Team meeting minutes were labeled with the meeting date (e.g., 
“EAST Meeting 3.10.10”), typed by the research assistant and saved on the secure server.    
Analysis 
 CAB transcripts and team meeting minutes were read in their entirety and the 
principal investigator of this dissertation study created memos throughout analyses of 
other data sources.  
Satisfaction Surveys 
All participants in the intervention study completed surveys to determine the 
extent to which they were satisfied with the session content, delivery and the facilitator.  
These data answered the question: How satisfied were the participants with the session?  
Responses ranged from “strongly agree” to “strongly disagree” on a five-point Likert 
scale (see Appendix J).  For client sessions, the moderator of the focus group discussion 
read each question and response options on the survey aloud in the event there were 
literacy issues among clients participating in the session.  Service provider surveys were 
self-administered and collected at the end of each session by one of the session observers. 
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Management and Organization 
  Satisfaction surveys were labeled to correspond with the site ID, group number, 
and participant ID (e.g., “AAG3-NGH65” for clients “AAAA1” for service providers).  
The research assistant created electronic copies of surveys by scanning each survey 
(within a given group) and saving the document in a corresponding session file on the 
secure server. Hard copies of surveys were filed with the corresponding session data in a 
locked file cabinet in the project coordinator’s office.  
Analysis  
  Preliminary analyses indicated very limited variation in participant responses, as a 
great majority of clients indicated, “strongly agree” or “agree” for survey items.  Among 
service providers there was some variation, but none of the service providers indicated 
dissatisfaction with any of the session activities.  As such, the primary mode of data 
collection to assess participant satisfaction for the dissertation study was through focus 
group discussions. 
 
 
 
  
 
Table 8: Process Evaluation Concepts 
Concept 
Process Evaluation Question 
Data Sources Tools/ Procedures 
Timing of Data 
Collection 
Data Analysis or 
Synthesis 
Context  
What are the external factors that directly or 
indirectly affect a specific session, or the entire 
series? 
• Team meeting  
 
• CAB meeting  
• EAST meeting 
notes 
• CAB transcripts  
• Weekly 
 
• Quarterly (four 
times a year) 
• Memoing  
Reach  What is the proportion of intended target audience that participates in the series? 
• Project grant 
application 
• Site recruiter 
• n/a  
 
• Recruitment 
tracking form 
 
• n/a 
 
• Prior to series 
implementation 
 
• Document review 
 
 
• Document review 
 
 
What proportion of those recruited attended each 
session? (Attendance) 
 Session 
facilitators 
 
 
• Attendance log 
 
• Each session 
 
• Percent of participants 
in each session 
calculated 
 
 
 
Recruitment 
 
What planned and actual recruitment procedures 
were used to attract individuals? 
 
What were the barriers to recruiting individuals, 
groups, and organizations? 
 
What planned and actual procedures were used to 
encourage continued involvement of individuals, 
groups, and organizations? 
 
What were the barriers to maintaining involvement 
of individuals, groups, and organizations? 
  COS 
 
 
 
 
• Recruitment 
tracking form 
 
 
 
 
 
 
 
 
 
• Weekly 
recruitment 
meeting 
 
 
 
 
 
 
 
 
• Percent of those 
recruited and those 
attended 
 
Fidelity Was the session implemented as intended? 
• Session observers 
 
 
• Session transcript 
 
 
• Session facilitators 
 
 
 
• Observation 
assessment forms  
 
• Implementation 
checklist 
 
 
• Debriefing 
interviews with 
session facilitators 
 
 
• Each session 
 
 
• N/A (secondary 
data analysis) 
 
 
• End of each 
session 
 
• Document review 
 
 
• Notes from checklist 
 
• Coding 
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Dose 
Delivered 
 
To what extent were all of the intended 
components of the session provided to 
participants? 
 
To what extent were all materials (written and 
audiovisual) designed for use in the session used? 
 
To what extent was all of the intended content 
covered? 
 
To what extent were all of the intended methods, 
strategies, and/or activities used? 
• Session observers 
 
 
 Session transcript 
 
 
 Session 
facilitators 
 
 
 
 
• Observation 
assessment forms 
 
• Implementation 
checklist 
 
 
• Debriefing interview 
with session 
facilitators 
 
 
• Each session 
 
 
 
• N/A (secondary 
data analysis) 
 
 
• End of each of 
each session 
 
• Document review 
 
 
 
• Count of deviations 
(primary) 
 
 
• Count of deviations 
(validation) 
 
Dose 
Received 
To what extent were participants present at session 
activities engaged in the activities? 
• Session observers 
 
 
• Participants 
• Observation 
assessment forms 
 
• Participant focus 
groups  
• Each session 
 
 
• After completion 
of entire series  
(SP); or each 
day (CL) 
 
 
• Memoing 
 
 
• Coding 
 
How did participants react to specific aspects of the 
session? 
• Session observers 
 
 
• Participants 
• Observation 
assessment forms 
 
• Participant focus 
groups 
• Each session 
 
 
• After completion 
of entire series  
(SP); or each 
day (CL) 
 
• Memoing 
 
 
• Coding 
 
How satisfied were the participants with the 
session? 
 
• Participants 
 
• Participant focus 
groups 
 
• After completion 
of entire series  
(SP); or each 
day (CL) 
 
 
• Coding 
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Validity 
Several strategies were used to maximize the credibility of study findings, the first 
of which was the creation of an audit trial (Rodgers & Cowles, 1993).  This method of 
consistent and concise documentation assists researchers in maintaining an accurate 
record of decisions related to data collection, analyses and interpretation.  The principal 
investigator of the dissertation study included four types of audit trial documentation:  
methodological, analytical, personal response (also known as “reflexivity”), and 
contextual.   Specific items included: prioritization of data analyses (in order to maximize 
objectivity in analyses), sensitivity of implementation checklists, and pertinent 
conversation with Project EAST staff.  The audit trail was kept on a secured electronic 
database that could be accessed from any remote location at any time of day.  This access 
was critical to capturing ideas as they occurred, in order to provide as much detail and 
context as possible in real time.   
 Additionally, transcripts for intervention sessions, facilitator debriefings and 
participant focus group discussions were validated through a four-step process, thus 
strengthening the accuracy of these data prior to analysis.  Minor variations in wording 
on transcripts had potential to completely change the context of a phrase, thus verification 
was imperative to ensure that terms, particularly those that related to terms associated 
HIV clinical trials, or regional terms used by participants, were transcribed appropriately.  
For example, transcription of a “can” as a “can’t” or omission of important concepts such 
as “clinical equipoise” due to the text being identified as “inaudible”, could have very 
important implications as it relates to analyses and interpretation of data.  
 The completion of implementation checklists after sessions took place, as 
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opposed to during the session, afforded the opportunity to triangulate this data with other 
sources as the checklist was completed.  Finally, achieving inter-rater reliability of data 
ensured proper scoring for implementation checklists; inter-coder reliability assisted in 
ensuring proper conceptualization and application of codes. 
 
 
 
 
 
 
 
 
  
 65
 
 
 
CHAPTER 5 
RESULTS 
 This chapter is organized into six sections: (a) reach and recruitment of study 
participants (clients and service providers, respectively), in addition to information about 
retention of participants over the course of the series;  (b) dose delivered; (c) fidelity; (d) 
dose received, including information about participant satisfaction and engagement; and 
(e) client, service provider, and facilitator suggested modifications for future intervention 
development, implementation.  Contextual data will be presented in the discussion 
chapter.  For presentation of dissertation findings, service provider and client groups have 
been labeled to reflect group type (“SP” and “CL”, respectively) and the order in which 
the group occurred.  
Reach and Recruitment 
Client Reach.  A lapse in communication between Project EAST research staff 
and the site recruiter regarding client eligibility led to the recruitment and inclusion of 
three participants that did not meet eligibility criteria.  Two clients in CL1 did not meet 
the criterion for race and one client in CL2 had severe cognitive issues.  The data for the 
client in CL2 was excluded from analyses for outcome data for the parent study.  Because 
all data was collected anonymously, and in a group setting, process data for the two 
clients in CL1 was included as part of the dissertation study findings.   
Baseline characteristics for clients, by group, can be found in Table 9.  The 
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majority of the sample was African American (n= 31, 89%) and male (n=22, 65%).  
Approximately 25% (n=8) were diagnosed with HIV within the past six years.  By group, 
the number of years living with HIV varied among clients, with the exception of CL3, 
where all four clients had lived with HIV for over 15 years.  Most clients heard of HIV 
clinical trials prior to their participation in the client sessions (n=20, 61%) and 41% (n 
=14) reported previous enrollment in a clinical trial.  Fifty-one percent (n = 17) of 
participants completed high school (or equivalent), 36% were unable to work because of 
a disability (n = 12), and 50% were uninsured (n = 17).  Additional client characteristics 
can be found in Table 9.  
 Adherence to recruitment procedures for clients was assessed through document 
review of the Project EAST recruitment manual, recruitment tracking forms and weekly 
meeting agendas.  The site recruiter completed all recruitment tracking forms, attended 
all scheduled weekly recruitment conference calls, and distributed recruitment flyers to 
eligible participants for three client groups.   He was not able to fully enumerate clients 
recruited for the CL4, however, as the site administrator reassigned these duties to the 
clinic nurse based on clinic needs at the time.  That said, the newly appointed nurse made 
clients aware of the intervention and documented the names of those agreeing to 
participate in the client series. The total number of clients approached by the nurse at this 
site is unknown, but the tracking document details confirmation of 11 participants.  Site 
staff assisting with recruitment noted the major reasons for non-participation, which 
included disclosure/privacy concerns, work/school conflicts, and lack of interest in 
participation.   
 67
 Client Recruitment.  The site recruiter completed a total of four recruitment 
forms, one for each group participating in the intervention study.  In total, 85 clients 
indicated interest in participating in the client series; of these 34 (40%) ultimately 
enrolled.  Seventeen clients were recruited for CL1.  Of these, 15 confirmed participation 
and 13 attended the first day of the series.  Of the 15 clients recruited for group 2, 10 
confirmed participation, and five attended the first day of the series.  As a result, a make-
up day (sessions 1 and 2) was offered to allow more clients to participate in the sessions.  
Through the recruitment efforts of site staff, fourteen additional clients were recruited.  
Ten confirmed participation and six attended this group.  These two groups combined 
brought the total number of participants in CL2 to 11 clients total.    
A third client group had to be cancelled altogether because one of the eight 
confirmed clients was present on the first day of the series.  Despite reminder phone calls 
and pre-arranged pick-up times and locations on the day of the session, an overwhelming 
majority of clients no longer had interest in participation, had schedule conflicts, or were 
ill.  One additional attempt was made to recruit clients for the last client group to occur at 
the study site (CL3).   Twenty-eight clients were recruited for this group; 11 confirmed 
participation and four were present on the first day of the series.   At the recommendation 
of the site administrator, one final group was held at a partnering site.  A total of 11 
clients confirmed participation in CL4; six were present on the first day of the series.  
Study site staff felt social desirability was a major contributor to the low participation in 
the client series, feeling that clients agreed to participate, but had no intention of enrolling 
in the sessions.  If a client enrolled in the series, but was absent for a session, or a pair of 
sessions occurring over the course of a day, the site recruiter documented reasons for 
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absence and relayed this information to the research assistant during the weekly 
recruitment conference calls. 
 Client Retention.  Full attendance was defined as completion of the series of six 
sessions over the course of three days.  Appendix K details client attendance and percent 
of sessions completed in the series.  Of the 34 clients beginning the series: 76% 
completed six sessions (n=26), 3% completed five sessions (n=1), 6% completed four 
sessions (n=2), and 15% completed one session (n=5).  At the group level, the average 
proportion of sessions completed for each group of clients  (in order of implementation) 
was .92, .83, .83, and .72, respectively. CL1 had the highest percent of clients completing 
the entire series (85%), while CL4 had the lowest percent, with 67% of clients 
completing the series. 
 Of note, CL1 clients were all members of an existing HIV support group in their 
county.  Of the two participants in this group that did not complete the entire six-session 
series, one had a schedule conflict and the other relocated to another city.  Likewise, a 
schedule conflict with work restricted one client in CL3 from attending sessions 4 
through 6.  Of the clients that completed four of the six sessions (4/6 =67%), both missed 
sessions occurring in the middle of the series (Day 2), but returned on the last day to 
complete the last two sessions.   The client with severe cognitive issues completed 87% 
of the series, but was unable to complete the last session. One client in CL4 and two 
clients in CL2 were lost to follow-up at the close of the client series.   
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Table 9: Client Characteristics, by Group  
Demographics CL1 (n = 13) 
CL2 
(n = 11) 
CL3 
(n = 4) 
CL4 
(n = 6) 
    Total 
(n=34) 
Age 
       Under 20 
       20-29 
       30-39 
       40-49 
       50-59 
       60-69 
 
-- 
1  (8%) 
2 (15%) 
5  (38%) 
3 (23%) 
2 (15%) 
 
1 (9%) 
-- 
1  (9%) 
5 (45%) 
2 (18%) 
2 (18%) 
 
-- 
-- 
-- 
-- 
2 (50%) 
2 (50%) 
 
-- 
1 (17%) 
2 (33%) 
-- 
3 (50%) 
-- 
 
1  (9%) 
2 (11%) 
 5  (15%) 
10  (29%) 
10  (29%) 
6 (18%)  
Race/Ethnicity 
Black 
Hispanic 
White 
 
11 (89%) 
--- 
2 (11%) 
 
11 (100%) 
--- 
--- 
 
4 (100%) 
--- 
--- 
 
6 (100%) 
--- 
--- 
 
31 (89%) 
--- 
2 (11%) 
Gender 
Male 
Female 
 
8 (61%) 
5 (39%) 
9 (82%) 
2 (19%) 
2 (50%) 
2 (50%) 
3 (50%) 
3 (50%) 
22 (65%) 
12 (35%) 
Years living with HIV 
Less than 1 
1-5 years 
6-10 years 
11-15 years 
16 + years  
 
3 (23%) 
1   (8%) 
4 (31%) 
2  (15%) 
3 (23%) 
 
--- 
2 (18%) 
8 (73%) 
--- 
1  (9%) 
 
--- 
--- 
--- 
--- 
4 (100%) 
 
2 (33%) 
--- 
2 (33%) 
2 (33%) 
--- 
 
5 (15%) 
3   (9%) 
14 (41%) 
4 (12%) 
8 (23%) 
Education 
Less than HS 
Some HS 
HS/GED  
Some College 
Completed 
College 
 
--- 
3 (23%) 
4 (31%) 
4 (31%) 
2 (15%) 
 
--- 
7 (64%) 
    1 (9%) 
3 (27%) 
--- 
 
3 (75%) 
--- 
--- 
--- 
1 (25%) 
 
2 (33%) 
2 (33%) 
2 (33%) 
--- 
--- 
 
5 (15%) 
12  (35%) 
7 (21%) 
7 (21%) 
3  (9%) 
Employment 
Part-time 
Full-time 
Home/Family 
School 
Retired 
Unable to work 
Other 
 
--- 
1 (8%) 
 2 (15%) 
--- 
1  (8%) 
3 (23%)  
6 (46%) 
 
1 (9%) 
--- 
1 (9%) 
--- 
--- 
8 (73%)  
1   (9%) 
 
--- 
1 (25%) 
--- 
3 (75%) 
 --- 
--- 
--- 
 
 
--- 
--- 
--- 
--- 
 1 (20%) 
 1 (20%) 
 3 (60%) 
*1 missing value 
 
1 (3%) 
2 (6%) 
3 (9%) 
3 (9%) 
2 (6%) 
12 (36%) 
10 (30%)  
Health Insurance? 
       Yes 
       No 
 
  
7 (54%) 
6 (46%) 
 
5 (45%) 
6 (55%) 
 
0 
1 (25%) 
*3 missing values 
 
2 (33%) 
4 (67%) 
 
14 (41%) 
17 (50%) 
Ever heard of a CT? 
Yes 
No 
 
9(57%) 
3(43%) 
*1 missing value 
 
6 (55%) 
5 (45%) 
 
 
3 (75%) 
1 (25%) 
 
 
2 (33%) 
4 (67%) 
 
 
20 (61%) 
13 (39%) 
 
Ever participate in a 
CT? 
     Yes 
     No 
 
 
3  (27%) 
10 (73%) 
 
6 (55%) 
5 (45%) 
2 (50%) 
2 (50%) 
3 (50%) 
3 (50%) 
14 (41%) 
20 (59%) 
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Service Provider Reach.  Reach for service providers was nearly double the 
intended goal as 11 service providers participated in the series.  The addition of the 
partnering clinic as a study site nearly double the reach for service providers  (n= 11, 
184%).   As  providers were able to select more than one than category for their 
occupation on the baseline survey, three selected dual roles at their site (i.e. nurse and 
case manager).  Nearly half of service providers were African American (n=6, 54%) and 
approximately three-quarters were female (n=8, 73%).  Twenty percent (n =1) of 
providers in SP1 identified HIV as their primary specialty, as compared to 50% of 
providers in SP2 (n = 3).  At baseline, 40% of providers in SP1 (n = 2) and 33% of 
providers in SP2 (n = 2) reported having referred at least one client to a clinical trial in 
the past six months.  Additional service provider demographics can be found in Table 10. 
Nearly half of the service providers in the study sample were case managers.   
While service provider type was not part of the intended reach a priori, addition of these 
individuals did reflect the profile of service providers suggested by the EAST CAB.  
Further, as transportation is a huge barrier for many people living with HIV/AIDS in 
rural eastern NC, access to major medical centers providing HIV care is very limited.  As 
a result, many HIV-positive clients receive case management services from community-
based organizations or local health departments or community-based organizations 
(Nguyen & Whetten, 2003).  That said, inclusion of non-clinicians in the intervention 
study produced a study sample that reflected the type of service providers available and 
accessible in many rural contexts.   
 Service Provider Recruitment.  Service provider recruitment was accessed 
through document review of team meeting notes and analysis of qualitative data from the 
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service provider focus group discussion occurring at the end of the series.  As service 
providers were selected based on specific criteria by administrators at each site, 
recruitment tracking forms were not applicable for this group. All service providers were 
sent e-mail by the site administrator that detailed what participation entailed, the dates on 
which the sessions would be held, as well as a brief summary of the intervention study.   
 Service Provider Retention.   Ninety-one percent of service providers completed 
all sessions in the service provider series (10/11=91%).  A change in scheduling of the 
last session (due to limited ACTU expert availability) posed a conflict for one service 
provider who had previous travel arrangements for work out of the country.   That said, 
all service providers completed 100% of the series, with the exception of one provider 
who completed 75% of the sessions.  Provider attendance, by group, can be found in 
Appendix L.   
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Table 10: Service Provider Characteristics, by Group  
Demographics SP1 (n=5) 
SP2 
(n=6) 
 
TOTAL 
(n=11) 
Age 
       20-29 
       30-39 
       40-49 
       50-59 
       60-69 
       70-79 
 
--- 
3 (60%) 
2 (40%) 
--- 
--- 
--- 
 
2 (33%) 
1 (17%) 
2 (33%) 
--- 
--- 
1 (17%) 
 
2 (18%) 
4 (36%) 
4 (36%) 
--- 
--- 
1  (9%) 
Race 
Black 
Hispanic 
White 
 
2 (40%) 
1 (20%) 
2 (40%) 
 
4 (58%) 
--- 
2 (31%) 
 
6 (54%) 
1 (9%) 
4 (36%) 
 
Gender 
Male 
Female 
 
 
1 (20%) 
4 (80%) 
 
2 (33%) 
4 (72%) 
 
3 (27%) 
8 (73%) 
Education 
Technical school/training 
Some College 
Completed College 
Graduate Degree 
 
 
 
1 (20%) 
--- 
1 (20%) 
3 (60%) 
 
 
 
--- 
1 (17%) 
4 (67%) 
1 (17%) 
 
 
 
1  (9%) 
1  (9%) 
5 (45%) 
4 (36%) 
 
Profession* 
      Physician 
      Physician Assistant 
      Nurse 
      Nurse Practitioner 
      Case Manager 
      Pharmacist 
      Health Educator 
 
 
1  
1 
1 
--- 
1  
1  
1  
 
 
1  
--- 
3 
1  
4  
--- 
--- 
 
  
2 
1 
4 
1 
5 
1 
1 
HIV Primary Specialty 
       Yes 
       No 
 
1 (20%) 
4 (80%) 
 
3 (50%) 
3 (50%) 
 
4 (36%) 
7 (64%) 
Number of clients referred to 
CT in last six months 
       0 
      1-5 
 
 
3 (60%) 
2 (40%) 
 
 
4(67%) 
2 (33%) 
 
 
7 (64%) 
4 (36%) 
*participants could choose more than one response 
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Summary: Reach and Recruitment 
 Approximately 85 clients were recruited for the client series.   Of these, 40% (n= 
34) ultimately participated in the sessions, and .  In general, recruitment procedures were 
followed with the exception of tracking  of clients in CL4.  This exception was due to re-
assignment of client recruitment to the clinic nurse by the site administrator.  The site 
recruiter attended all weekly recruitment meetings with the Project EAST research 
assistant and also ensured timely completion of the recruitment tracking forms prior to 
the implementation of the series with each group.    Overall, service provider recruitment 
was successful, as 11 service providers were ultimately recruited to participate in the 
series.  “Direct involvement with clients” as recruitment criterion was somewhat 
subjective as nearly half of the service providers did not interact with clients on a regular 
basis, nor was HIV their primary specialty (see Table 10).  This was not problematic for 
implementation of the series, but may have very important implications related to the 
outcome for the larger parent study: increase service provider willingness to refer eligible 
African American people living with HIV/AIDS to HIV clinical trials. 
Dose Delivered and Fidelity 
 This section will begin with presentation of dose delivered findings for client and 
service provider groups, separately, then within and across groups.  Fidelity findings will 
then be presented, incorporating qualitative findings from the facilitator debriefing 
interviews and memos captured on implementation checklists. be organized to view 
convergent and divergent themes among the two data sources (implementation checklists 
and facilitator debriefing interviews), then by group type (client and service providers).    
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Client Series.  Dose delivered scores for all client groups, by session number are 
detailed in Table 11.   Five of the six sessions across all client groups had average dose 
delivered scores higher than the .85 acceptable score.   The highest average score among 
the client groups was .90 for CL2 make-up group and the session carried out with the 
highest dose delivered score across all client groups was Session 4 (“Support: What is It 
and Where Can You Get It”), with an average dose delivered score of .96.  This session 
provided information about ways eligible clinical trial participants can seek out support 
as part of their decision-making process.  The exercises in this session were guided by the 
social support framework and allowed clients to explore how the four types of support 
(emotional, instrumental, appraisal, and informational) could influence clinical trial 
participation.  Clients also learned communication skills as it related to seeking support 
for trial participation.   
The session implemented with the lowest dose delivered score across all client 
groups was session 3 (“Participant Rights and Informed Consent”).  The average score 
for this session was .77, with the lowest scoring session occurring with the second clients 
group (CL2).  While the majority of session tasks were delivered at or above the 
acceptable dose delivered score of .85, failure to distribute handouts to clients (e.g., “Key 
Questions to Ask Clinical Trial Staff”), compile solutions to from session activities (e.g., 
“Break the Barrier”), introduce the “parking lot” and/or session objectives at the onset of 
the session, provide responses from the previous week’s “parking lot” questions, or 
summarize the session’s objectives and associated activities lowered dose delivered 
scores considerably.  The “Key Questions to ask Clinical Trial Staff” handout in session 
3 was not distributed for two of the four client groups.   The facilitator of the CL3 series 
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noted in her debriefing interview, however, that the series curriculum directed facilitators 
to distribute the handout in two separate sessions, but she was unclear as to why this was 
the case.  The curriculum did not clearly indicate how to integrate the sample questions in 
to the content of either of the sessions, nor did it specify whether the second provision of 
the handout was a reinforcement for the previous activity (thus meeting the same 
theoretical objectives) or whether the handout stood alone within each session (thus 
meeting separate theoretical objectives).  Facilitators who were part of intervention 
development were more familiar with the purpose of the handout, and why it was 
distributed twice during the series.  Two activities for which the handout was provided as 
a resource: a) questions to ask as part of the informed consent process (Session 3) and b) 
information to consider as part of client-service provider communication regarding trial 
participation (Session 5). 
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Service Provider Series.  Dose delivered scores for the service provider series are 
detailed in Table 12.  These findings revealed dose delivered scores for all sessions were 
above the acceptable score of .85, with an overall average of .92 for all sessions.  The 
lowest dose delivered score among all service provider sessions was .88 (Session 1: 
“Clinical Trials 101”) with service providers at the partnering clinic.  This was due to the 
facilitator’s failure to have participants create ground rules and failure to forecast 
information about overcoming barriers to clinical trial participation at the end of the 
series.  Interestingly, the first service provider session also had highest dose delivered 
score among all service provider sessions implemented, with a full dose (1.0) delivered to 
service providers at the original study site.   Both sessions were led by the same 
facilitator, BF1, however fidelity data from the implementation checklists provided 
Table 11: Dose Delivered Scores (Client Series) 
Session Session Content CL1 CL2 
CL2* 
make-up 
group 
CL3 CL4 Average Score 
1 Clinical Trials Basics .73 .92 1 .75 .82 .86 
2 
Referral, 
Participation and 
Types of Trials 
.93 .80 .80 .93 .87 .87 
3 
Participant 
Rights and 
Informed 
Consent 
.92 .69 -- .77 .77 .77 
4 
Social Support 
and Trial 
Participation 
1 1 -- .92 .96 .96 
5 
Locating Clinical 
Trials and 
Confidentiality 
.92 .85 -- 1 .91 .91 
6 “Ask the Expert” .80 1 -- .80 .90 .90 
Average Score (per 
group) .88 .88 .90 .86 .87 .88 
*completed sessions 3-6 with CL2 
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insight into the discrepant scores for this session: “The session began approximately 
thirty minutes late as facilitators arrived late—told participants they would skip ground 
rules in light of time and requested that participants silence their cell phones.” The 
facilitator confirmed this during the debriefing interview:   
 “… [We] got here late--took a wrong turn into [name of town]…even given our 
leaving two hours ahead of time.  Ground rules--I completely skipped over… 
when I looked down we didn’t have time to do a five minute ‘talk about what you 
all want to do’…the only thing I did mention was cell phones.”   
 
 
Table 12: Dose Delivered Scores (Service Provider Series) 
Session Content SP1 SP2 Average Score (per session) 
1 Clinical Trials Basics and Types of Trials 1.0 .88 .94 
2 
Referral, Participant Rights and Informed 
Consent  .91 .94 .93 
3 
Locating Clinical Trials, Support, and 
Communication .93 .93 .93 
4 “Ask the Expert” .90 .91 .91 
Average Score (per site) .94 .92 .92 
   
  Facilitator Characteristics.  As facilitators varied by race, gender, education, and 
status of employment with the project, it was important to examine if and how facilitator 
characteristics may have affected the dose delivered of intervention sessions.  Table 13 
details demographics of facilitators, as well as the number and type of sessions each 
person facilitated over the course of the intervention.  All facilitators completed an 
undergraduate degree, two of whom were currently enrolled in graduate programs at a 
local university.  Two facilitators were not paid staff, and none of the facilitators had 
previous experience facilitating or taking part in clinical trial outreach efforts.  Two 
facilitators were, however, heavily involved in the development and pretesting of the 
intervention, as well as the development of process and outcome evaluation measures.  
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Table 13: Facilitator Characteristics 
 ID Race Gender Educational Attainment Paid 
Number of 
Sessions 
Facilitated 
 
Average Dose 
Delivered 
Score 
Clients Service providers Clients 
Service 
providers 
BF1 Black F Graduate Y 11 8 .84 .93 
WF1 White F College Y 2 -- .85 -- 
BM1 Black M College* Y 2 -- .93 -- 
BF2 Black F College* Y 6 -- .90 -- 
BM2 Black M College N 4 -- .91 -- 
BF3 Black F Graduate N 1 -- .87 -- 
                  *currently enrolled in graduate program 
 
 Facilitator average dose delivered score for client sessions exceeded the 
acceptable score of .85, with the exception of facilitator BF1 (average score = .84).   She 
was the primary facilitator for all service provider sessions, and her average dose 
delivered score was .93 for this group.  The top two scorers for client sessions were black 
males, one paid staff member and one unpaid staff members (.93 and .91, respectively).   
Both had undergraduate degrees, and one was pursuing doctoral studies.  There were no 
differences in dose delivered by race or educational attainment.  In sum, dose delivered 
did not seem to be a function of the facilitator’s race, education, or employment status 
with the project.  The average reliability score for implementation checklists was .92 with 
the majority being due to coder error.  
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Fidelity 
  Fidelity, which measured the quality and integrity of intervention delivery, was 
assessed through analysis of facilitator debriefing interview data and a review of notes 
documented on implementation checklist by the principal investigator of this dissertation 
study.  Implementation checklists provided outsider’s perspective of variations in 
intervention delivery to session participants.  Although curricula were provided for 
facilitators to follow, some variability in delivery was expected, as each facilitator his 
own style.  Some barriers to implementation were beyond the facilitator’s control, such as 
malfunctioning equipment or late arrival of session participants, and some were a 
function of facilitator error, such as lack of preparation or incorrect provision of 
information. Two analytical approaches were used to assess intervention fidelity: 
qualitative coding of facilitator debriefing interviews—viewed across groups and 
comparative analyses between facilitator debriefing interviews and fidelity notes captured 
on implementation checklists.  In the next section, salient factors found to affect 
intervention fidelity in both series are presented, followed by factors found to be specific 
to the client and provider series, respectively. 
The principal investigator of this dissertation study created visual displays of 
fidelity data across and within groups.  See Appendix M for a sample visual display for 
client sessions.  Exploration by data source afforded the opportunity to determine the 
reliability in which data was reported by the facilitator and data captured by the principal 
investigator.  These tables detailed fidelity findings for client and service provider 
sessions by group number and data source (implementation checklist and facilitator 
debriefing interviews).  The final column detailed findings captured from both sources.  
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Visual displays yielded information on why an activity had not been carried out in the 
manner in which it was designed, and thereby, complemented findings from quantitative 
data in implementation checklists.   
Delayed Implementation of Sessions.  Late arrivals of project staff or clients 
resulted sessions beginning up to half an hour after the designated start time.  At the onset 
of the series for each of client groups (sessions #1 and 2),  research staff arrived late 75% 
of the time (three of the four groups).  This often led to session activities being split into 
smaller time frames to allow participants to take lunch breaks at the designated time on 
the schedule.  Facilitator debriefing interview data did not give context as to why 
research staff members were late, other than a facilitator’s comment regarding the need 
for the team to depart UNC on time.    
 Technical issues also lead to late start times for client sessions, or interruptions 
during the sessions.  While baseline survey administration was not a formal part of the 
client series, the audience response system used to administer the survey was problematic 
in three of the four client groups.  This software used remotes, or “clickers”, to allow 
participants to respond to multiple-choice questions via the remote.  Solutions for this 
problem were to troubleshoot until the software worked or administer backup, paper 
copies of the survey.  Both had implications as it related to beginning the session at the 
designated start time.  Additionally, the audio quality of the clinical trial participant 
testimonial video led was poor in each of the four client groups.  Each facilitator noted in 
his/her debriefing interview that the speakers projected a low, muffled sound or hearing 
“static” during the video.  DVD compatibility was also problematic for one group, as a 
variety of laptops were used while staff were in the field.  
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Adherence to Curriculum Script.  In general, most issues related to variability in 
intervention delivery for client and provider sessions were due to facilitator deviation 
from the scripted text in the curriculum.  Text was sometimes paraphrased by facilitators 
or omitted altogether, the latter appearing to be function of the session not beginning on 
time or over-scripting in the curriculum.  Activities associated with lower fidelity for 
service provider sessions were those that had heavier scripting in the curriculum.  For 
example, in Session 1 the introductory scripting for “The CARD” (a pamphlet that lists 
all available HIV clinical trials offered at the UNC ACTU) was not read in its entirety by 
the facilitator either time the session was offered.  The facilitator did not highlight this 
during the debriefing interview for SP1; it was however mentioned in the debriefing 
interview for SP2.    This resource produced by the UNC ACTU quarterly, and is 
available for service providers to stay abreast of clinical trials for which their patient(s) 
could be eligible.  The follow-up exercise to the introduction of The CARD required the 
facilitator to tie four “eligible participant” profiles to trials currently offered on The 
CARD.  The scripting for this exercise also spanned several pages in the module, which 
may not have been practical for facilitators to read in their entirety.   
Variations also included facilitator provision of content beyond the information 
provided in the curriculum, as one facilitator detailed a considerable amount of 
contextual information about history of Project EAST (i.e., phases of the parent study, 
formative data findings, the community advisory board, and the refinement of the 
intervention study from the onset of the parent study).  Another facilitator provided 
analogies related to randomization, but drew examples from non-HIV clinical trials (e.g.,, 
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breast cancer and prostate cancer).  These examples were drawn in an effort to illustrate 
gender differences in the context of eligibility criteria for a clinical trial.   
 Most facilitators appropriately referenced critical information located in the 
speaker’s notes from PowerPoint presentations, but some were omitted altogether.  The 
use of “we” and “us” by the session facilitator was also documented on the 
implementation checklist, particularly in the context of clinical trial participation.  For 
example, if the facilitator stated, “We want to ensure that every clinical trial participant is 
treated the same…”, this had the potential to confuse clients, as the intervention study 
was not a clinical trial.  While none of the clients mentioned being confused based on the 
facilitator’s use of “we” or “us” during the follow-up focus group discussion, conflation 
between the intervention study and a clinical trial was noted by most facilitators at the 
onset of each series.     
Clear directives.  For service provider sessions, role play activities had the lowest 
fidelity, primarily due to time constraints and lack of adherence to introductory scripting 
for the exercise by the facilitator.  This introduced some confusion among participants 
prior to beginning role plays, as stated by one of the service providers SP1 during their 
focus group discussion at the end of the series.  The facilitator to be aware this, as it was 
not mentioned in either of the debriefing interviews for provider series.  The facilitator 
did however note participant confusion when starting role-plays:  
I think with role plays people always take a second to kind of figure out like, 
“Okay, what is this?” Perhaps given a better description but that’s pretty much, I 
don’t know what I would like for the role play--on the other hand but people 
definitely were kind of like, “Uh, exactly what am I?” 
        -Facilitator, SP2 (session 3) 
 
 83
Participant Involvement in Intervention Delivery.  Facilitators occasionally 
invited clients to take part in session activities that were designed to be carried out with 
members of the Project EAST research staff.  For example, a client in CL1 performed a 
skit with the session facilitator regarding patient-provider communication regarding trial 
participations..  While this was not identified on the implementation checklist for this 
session (nor was it mentioned during the facilitator debriefing interview), the session 
observer recorded the following information in his narrative summary: 
“One of the clients participated in the role play with the facilitator. Other 
[participants] seemed engaged during the role play.  One of the [participants] was 
observing and took notes. One mentioned that she liked that the service provider 
during the role play didn’t influence the [client participating in skit’s name] in 
participating in a clinical trial. [Session participant observing skit name] noticed that 
the service provider’s purpose was to inform and reassure [client participating in 
skit’s name] about clinical trials.” 
 
Facilitators also encouraged providers and clients participating in the sessions by 
inviting them to read information aloud from recap PowerPoint presentation shown at the 
beginning of each session.   These ranged from having clients read definitions of 
previously covered concepts to posing questions that encouraged their feedback (e.g., 
“Who remembers the four types of support we covered last week?”).   Additionally, 
clients in every group were offered the opportunity to assist with the introduction to read 
the “Type of Trials” handout.  Participant involvement in content delivery during the 
session was rarely noted during the debriefing interview by facilitators.   
Summary: Dose Delivered and Fidelity 
 The dose delivered and fidelity findings above highlight a few important points.  
First, as pointed out by several researchers, multiple methods are essential to assess 
process evaluation concepts for complex interventions.  The triangulation of data sources 
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in the dissertation study afforded the opportunity to objectively determine the extent to 
which intervention components were delivered as designed and the quality, or fidelity, of 
intervention delivery by session facilitators.  Additionally, the variety of data sources 
provided a means for findings to be validated or for gaps to be filled in the event that 
information was not captured by other data sources. For example, observational data 
highlighted participant involvement in the skit in Session 1 for the first group of clients.   
Neither implementation checklists nor debriefing interview data captured this 
information.    
 The dose delivered scores for client and provider series clearly demonstrate 
completeness of sessions across groups and group types to be very high, as the average 
dose delivered scores for these groups were .88 and .92 respectively.  Both average 
scores exceeded the acceptable score of .85.  Each facilitator’s average score also 
exceeded the acceptable score, with the exception of one facilitator whose average was 
slightly below at .84.  These data in isolation would lead researchers to conclude the 
intervention to be implemented very well across all sites.  Fidelity data however provide 
very important insights into how well session content was covered.   Major deviations 
from the script occurred with three facilitators, all of whom were offered remediation 
before reentry to the field.   
Facilitator exchange of terms like “luck of the draw” and “flip of a coin” had 
potential implications as it related to proper delivery of intervention content.  These 
deviations caused confusion among participants and indicated a lack of mastery with 
session content on the part of the facilitator.  Other incorrect information shared with 
participants included Project EAST’s use of participant identifiers (participant names 
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were not taken), and repeated inquiries from the facilitator as to whether participants 
disclosed their HIV status to anyone (this was not a part of the curriculum).  Lack of 
familiarity with session content was reflected in the delivery of sessions of facilitators, 
and mentioned by facilitators during their debriefing interview.  
Among service provider sessions, most variations in fidelity occurred with 
providers in SP2.  Due to the late arrival of facilitators on the first day, activities from 
session 1 had to be rearranged and placed in subsequent sessions.  The testimonial video 
for session 2 was forgotten when the session was implemented, so the video had to play 
during the following session (Session 3) for this group.  While all session activities were 
complete (as indicated through dose delivered scores on the implementation checklists), 
there was some variation in when the activities were implemented.    
Finally, the “Ask the Experts” session for participants in CL4 and SP2 were 
scheduled to be implemented on the same day due to the limited availability of the ACTU 
expert to moderate the last session.  This change meant the ACTU expert had to meet 
with service providers at the original study site and drive approximately 45 minutes to 
another site to meet with clients from the partnering study site at the local town hall.  This 
change shortened the service provider discussion time with the expert, and also caused a 
late arrival of the expert for client session.  
Dose Received  
 The following section details participant dose received for client and provider 
series.  Qualitative data from participant focus group discussions are presented to detail 
participant satisfaction with session content and activities.   The prinicipal investigator of 
the dissertation study created visual displays that organized these group type, group 
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number, and session number.  See sample displays in Appendices N and O for visual 
displays illustrating client and service provider satisfaction, respectively.  Convergent 
themes among clients and providers were related to satisfaction with: (a) discussion with 
the ACTU expert, (b), facilitator characteristics, and (c) interactive activities offered 
during the session.   Satisfaction data were also compared to facilitator perceived 
engagement themes for each respective group through the creation of visual displays (see 
Appendices P and Q for select sessions).  These analyses afforded an opportunity to 
explore convergence and divergence between these two concepts.  Like satisfaction data, 
visual displays were organized by group type, group number, and session number.   The 
following section will present convergent and divergent themes among clients and 
service providers, followed by comparitive analyses of these data with facilitator 
perceived engagement. 
Discussion with the ACTU Expert.   The last session in the client and provider 
series consisted of a 50-minute discussion with an infectious disease physician, or 
“expert” from the UNC ACTU.  The two physicians were also co-investigators on the 
parent study, and were involved in the development of the intervention activities.  Across 
the four client groups, participants were satisfied with the experts’ honesty and openness 
about the clinical trial referral and participation processes, and their use of lay terms to 
explain the referral and enrollment processes.  Prior to the discussion with ACTU expert, 
participants in every group stated a desire to hear more about the negatives related to trial 
participation as they felt the testimonial video only showed one side of the story by 
highlighting benefits of trial participation.  The following dialogue is from participants in 
CL1 regarding expectations of the “Ask the Experts” session: 
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R10:  It was totally different. 
R3:   Very different. 
R10:   Because we had the doctor.   
R7:   But also it was similar because he was informed and he was on top of the 
 trials and results.  He had examples of things that have been tested and, 
 and passed but not, you know, not perfect but working towards 
 perfection as far as curing HIV and AIDS.   
R11:   And he had testimonials I hadn’t heard before. 
R7:   The positive and the negative.  Because he said some people, some trials 
 were given that he thought that the people passed on so, you know, so 
 there was a positive and a negative in there with [this] conversation.  
R11:   I just think it was too short. 
R10:    It could have been longer. 
R7:      It should have been.  It was good though.   
 
Facilitators also noted this as being the most liked session overall by clients, often 
referring to participants “sitting forward” or “being attentive”.  Previously disengaged 
participants also dialogued with the expert, as highlighted by the session facilitator for 
CL1: 
I think that’s the first time I’ve seen [identifier - name] sitting up at attention at 
ninety degrees.   [identifier - name] as well sitting forward.  Nobody was looking 
away or distracted by anything during those sixty minutes. 
 
 A few interesting points were raised among facilitators and observers about the 
nature of client questions during the “Ask the Expert” session.  First, many of the 
questions in this group were previously answered through “parking lot” responses from 
the ACTU physicians.  Participants were made aware that all “parking lot” questions 
were being sent to the physicians from the ACTU, and hard copies of the responses were 
distributed to participants one week prior to meeting the expert.    Inquiries ranged from 
specific in nature (i.e. “Are there trials for non-progressors at UNC”) to general (“Do I 
have any rights?  If so, what are they?”).  The reasons for the redundancy of inquiries are 
unknown, as participants did not provide any information during their focus group 
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discussion about their rationale for asking questions a second time (i.e. validation of 
information, unsatisfactory responses from the Parking Lot, etc.).  When asked what 
participants like most about session 6, however, one participant stated, “That your 
questions were answered directly”.   Overall, the numbers of clinical trial-specific 
inquiries for the expert were relatively low among all client groups.  Participants asked 
questions about medical treatment, co-infection and other general HIV transmission 
questions. The facilitator of CL2 stated: 
Overall I, think [the session] was fine.  A lot of the questions were not 
necessarily--besides the ones that may have been on the “parking lot”--pertaining 
to clinical trials participation.  It was more HIV related care.  I think the expert 
was great but I think just like I said, the questions she was asked, especially the 
first question it seemed like it took fifteen to twenty minutes to answer and it had 
nothing to do with clinical trials…we had our two people [out of nine] who were 
mostly doing the talking, but everybody seemed to be really engaged. 
 
Providers, like clients, service providers liked the “Ask the Experts” session and found 
the information provided by the expert to be helpful.  Suggestions were made, however, 
to integrate the expert more in the activities during the last session, perhaps involving the 
expert in a role-play or having the expert give feedback to service providers on mastery 
on communication skills. 
 
 Facilitator Characteristics.  Clients and providers often referred to session 
facilitators as being “informative” or “personable”.  One client stated that she expected 
the series to be led by a doctor or nurse, but was glad to see college students facilitating 
the sessions.  This comment was mentioned in the context of facilitators being able to 
inform the “next generation” about HIV/AIDS so they would be knowledge of how to 
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protect themselves from HIV/AIDS.  One client described facilitators as being 
“informative”, but also making use of the “parking lot” when needed:  
Client: They were very informed, very knowledgeable and questions that were a 
“question mark”, they put on the parking lot and came back with an answer.  So 
they were good, excellent, top shelf. 
Moderator: So that was important to you to have good instructors?   
Client:  Yes. Somebody that’s teaching that knows and is aware of what’s going 
on. 
     -Female, year of diagnosis unknown, CL4 
Clients also spoke about being treated with respect and not being berated or talked down 
to “like they were in the sixth grade” and appreciated the reciprocal learning that took 
place during the session, stating:   
“You all keep it down to earth.…you all make us feel like you are learning just 
like we are.”   
 
Facilitators were trained to “use the wisdom in the room” in order to allow space to all 
participants to talk through any potential disagreements, value statements or inquiries or 
misconceptions related to HIV transmission or clinical trials research.   
 Interactive Activities. Clients and providers expressed satisfaction with a variety 
of interactive activities that facilitated an understanding of what clinical trials were, 
where they are offered, how to locate them, and what they should expect as part of the 
referral and enrollment processes in a clinical trial.  Clients and providers identified the 
“Break the Barrier” activity as the “most liked” or “most memorable” activity in the 
series.  In this activity, each group brainstormed a list of barriers to clinical trial 
participation.  After this list was generated, participants were divided into small groups 
and competed to provide solutions to the barriers, thus “breaking them”.  Clients 
appreciated having an opportunity to engage with one another during session activities, as 
opposed to having to be seated the entire time.  One participant stated this form of 
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instruction and the layout of the series allow clients to “full view of what’s going on” 
instead of just being told”.   After taking part in the randomization activity during the 
“Clinical Trials 101” activity, one session participant stated: 
I liked that flip a coin deal because… like she said, when you put your hand in 
that bag and you take out something, you don’t know what class you’re going to 
be, A, B, C, D, or E…So it helped me understand that better. 
       -Female, diagnosed < 1 year, CL4 
 All clients mentioned skits as their “most memorable” or “most liked” part of 
participation in the series.  One participant perfectly summarized a patient-service 
provider skit during the session by saying the participant was “informed, but unsure” and 
met with her case manager to get reassurance as part of her decision-making process.   
She went on to say later during the follow-up focus group discussion: 
… it was like questions that you may have in your mind and you may not know 
how to formulate it but…she asked the questions that I might not have put in 
words the way I wanted to…and it helped me to get a better idea as to how I 
should proceed as far as getting this information and then bringing it to my 
service provider to help me help myself.  Basically that’s what this class is about--
it’s about teaching you how to help yourself and get information and that’s a 
good thing. 
       -Female, year of diagnosis unknown, CL1 
 
 
Like clients, the “most liked” activities were those that required a considerable 
amount of participant engagement.  In addition to “Break the Barrier”, service providers 
identified the “Locating Clinical Trials” internet activity and Informed Consent Jeopardy 
(an activity that that familiarized service providers with the major sections of the 
informed consent form).  When asked about suggested modifications to the curriculum 
during the focus group discussion, one service provider exclaimed, “Don’t do away with 
Jeopardy!”  While facilitators and observers noted heightened energy and playfulness of 
service providers at both sites during the Jeopardy activity, this was an interesting 
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finding, as session facilitators at both sites stated they felt like they were teaching 
material to service providers who already knew about clinical trials at some level, thus 
providing elementary information.  One facilitator stated during a debriefing interview: 
Um, the doctor…I always wonder when you’re sitting in a room with a physician 
teaching him stuff with handouts and colors and teaching stuff on a very 
elementary level how that plays out… 
                   -Facilitator, SP2 
 
The HIV physician in this group spoke to the contrary, as described below:  
It’s a tough time for any presentation because it’s right after lunch or during 
lunch.  Your attention, attention span is going down as it is, but the role play and 
the computer and hands on, you know, get you participating.  And the Jeopardy 
and all those things will definitely need to stay [up]. So you stay up. 
         -HIV Physician, SP1  
 
Peer Influence.  Service providers described the testimonial video as an 
“excellent” tool for clients as it showed someone who participated in a clinical trial and 
“is still alive to share his story.” This mirrored some of the sentiments shared by clients 
regarding the likelihood of death as a trial participant, and requests to provide mortality 
and/or serious illness statistics to participants in the clients groups.  Service providers as 
both sites were described as being attentive during the video by observers and facilitators 
in the sessions.  Providers in SP1 provided a considerable amount of feedback on the 
video and had questions related to clinical trial participants being able to switch from one 
trial to another for treatment of their HIV (rollover studies).  One service provider also 
shared concern about patients moving their primary care to UNC during trial 
participation. 
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…the apprehension with some of the service providers in the rural areas is that 
am I going to be [losing my patient].  Now the problem is that UNC might have 
the resources within the study to provide 24/7 outreach over the phone whereas 
local places might not and they say well, “UNC is doing more for me now that 
I’m participating in this study.  Why would I go to my old service provider?” 
           -Pharmacist, SP1   
  Group Setting.  An additional salient theme among clients was being offered the 
opportunity to be in a group setting with other people living with HIV/AIDS.  Session 
facilitators observed this during CL4 where participants shared testimonials about their 
diagnoses, experiences with discrimination, and breaches of confidentiality by others in 
the community.  These discussions occurred during the session, and well into their lunch 
break.  During the follow-up focus group discussion for CL2, which was one of the most 
heterogeneous groups in terms of prior knowledge of one another, one participant stated: 
 Well you’re more relaxed and you’re able to just say what you have to say and 
you don’t feel uncomfortable to talk, because you’re around people that have the 
same problem. 
       -Male, year of diagnosis unknown 
 While clients often gave brief responses as the most liked activity during the 
session (e.g., “the video”), service providers described as an excellent tool for clients 
considering clinical trial participation, as it showed a rural, racial and ethnic minority 
who participated in several clinical trials at the UNC ACTU.  Clients participating in the 
sessions did suggest, however on several occasions that a “real” person give their 
testimony.  During the last focus group discussion for CL2, one participant explicitly 
requested “a real person, not the video”.    
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Satisfaction and Perceived Engagement 
 Engagement in the form of questions and/or feedback varied among client groups, 
with CL1 being the most engaged participants, from the perspective of facilitators and 
observers at both sites.  Interactive activities, however, heightened participant 
engagement across all groups, even if engagement at the onset of the session was 
considered to be low by the session facilitator.  All participants (service providers and 
clients) were attentive and engaged with ACTU expert, with the exception of service 
providers in SP2, where the nurse practitioner posed a great majority of the questions.  
This raised a broader concern of perceived disengagement of service providers at this 
site, as the facilitator noted stark differences in engagement of service providers across 
sites.  During each facilitator debriefing interview for SP2, service providers were 
described as being “tired” or “nodding off”.   A partial explanation of this disengagement 
could have been due to the extra work and time required for service providers in this 
group, as the session was held in a town hall approximately a 30-45 minute drive to the 
sessions.  This was not the case for providers in SP1, as sessions were carried out in their 
clinic, a few short minutes away from their offices.   
Dose Received: Satisfaction & Facilitator Perception of Engagement 
 There was not a formal inquiry into which session(s) were “most liked” of all the 
sessions offered, but across all groups a common theme was interactive activities.  
Among all client groups, skits, the discussion with the ACTU expert and the “Break the 
Barriers” activity were mentioned the most as being the most liked activity.  Facilitators 
and observers also noted heightened engagement among participants during these 
activities.  Among service providers, the activities identified as “most liked” were the 
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clinical trial participant testimonial video and Jeopardy, both of which were documented 
as very active activities by the facilitator, particularly service providers in PR1.   
 An important finding, however, was a lack of concordance in facilitator 
perception of engagement and participant report of satisfaction with activities in the 
session.  This was partly due to the facilitator’s: a) observation of the lack of feedback or 
questions from session participants, b) interpretation of body language as tired or bored, 
or c) perception of participant frustration of facilitator’s lack of knowledge about clinical 
trial specific questions.  One example of this disagreement was with the “Referral to 
Participation” presentation, as the facilitator sensed the providers in SP1 felt they were 
“being lectured to” and preferred to have their questions answered before moving on the 
next exercise (as opposed to being put in the Parking Lot to bring back at the subsequent 
session).  Service providers stated during the focus group discussion, however, the 
comprehensiveness and detail of the activity was very helpful and provided a visual 
representation of the entire referral process.   
 Divergence in themes was also seen between facilitators and service providers in 
group SP2.   The facilitator and observer noted the service providers to be attentive 
during the testimonial video, but were surprised at the lack of feedback during the post-
activity discussion.  Additionally, the facilitator noted three participants’ body language 
still appearing to be disengaged during the locating clinical trials activity (e.g., talking on 
the cell phone, leaving the room for extended periods of time, engaging in side 
conversations) but each contributed to the brainstorm activity for this exercise.  Both 
activities were identified as the “most liked” for service providers in this group. 
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Summary: Dose Received 
 Qualitative dose received data provided very important insights into participant 
engagement and satisfaction, and further illustrated the need for triangulation of data for 
process evaluation research.  Objective data from the perspective of observers was 
essential in better understanding non-verbal indicators of participant engagement.  For 
example, participant excitement, spatial arrangements, or even nodding off were 
important in better exploring indicators of participant engagement. 
Intervention Modifications and Future Recommendations 
Client Suggested Modifications 
 
 The principal investigator of the dissertation study Suggested modifications to 
improve the content and delivery of intervention activities were assessed through and 
participant focus group discussions (clients and service providers) and facilitator 
debriefing interviews.  Additional findings for each group are presented below.  
More time with ACTU expert.  A salient theme for clients and providers was a 
desire by to have more time to interact with ACTU expert.   This “interaction” varied, 
however, as providers wanted to incorporate the ACTU expert in session activities in 
order to understand how he, as an HIV physician, has overcome common barriers 
associated with clinical trial referral and participation.   The “Ask the Experts” session 
for providers was designed to implement “Break the Barrier” before the discussion with 
the expert.  As service providers brainstormed barriers on two separate occasions during 
the series (session 1 and session 4), they suggested that the latter brainstorm be removed 
altogether and instead have the expert spend the session having conservation with the 
local service providers.  They further stated the expert could also revisit the barriers 
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generated during the first service provider session, and offer his advice on “breaking” 
those barriers.  The text below illustrates service provider feedback on integrating the 
expert in the “Break the Barrier” exercise in the final session: 
“Why not have the expert tell me how a particular group has already addressed 
these barriers?  Why do I need to come up with ways around it when I’m really 
operating on a referral source format.  What has UNC or any other particular 
group done to overcome those? 
         - Case Manager, CL1 
Clients liked the forum-like question and answer session and simply wanted to continue 
conversing with the doctor.  Participants stated they could have continued the discussion 
for at least another hour given the additional time.  Clients also proposed inviting 
additional physicians from UNC join the discussion, possibly in a panel format.  One 
client stated the number of panelists would essentially reflect what they experience a part 
of their HIV care--multiple doctors over the course of the day.  The same participant 
referenced wanting to see a “real doctor” that “has an office”.   
Provision of session materials.  Clients and providers expressed a desire to be 
provided with session materials (e.g., handouts) both in-session and as take home 
materials.   As part of the informed consent activity with clients, a sample consent form 
was made available for participant perusal during session breaks.  Some participants 
requested copies of sample consent forms to review on their own.  Additionally, a 
participant in CL3 expressed the necessity of providing handouts to assist participants 
with retention of information to the facilitator during the second half of the “Clinical 
Trials 101” PowerPoint presentation that detailed the informed consent process:  
Client: It’s, just something to reflect on.  You know? I mean because we can’t 
remember everything on a blind, slide.  If it’s in front of us and we want to 
go back and reflect on it, we’ll have it.  That’s all. 
Facilitator: Right.  What we have done is give out notepads and pens. 
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Client:  Well the whole point is you can’t expect us to keep all this in our heads. 
Moderator:   I understand.  
Client: And some people just can’t write that quick.   All this stuff you’re all going 
over, I cannot just sit here and write everything down. It ain’t going to 
work. 
    -Male, diagnosed 15+ years, CL3  
 Interactive Activities.  Clients expressed a desire to have more interactive 
activities as part of their participation in the sessions, (e.g., role-play activities) and a 
desire to provide more challenging activities.  Role-plays were not a part of the client 
curriculum, so as to not make any participants uncomfortable if they had any literacy 
challenges.   Modifications for this group also included “mixing up” images for the social 
support poster activity to challenge their thinking during the activity.   The activity 
consisted of participants matching paper slips containing short vignettes about a potential 
clinical trial participant to one of four corresponding posters that illustrated the four types 
of support.  Vignettes and posters had identical images that conveyed people receiving 
picture receiving support.    The majority of clients wanted the vignettes to remain the 
same, but for the images on the vignette to be rearranged, so that the images no longer 
matched or corresponded to the poster.   One client group failed to observe the 
association between the images on the vignettes and posters, despite several probes from 
the facilitator.   
Accessibility of Clinical Trial Information.  Clients inquired about alternative 
ways to access information about clinical trial opportunities on the Internet, particularly 
those with limited computer skills.  One participant acknowledged the Internet as being a 
“quicker” resource to locate clinical trials, but he would need assistance or training to 
navigate these opportunities.  At the end of the “Locating Clinical Trials” Internet 
activity, another participant highlighted several concerns as it related to accessing 
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information about clinical trials offered at major medical centers, also suggesting 
alternative forms of dissemination.  He went on to highlight challenges with Internet 
accessibility and availability for many other people living in rural areas:  
I was just wondering if there was a forum or something you could visit or be a 
part of or maybe a mailing list where they mail you different things letting you 
know--that way you’re not always everyday out there looking for these trials, they 
come straight to you. It looks like they would put people that are interested in 
clinical trials right on a mailing list…because not everybody wants to keep going 
to the different websites--you might not always have access to a computer. 
Sometimes I go months without being able to get on a computer, and when I do 
get on, I don’t be thinking about clinical trials.   
       -Male, diagnosed 15+ years, CL3  
 Participants in CL2 also expressed a desire to visit a major medical center as part 
of their participation in the series.  While observing the clinical trial brainstorm and 
Internet exercise during a client session, one facilitator noted:  
We need to know where [clinical trial opportunities] are here…making [the 
exercise] more culturally or context appropriate--their local newspaper or 
whatever…because these are typically offered by major medical centers.  But, I 
was just sitting there thinking--watching the activity like [the nurse practitioner in 
CL1] told us [before] they’re not advertised here…  
 
 In-Person Clinical Trial Participant Testimonial.  The most salient theme as it 
related to client suggestions for modifications was to provide an opportunity for 
participants to dialogue with a former or current HIV clinical trial participant.  Many 
referenced wanting to hear the “pros and cons” of participation because the sessions 
provided the benefits of participation, but no information on unknown or undesirable side 
effects experienced by former participants.  Some referenced wanting to hear a “true 
testimony”, “outcomes”, or “statistics” in this regard.  Another important finding was 
related to client perspectives on the role of peer influence in the clinical trial decision-
making process.  During focus group discussions, clients were asked to provide thoughts 
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about additional information they felt was needed to make the decision to participate in a 
clinical trial, or what modifications they would suggest for future implementation of the 
client series.  Most indicated a desire to have a face-to-face discussion with a former or 
current clinical trial participant.  This was among the most salient themes across all client 
focus group discussions and was mentioned several times over the course of the client 
series.  
Facilitator Suggested Modifications (Client Series) 
Interactive activities.  Modification themes for facilitator suggestions were 
consistent with client suggestions for more interactive activities.  For example, one 
modification suggested by a session facilitator was to make the informed consent activity 
(which consisted of participants developing a “silly” consent form) more closely related 
to participants’ everyday lives in order to foster more interaction and dialogue: 
…before you jump into all of this heavy duty language… what are some other 
things that maybe that they would have to give consent for outside the medical 
field or research field…something that indicates agreement between [them] and 
someone else?  I wonder if we could do like, “How many of you guys have 
apartments or other things that other people have to do some sort of contract 
with- -and what are some things that you would have to, what are things you want 
to know?” 
 
Remove activity.  Facilitators questioned the utility of homework assignments for 
service providers and clients.  Across all groups, a few participants completed the 
“Locating Clinical Trials” homework assignment to search for clinical trial opportunities 
advertised in their communities.  The greatest proportion of participants completing the 
homework assignment was in CL1, as four of the 11 participants (36%) completed the 
assignment prior to session 5.   
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Pictorial Additions.  The most salient challenge for clients, according to facilitator 
debriefing data, was conflation of HIV care with HIV clinical trials.  Of the clients 
having challenges making the distinction between the two treatment options, the 
confusion was a result of their familiarity with terms such as  “tests”, “test run”, or “trial” 
used in the context being switched from one treatment regimen to another as part of their 
regular HIV care.   A few participants believed the intervention study to be clinical trial 
because they were “learning new things”, or because they were completing surveys as 
part of their participation in the research study.  Given the conflation of HIV care with 
HIV clinical trials by some clients participating in the intervention study, facilitators 
noted the need for a clear distinction to be made prior beginning the intervention 
sessions, by offering a pictorial representation of the continuum of HIV care: 
 …describe how HIV fits into HIV care… I think they’re still conflating the two 
and I think that’s because--perhaps we should preface this whole exercise with, 
“This is HIV care.  You go to your doctor for this.  This is probably what all of 
you are doing right now in some form or fashion”, and [then], “This is what a 
clinical trial is…   
 
Clients did not express this need for this distinction during any of the sessions, but 
questions asked during subsequent sessions, including the session with the ACTU expert, 
indicated a need to make these concepts clear and distinctive at the onset of the series.   
Service Provider Suggested Modifications 
Restructure Role Plays.  For service providers, most suggestions for modifications 
to session content revolved around communication and skill-building.  There was an 
overall feeling that role plays seemed to be “crammed in” at the end of sessions, and that 
clear directives needed to be given before service providers were expected to begin these 
activities.  Providers also suggested role-plays incorporate observation and feedback from 
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facilitators or ACTU expert in order to determine if key skills to be learned by service 
providers were indeed mastered.   
Clear expectations/directives.  Service providers also noted the need to restructure 
the “Break the Barrier” activity, as the content seemed to overlap with the barriers they 
generated at the onset of the participation in the series.  This led to some confusion 
among participants at the beginning of the activity, as they believed the session was 
dedicated solely to conversing with the ACTU expert for the 60-minute session.  One 
participant stated: 
We’re going to talk about these barriers again and how we can break them down 
and then we’ll have an expert here to address some of those barrier issues but 
that wasn’t how I felt it was communicated to us.  So it did not seem to really 
flow- -or you know, it wasn’t what I expected.  And I thought, “Why are we 
talking about barriers when we talked about that in the first session?  We’re back 
to where we started. 
           -Nurse Practitioner, SP1 
Restructure “Locating Clinical Trials” activity.  During the “Locating Clinical 
Trials” Internet exercise in session 3, providers in SP1 requested that a handout detailing 
a list of the bookmarked CTs on the laptop computers be provided from them to use as a 
reference in the clinic.  This was referenced again during the focus group discussion for 
participants after completion of the entire series.  Service providers also suggested 
integrating the Internet activity with other session activities in the form of a case study to 
replace the homework assignment: 
I guess maybe having a case study, a case scenario.  “You have this patient.  This 
is the criteria they fall under now go surf the Internet and find a study that they 
would be able to--” instead of doing [the homework]. 
           -Nurse Practitioner, SP1 
  HIV Clinical Trial Referral Liaison.  Finally, service providers shared the realities 
of their everyday work schedules: demands at work limited the extent to which they were 
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able to spend time engaging in dialogue with eligible trial participants.  This, in addition 
to the challenges with the referral process caused service providers with previous referral 
experience to be less likely to refer other eligible clients.  While they found the sessions 
to be helpful in learning more about clinical trials and clinical trial opportunities, they felt 
that provision of a liaison from a major medical center, or a direct phone number was the 
best way to increase referral of their eligible clients.  Additionally, one service provider 
noted that while he fully understood the importance of the four service provider roles 
suggested in the curriculum (inform clients about clinical trial opportunities, listen to 
concerns about trial participation, address misconceptions related to HIV and HIV 
clinical trials, and to support clients in a neutral and balanced way), he could not serve in 
the capacity of a “neutral” party if he felt a clinical trial was the best option for his client.   
Facilitator Suggested Modifications (Service Provider Series):  
Restructure Role Plays.  A salient them for facilitators was the need to restructure 
service provider role-plays as participants often ran out of time to complete the activity 
during each session.  Unlike service providers, facilitators did not suggest a modification 
of providing feedback to session participants.  A suggestion was made, however to 
remove a role-play from a previous session in order to allow service providers to have 
more time with the expert, and to spend more time completing the final role-play in the 
series: 
 …  If you had asked me an hour ago, I would have just said to keep it [solely as] 
a “Ask the Experts” session but I do think giving [service providers] one final 
opportunity to mull through everything they learned in all the sessions and what 
they learned from the expert being there--move “Break the Barriers” somewhere 
else and take out another role play…possibly the role play with the referral 
source because Dr. [ACTU expert] ends up being the clinical trial staff member 
… 
             -Facilitator, SP1 
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Summary: Suggested Modifications 
Convergent modification themes for clients and facilitators included relevance of 
session materials and the need for more interactive activities. Facilitators noted a need for 
the locating clinical trials homework/internet activity to be restructured to be relevant for 
service providers and clients in the study counties.  While facilitators identified a need to 
explore where, or if, opportunities were advertised in the community, clients gave 
recommendations ranging from a community forum to a mailing list.  Facilitators and 
clients also identified a need for more opportunities for clients to be involved in more 
interactive activities, specifically in session 3, which is the longest in the intervention 
study (80 minutes).   
 Both service providers and facilitators suggested modifications for “Break the 
Barrier” activity, but service providers suggested complete removal from the activity in 
the last session.  Likewise, both groups saw a need to restructure the “Locating Clinical 
Trials” homework activity, as completion of the handout was minimal for each service 
provider group.  Service providers suggested the handout be integrated with the 
“Locating Clinical Trials” Internet activity to afford service providers the opportunity to 
find trials for eligible patients.  One service provider suggested that vignettes be provided 
from the “Referral 101” activity, so each service provider would have a sample profile 
from which he/she could begin the search for a trial on the web.  The handout would then 
serve as a place to document the relevant information for the clinical trial.  The facilitator 
simply suggested removing the homework altogether.  
  
 
 
 
CHAPTER 6 
     DISCUSSION 
 
 The purpose of this dissertation study was to evaluate the implementation of the 
Project EAST intervention study, which was designed to increase rural service provider 
willingness to refer eligible racial and ethnic minority clients to clinical trials and to 
increase these clients’ participation in HIV/AIDS clinical trials.  The intervention study 
built upon previous educational outreach studies by using a multilevel approach to 
educate both of these groups concurrently, with a staggered approach.  As the Project 
EAST intervention was the first of its kind, it is important to highlight implications of the 
process evaluation findings to inform intervention development, implementation, and 
evaluation for comparable efforts in rural contexts.  This dissertation study assessed the 
intervention study’s reach and the context in which it was implemented, as well as the 
recruitment of series participants (service providers and clients).  Additionally, the 
dissertation study assessed the fidelity, dose delivered, and dose received of each series in 
the study independently, and comparatively across groups.  This chapter will revisit the 
study aims to determine the extent to which the intervention was implemented as 
designed, provide recommendations for evaluation methodology, curriculum 
modifications, and staff trainings based on the relevant process evaluation concept.  
Context findings will conclude this section.  The chapter will conclude with presentation 
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of the dissertation study’s limitations and strengths, as well as implications of the process 
evaluation findings for public health research and practice.   
Achievement of Study Aims 
Aim # 1: Evaluate the implementation of an educational HIV clinical trial intervention 
with rural, African American people living with HIV/AIDS (PLWHA).  
Reach and Recruitment.  Overall, the client series was implemented as intended.  
The recruitment goal for the intervention study was 40 racial and ethnic minority clients 
receiving HIV services at the participating clinics; thirty-four ultimately participated in 
the client series.  Of these, two clients did not meet the eligibility criteria for race.  
Additionally, research staff discovered after series implementation that an additional 
client had severe cognitive functioning challenges.  Recruitment procedures for clients 
were followed in general by Project EAST research staff and the study site recruiter albeit 
reassignment of staff responsibilities at the original clinic prior to implementation of the 
last client group (CL4).    
Recruitment efforts could be enhanced by providing more in-depth training for all 
site staff involved in recruitment of clients to ensure all session participants meet 
eligibility criteria prior to implementation of the series.   Associations between process 
and outcome data for the parent study will be explored through analyses of various client 
characteristics linked to a variety of their respective service provider’s characteristics (at 
baseline and across time points).  That said, it is imperative for research staff to clearly 
communicate eligibility criteria for clients to ensure site recruiters are fully aware 
inclusion and exclusion criteria.  While this recruitment error was negligible for process 
data collection and interpretation, it may pose challenges in making associations between 
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process and outcome data, and further exploration of these relationships through linkages 
of client and service provider outcome data at the site.  For example, if a client does not 
receive his HIV care at the participating study site, his outcome date data (i.e., 
willingness to participate) cannot be linked to any service provider outcome data (i.e., 
willingness to refer) at the site.  Perhaps a more effective recruitment strategy is to have a 
member of site staff in the clinic identify eligible clients from medical and case 
management records based on the six service providers selected to participate in the 
series.  These clients could be contacted by a designated member of the clinic staff 
associated with his care via telephone, by a peer who is also HIV-positive, or during an 
in-person visit.  A reinforcing strategy could be to place a an informational flyer about 
the intervention study in the client’s medical or case management record to have service 
providers offer the opportunity to eligible clients during their clinic visit.  Or, if 
medications are dispensed within the participating clinic’s pharmacy, the flyer could be 
placed in the client’s pharmacy bag.  For quantitative process data collection and 
analyses, the number of: 
- eligible clients (based on determination from medical records),  
- clients contacted or approached (via telephone or in-person invitation) 
- follow-up communication attempts were made for interested clients 
- clients agreed to participate in the series,  
- present at the onset of the series,  
- present during each session 
- peer interactions, and  
- flyers distributed (distribution in-person and in pharmacy bags)     
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Dose delivered and Fidelity.  The average dose delivered score for the entire 
client series across all groups was .88, which was slightly above the acceptable score of 
.85.  While there were no major variations in dose delivered scores based on facilitator 
characteristics for service provider or client series, intervention delivery varied 
considerably.  These variations ranged from provision of incorrect information about 
clinical trial concepts to incorrect delivery of intervention activities, both of which had 
implications as it related to participant process (i.e. engagement, satisfaction) and 
outcome (i.e. knowledge, attitudes, or self-efficacy) data.    For example, if the facilitator 
paralleled randomization to the “luck of the draw” as opposed to the scripted reference of 
“flipping of a coin”, this could affect response to the knowledge item on the survey that 
parallels randomization to flipping a coin.  Further, in this context of the former analogy, 
participants may interpret randomization as gamble of sorts, as opposed to an equal 
chance of receiving treatment.  These deviations from scripting were often identified and 
corrected during the session or during the subsequent session, however a concept as 
integral has no room for variation in delivery.  
There were, however, variations in facilitator delivery of the session content that 
appeared to be a result of some ambiguity and lack of clear directive training materials 
(recap presentation) and insufficient mastery of clinical trial content and curriculum, as 
well as A review of facilitator training materials, intervention curriculum, and session 
transcripts indicated the need for a few modifications.  There is a growing recognition of 
the importance of fidelity of implementation (FOI) in intervention research, however 
challenges persist with conceptualization and measurement of this concept (Century, 
Rudnick, & Freeman, 2010).  
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Deviations from scripting could be better assessed through coding of session 
transcripts to determine the type of deviations (e.g., omission of information, rewording 
of scripting, etc.) to better understand if these variations were due to intervention failure 
or implementation failure.  Qualitative fidelity data could be supplemented with 
quantitative fidelity data to assess the influence of fidelity on main study outcomes and 
provide contextual information as to what barriers were to maintaining the quality and 
integrity of the intervention.  
Intervention developers should determine what items are considered to be core 
components are it relates to study outcomes, and what items can afford some variability.   
In other words, identify what components of the intervention will have the strongest 
influence on the study outcomes based on sociobehavioral theories or researcher 
experience.  This could be a very integral part of ensuring these components are delivered 
as intended, by incorporating this information in facilitator training.  Facilitators should 
be provided with indicators of acceptable adherence as part of their training to ensure 
readiness to enter in the field, and full comprehension of the intervention curriculum for 
clients and service providers.   There is a recommendation to re-educate participants if 
more than two months have passed between clinical trial education and the actual 
informed consent process to enroll in a trial due to the complexity of clinical trial 
information (Campbell et al., 2008).    
 
Dose Received.  Another important finding for the client series was related to 
client perspectives on the role of peer influence in the clinical trial decision-making 
process.   A great majority of clients suggested having an in-person testimonial from a 
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current or former clinical trial participant.  This finding was surprising for a few reasons.  
First, to lessen any client fears or apprehension of involuntary disclosure of their HIV 
status, the research team involved in intervention development intentionally did not 
introduce individuals who were not participating in the series, including HIV-positive 
clinical trial participants.  As such, the clinical trial participant testimonial video was 
chosen as an alternative form to convey an HIV clinical trial participant’s experience at 
the UNC ACTU.   Surprisingly, clients did not express any apprehension with the 
addition of in-person testimonial.  This delicate balance of peer influence within client 
risk assessment leads to a broader question of how clients process risk as part of the 
decision making process.   Not a great deal of formal inquiry into clinical trial basics.  
Does peer influence supersede provision of detailed information about clinical trials?  
Should both be used in concert to achieve the goals of increasing awareness about clinical 
trials, and ultimately participation in clinical trial research?  There are not established 
best practices associated with normative beliefs, or peer influence with African 
Americans living with HIV/AIDS, or rural, African Americans living with HIV/AIDS in 
the context of HIV/AIDS clinical trials. 
Results from the ACT2 study do however shed some light on the effect of direct 
peer involvement, as their study reported a 55-fold increase in screening for clinical trial 
enrollment when patients were given a component that included a peer discussion 
compared to those who did not receive a peer component (Volkmann et al., 2009).  This 
study also used respondent-driven sampling (RDS), a method that afforded participants 
completing the intervention to then have the opportunity to serve as peer educators for 
subsequent trainings.  This type of sampling has been recommended where identification 
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and selection of participants can be difficult, such as populations that have been 
marginalized by society or a those that have a history of mistrust from the research 
community (Kogan et al., 2011).  Future studies should consider training former trial 
participants who are interested in serving as peer recruiters, or RDS “seeds” to recruit 
potential participants for the educational series, and ultimately, clinical trials.   Clients in 
the Project EAST intervention study expressed interest in serving as peers in educating 
other people living with HIV in their communities about information learned during the 
series. 
 The majority of clients had question onset of series implementation that related to 
content covered in subsequent sessions in the series.   Facilitators noted participants 
“frontloading” with questions covered in future sessions and felt there was a sentiment of 
“solicitation”, and therefore a “cut to the chase” response.  Client inquiries at the onset of 
series implementation ranged from access to medication after clinical trial participation to 
participant rights and researcher responsibilities in the event of an adverse event.    
These questions were also asked of the expert, despite answers being given through 
“parking lot” responses the week prior.  It is not clear whether there was a lack of interest 
in clinical trials participation a desire to use the opportunity to answer lingering questions 
regarding their care.  The research team original thought the name of the session “Stump 
the Experts” set a tone of challenging the expert to assess their clinical trial knowledge, 
as opposed to using the session as an opportunity thus the name was changed to “Ask the 
Expert”.  There were still numerous of questions about HIV treatment in general, and 
specific questions related to a client’s particular regimen.   Consideration should be given 
to introducing the ACTU expert at the onset of the series to give an overview of what he 
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does as part of his role as an ACTU researcher, what a typical participant experiences as 
part of the referral process, and then preface what the remainder of the intervention 
sessions entail for clients participating in the series.  
 An additional modification for the client series is to incorporate analogies 
provided by the ACTU physician during the “Ask the Expert” session.  Pretesting of the 
curriculum revealed some anticipated questions, and afforded the opportunity to the 
research team to refine the curriculum prior to implementation of the intervention study 
The ACTU expert parallel HIV and host cell receptors to a “lock” and “key” to illustrate 
how HIV seeks out a specific receptor on the host cell to attach and insert its genetic 
material (RNA) to be replicated by the host cell.  Another analogy provided by the ACTU 
expert was the explanation of trials offered at the UNC ACTU.  The expert explained that 
most trials at the ACTU were phase 3 or phase 4 trials, so they were essentially 
comparing Coke with Pepsi—two medications known to already work, just seeing which 
works best for a given population.   
Process Evaluation Methodology.  Client focus group discussions raised few 
concerns for collection, analysis and interpretation of dose received of study participants..  
First, satisfaction of each participant was difficult to assess as, a group format does not 
necessarily ensure feedback from each individual in the group.  For example, if there was 
a dominant speaker in the group who answered the majority of questions, with verbal or 
non-verbal affirmations from others in the group, it is difficult to assess the extent to 
which the responses truly reflected the thoughts of everyone in the group.  Secondly, 
brevity of some client responses regarding what was “most liked” or “most memorable” 
about the sessions did not provide a wealth of information, even if probed further by the 
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moderator of the discussion.  Third, the frequency with which these group discussions 
occurred may have led to fatigue on the part of the clients.  While it is not possible to 
determine if repeated questions during each focus group limited client feedback, it is a 
consideration for future process evaluation studies in determining the best methods to 
assess participant satisfaction, including the frequency of data collection.  Lastly, focus 
group discussion guides should be modified to reflect the theoretical objectives and 
associated activities of each session, as opposed to general questions asked for each 
session.  For example, clients were asked about their confidence in speaking to a referral 
source during each focus group discussion held in their series.  It was not clear if the 
questions were related to changes in confidence over time given the variety of activities 
offered, or if change in confidence was a direct result of a specific activity from the day’s 
session.  Conversely, the focus group method to assess dose received worked much more 
effectively for service providers as compared to clients in terms of feedback and 
satisfaction with session content.   
Satisfaction surveys provided very little variability for clients and providers, as a 
great majority of participants indicated they “strongly agreed” or “agreed” with each 
statement on the survey.  Qualitative methods should be explored to better understand 
what activities were most liked and why intervention participants liked them.  
 A final concern in the rural context related to potential literacy issues among 
clients participating in the intervention sessions.  A small number of clients expressed 
literacy challenges at the onset of their respective series by openly stating they could not 
read, or by requesting help from a member of the research team in completing surveys or 
handouts given during the session. While this did not seem to be a barrier to retention in 
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the series, one participant in CL4 who expressed this concern did not return after the first 
day of the series and was lost to follow-up.  Literacy also may have played a role in the 
limited feedback given during focus groups discussions or during the intervention session 
itself, but assessing how this may have factored into participant engagement or 
comprehension of session content is not possible.  While demographic data, including 
educational attainment, was collected at baseline, these data are not indicators or proxies 
for literacy. 
 
Aim # 2: Evaluate the implementation of an educational HIV clinical trial intervention 
with rural service providers. 
 Reach and Recruitment. The service provider series was also implemented as 
intended.  Fidelity was a concern for the second service provider group (SP2), as session 
activities were rearranged as a result of the delayed start time for the first session in the 
series.  This modified sequence did not appear to compromise the fidelity of intervention 
delivery, as none of the rearranged activities (i.e., clinical trial testimonial video or 
patient-service provider skits) was reliant upon content presented in previous sessions.  
Dose delivered and Fidelity.  Average dose delivered scores for the entire 
provider series were slightly higher than those for client series (92, and .88 respectively), 
which may be attributed to a smaller number of sessions and shorter duration of sessions 
(thus less opportunity for variability in provision of session content).  Fidelity long 
scripting condense and identify what information is most salient, core components 
Intervention Modifications.  Service providers, like clients, also raised several 
concerns related to post-trial availability HIV medication for their clients, as well as 
expectations of local service providers in resuming the patient’s HIV care, particularly if 
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neither is aware of treatment their client received while in a clinical trial.  While blinding 
increases methodological rigor and ensures equal treatment for participants, it also it one 
of the biggest concerns of service providers resuming their clients HIV care after the trial.  
Service providers acknowledged having limited time available to fully engage in 
informing their clients about clinical trials due to their responsibilities in the clinic), yet 
there was consensus about the importance of understanding the comprehensive picture of 
what the referral and enrollment processes look like for local service providers, clients, 
and clinical trial staff—including responsibilities of all parties involved.   Provision of 
practical examples of client post-trail linkages to care, including associated forms or 
contracts, information about the average duration of post-trial care, and alternative 
options beyond trial participation. 
 Second, intervention developers should collaborate with researchers and 
practitioners at ACTU prior to intervention development to discuss alternative forms of 
dissemination of clinical trial opportunities, particularly for rural populations who may 
not have access to the Internet, or limited skills to use the Internet to find these 
opportunities.  As the epidemic continues to burgeon in rural areas, this is a very 
important factor in ensuring availability and accessibility of information about clinical 
trials to those who are most disproportionately affected by HIV/AIDS.  Sharing 
information about the accessibility and availability of clinical trials with participants was 
one of the goals of the EAST series.  The Internet, while useful for many may not be an 
ideal way to disseminate information about available clinical trials.  As the epidemic 
continues to affect the poor and underserved, researchers should rethink efforts to recruit 
minorities, particularly in the rural Southeast.   One participant suggested a mailing list or 
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forum to share information about trials with rural clients, as many people in rural areas 
have their mail sent to post office boxes, which would ensure their privacy.   As the 
intervention is a multilevel effort, researchers and practitioners should provide a forum or 
mechanism by which providers and clients interact to discuss concerns or questions about 
clinical trial participation. 
Implications for Process Evaluation Research 
 Process evaluation research, while valuable, is complex and can be very extensive 
for intervention research.  A variety of data collection methods can be used to assess the 
extent to which process evaluation concepts were met, therefore evaluation researchers 
must be strategic in determining the most efficient way to achieve the goals of the 
evaluation (Linnan and Steckler 2002).  The following section will highlight implications 
based on methods and analyses used for the dissertation study.   
 Dose received is perhaps the process evaluation concept that most warranted 
triangulation of data sources, as satisfaction or engagement from an outsider’s 
perspective could have varied from participant report of satisfaction.  Engagement is 
subjective and could be misinterpreted by session facilitators or observers.  For example, 
the facilitator may interpret participant lack of response or feedback during a session 
activity as a lack of engagement or dissatisfaction with an activity, while participants 
express the contrary on both counts.  This leads to a broader inquiry of the best methods 
to assess participant engagement and satisfaction.  If multiple data sources are used (e.g. 
observational data, facilitator debriefing interview, and focus groups discussions, and 
satisfaction surveys) researchers should have well defined processes as to how 
discrepancies between these data sources would be resolved.  The dissertation findings 
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speak to the need for reduction in the sensitivity of implementation checklists and 
exploration of session transcripts as qualitative data sources for participant satisfaction.   
 Intervention Context.  Future studies should consider ways to fully document and 
measure the effect of potential policy changes on individual motivation to participate in 
the EAST intervention, and ultimately CTs by capturing this data as part of survey data at 
each time point.  As stated previously, contextual data captured external factors 
influencing implementation.  However, more distal political influences were not captured 
as part of the dissertation study.  For example, there were fiscal changes in the state AIDS 
Drug Assistance Program (ADAP) which severely limited access to HIV medications for 
PLWHA across the state (AIDS Legal Project, 2010).  A few short months prior to 
recruitment and implementation of the intervention at Site A, over 800 people living with 
HIV/AIDS across the state were placed on a waiting list for treatment as a result the loss 
of ADAP funding.   
 As PLWHA meeting the criteria for ADAP (gross income at or below 300% of 
interest in clinical trials may have been heightened for these individuals.   Unfortunately, 
the extent to which this policy change may have affected client or service provider 
interest in the Project EAST intervention study or HIV/AIDS clinical trials is unknown, 
as there was no formal inquiry of this change as part of data collection.  All participants 
in the intervention were asked during their respective focus group discussions what their 
motivations were for participation in the series; neither service providers nor clients 
mentioned the closure of ADAP, or any other contextual barriers restricting client access 
to treatment.  This type of contextual data may have had important implications for the 
outcome evaluation.  That is, lack of access to HIV medications due to policy changes, 
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such as this, could have influenced a client’s participation in HIV/AIDS clinical trials, as 
well as service provider referral to HIV clinical trials. 
 Another value for documenting context relates to capturing potential threats to the 
outcome evaluation’s internal validity.   The intervention study was carried out with 
organizations that received state funds from Ryan White Part D, a federal program that 
supports public and private organizations to provide family-centered and community-
based services to children, youth, and women living with HIV and their families (Health 
Resources and Services Administration, 2011).  This program also supports activities to 
improve access to clinical trials and research for these populations, thus there may be an 
impetus for organizations to take advantage of opportunities to increase awareness about 
and access to this information to meet funding requirements.   Baronowski and colleagues 
(2010) suggest documenting the number of competing programs reaching participants in 
a study to determine the external contamination rates (ECRs) over the course of 
intervention implementation.  Future process evaluation studies should consider 
conducting interviews with site administrators and/or staff at study sites to document 
potential contamination threats to gain more in-depth information regarding the number 
of competing programs could affect implementation of the intervention.   Additionally, as 
part of client and service provider baseline surveys, an additional item could be added to 
determine whether they received information about clinical trials or clinical trial 
opportunities from other efforts from local organizations or major medical centers.  
Assured this in no way affects participation in the EAST series, partnership, or care   
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Implications for Practice 
 For grassroots organizations, health departments, faith-based organizations and 
community-based organizations, there are two considerations for intervention 
implementation: staff capacity and access to a clinical trial expert.  Perhaps the most 
important consideration is organizational capacity of the research team and the partnering 
sites in the intervention.  The Project EAST staff consisted of a project coordinator, two 
research assistants, and up to six volunteers at any given time.  Five members had 
capacity to serve in dual roles: facilitation and observation.  An additional three staff 
served solely as observers.  At a minimum, three staff persons were needed for a large 
group of clients (12-15 participants): one facilitator, one observer, and one person to 
oversee other logistics for the site (audiovisual setup, catering, transportation, etc.).  As 
research is not the primary goal for practitioners, staff size is as not as important, 
particularly if the intervention is implemented in one location,   
Personnel time at partnering sites included time to recruit, document, and track 
clients for each session, reserve meeting space, and oversee transportation logistics for 
clients, if needed.  With all of these factors considered, practitioners and researchers 
should consider organizational capacity well before implementation of the intervention as 
well as research staff capacity to collect and verify qualitative data process evaluation 
data collection and analysis. 
Clinical Trial Expert.  Access to clinical or clinical trial expert is vitally important 
for the intervention, as the last session for both groups (clients and service providers) 
consists of a conversation with an expert.  While this was carried out in-person for the 
Project EAST intervention, future implementers can consider using other forms of media 
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to allow participants to engage in a dialogue with the expert(e.g. Skype, videoconference, 
etc.), particularly if distance or time involved in transit to and from the site is problematic 
for the expert.    
Study Limitations  
 As mentioned in Chapter 3, the principal investigator of the dissertation study also 
served as the project coordinator for the larger, parent study, Project EAST.  In this 
capacity, she assisted with the development, pretesting, and refinement of the curriculum 
for the intervention, as well as facilitation of service provider and client sessions at both 
study sites.  Potential biases for the dissertation study were mitigated by her memo-
writing and documentation of reflexivity notes during data interpretation and analysis.  
Both methods have been well documented in the literature as strategies to mitigate 
potential biases for qualitative researchers (M. B. Miles & Huberman, 1999; Watt, 2007). 
 Social desirability on the part of clients may have led to favorable responses 
regarding satisfaction with session materials or the main outcomes for the parent study: 
willingness to refer to, or participate in, a clinical trial.   There was very little dissention 
among clients as it related to satisfaction with session activities. As clients spent a 
considerable amount of time in the outreach sessions and interacted with facilitators and 
other Project EAST staff, and were compensated for their time, there is a possibility that 
they felt obligated to give favorable responses despite EAST staff making it clear that 
participants’ feedback was about the “product”, or the series, and that all feedback was 
kept anonymous and confidential.  Social desirability has been documented in the 
literature, particularly in the context of focus group discussions where conformity 
pressures may lead participants to adjust their opinions to match those of others 
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(Hollander, 2004). 
 Failure to establish adherence standards for FOI limited the extent to which I 
could state that the fidelity was acceptable, or not acceptable, for a given session, group 
or facilitator.    Despite this shortcoming, the PI took detailed notes from audio files and 
session transcripts as part of the completion of session transcripts and made note of 
extreme deviations from scripting or instructions in the curriculum.  These findings were 
detailed in Chapter 5. 
Study Strengths 
 Project EAST provided a novel approach to increase access to increase awareness 
about clinical trials and clinical trial opportunities through a multilevel approach with 
rural, African American clients and their local service providers.  This is very important 
in the rural context where a client’s primary care service provider may not be integrated 
within, or in close proximity to the site conducting the clinic trial.  Further, the concurrent 
education of both groups (service provider and clients) ensured comparable delivery and 
measurement of theoretical based behavioral objectives.   
 The primary strength of the process evaluation was triangulation of data sources 
for the analysis.  This method has been encouraged by several qualitative researchers to 
strengthen validity through the support of study findings from independent data sources 
(M. B. Miles & Huberman, 1999; Patton, 1999).  For example, dose received data for the 
dissertation study was captured from two data sources: focus group discussions, and 
observation notes.  These data allowed for validating findings by comparing two data 
sources.  Additional methods included memoing and using a data audit trail during 
qualitative data analysis, and both of which have been documented in the literature as 
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methods to strengthen validity of qualitative findings (Mauthner & Doucet, 2003; 
Rodgers & Cowles, 1993).  These methods have been suggested to increase objectivity of 
findings, by reducing potential bias of the researcher in interpretation of findings.   
Community Advisory Board-Informed 
 The intervention was developed with the guidance and feedback of a 
community advisory board (CAB).  The importance of community input and involvement 
in research has been well documented in the literature (Cargo & Mercer, 2008; Minkler, 
2005).   CABs ensure that intervention content is culturally appropriate and relevant for 
community members.  More importantly they are the facilitators and drivers of 
engagement, buy-in, and trust for research institutions and minority communities.   
Despite the recognized benefits to research design and implementation, relatively few 
HIV interventions have been designed using participatory methods, including the 
involvement of a CAB.   
 The findings from this process evaluation provided important insights into how 
behavior change occurs by investigating the degree to which the intervention was carried 
out as planned.   This has been a critical omission in the literature as it relates to behavior 
interventions in general (Linnan & Steckler, 2002) as well as those developed to increase 
racial and ethnic minority participation in clinical trials.  Of the five studies targeting 
racial and ethnic minority participation in clinical trials in the literature, only one reported 
process evaluation measures: dose delivered scores (Gwadz, Cylar et al., 2010; Gwadz et 
al., 2011; Linnan & Steckler, 2002).  Therefore, this dissertation study is the most 
extensive process evaluation to date of an intervention to increase African American 
participation in HIV clinical trial research.  In the context of HIV clinical trial education 
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and outreach, which is in its infancy among African Americans in general and African 
Americans in rural areas, findings from this process evaluation will provide a foundation 
upon which future efforts can build their intervention efforts with comparable 
populations.  The inclusion of multiple process evaluation concepts (reach, context, 
recruitment, fidelity, dose delivered and dose received), afforded the opportunity to fully 
explore factors related to intervention implementation.  While this was strength for the 
dissertation study, researchers and practitioners should determine the feasibility of 
collection, management, verification, and analysis data, as these may require a great deal 
of human and financial resources. That said, researchers and practitioners should 
prioritize which components are most relevant in answering their research questions 
(Linnan & Steckler, 2002). 
  
 123
Appendix A: Client Intervention Series 
Session 1: CLINICAL TRIALS 101 
• Presentation: Overview of Project EAST 
• Discussion: “Clinical Trials Defined” 
• Presentation: Clinical Trials Basics Power Point -Part 1 
 
 
Session 2: REFERRAL AND TYPES OF TRIALS 
• Presentation: HIV Clinical Trial Participant Testimonial Video  
• Activity: Exploring the Types of Clinical Trials 
• Activity: Referral to Participation  
 
 
SESSION 3: OVERCOMING BARRIERS TO CT ENROLLMENT 
• Presentation: Clinical Trials Basics Power Point  -Part 2 
• Activity: Informed Consent Exercise  
• Activity: “Break the Barrier”: Identifying and Overcoming Barriers to CT Participation 
 
 
SESSION 4: SUPPORT:  WHAT IS IT AND WHERE CAN YOU GET IT? 
• Activity: Support: What it Means to You 
• Activity: Circle of Connections  
• Skit: Seeking Family Support  
                   * Homework :Locating Clinical Trial Opportunities (Scavenger Hunt Sheet) 
 
SESSION 5: CLINICAL TRIALS:  WHAT SHOULD YOU EXPECT? 
• Activity: Scavenger Hunt Reflections 
• Role Play: Communicating with Your Service provider  
• Discussion: Protecting Your Confidentiality 
*Homework:  “Ask the Experts”  
 
 
SESSION 6: CONVERSATION WITH THE EXPERTS 
Discussion: “Ask the Experts” :Real Life Experiences of Clinical Trial Staff  
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Appendix B: Service Provider Intervention Series 
 
SESSION 1: CLINICAL TRIALS 101 
• Presentation: Overview of Project EAST 
• Presentation: Clinical Trials Basics Power Point  
•  Activity: Referral 101: Exploring the Types of Clinical Trials  
•  Skit:  Informing Your Client About Clinical Trials  
 
 
 
SESSION 2: SERVICE PROVIDER-CLIENT/PATIENT COMMUNICATION 
ABOUT CLINICAL TRIALS 
•  Video: HIV Clinical Trial Participant Testimonial Video  
• Presentation: Referral through Participation  
• Activity: Clinical Trial Jeopardy 
• Skit/Role Play: Communication Show and Practice 
                  * Homework :Locating Clinical Trial Opportunities (Research Resource Sheet) 
 
 
SESSION 3: LOCATING CLINICAL TRIALS RESOURCES:  WHERE DO I GO? 
• Activity: Locating Clinical Trial Opportunities 
• Activity: Circle of Connections: Establishing Networks with Other Service providers 
• Role Play: Discussion with a Referral Source  
                  * Homework: “ Ask the Experts” 
 
 
SESSION 4: SYNTHESIS OF INFORMATION 
• Activity: “Break the Barrier”: Identifying and Overcoming Barriers to CT Participation 
 Discussion: “Ask the Experts”: What Happens to My Client During the Trial?  
• Role Play: Talking with Your Client about Clinical Trial Participation   
 
 
 
 
 
 
 
 Appendix 
 
 
 
 
 
ID Race
 Black 
1.
 
          
2.
 
  
3.
 
  
4.
 
  
5.
 
  
6.
 
  
7.
 
  
8.
 
  
9.
 
  
10.
 
  
11.
 
  
12.
 
  
13.
 
  
14.
 
  
15.
 
  
16.
 
  
17.
 
  
18.
 
  
19.
 
  
20.
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C: Client Recruitment Tracking Form 
 
 
 
 
  
 
 Date Recruited 
Agree to 
Participate? If no, why?
Latino  Yes No 
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Appendix D: Sample Implementation Checklist 
 
 
 
Group ID: 3AACL3.4  
 
Date of session:   11/17/10                                                             Facilitator ID:  BF2 
 
Session 3 Tasks Yes 
=1 
No = 
0 
Notes 
1. Facilitator introduced 
him/herself and project staff to 
participants. 
1 •  
2. Facilitator presented Session 2 
recap PowerPoint presentation  
1 • Not clear if every type has to be reviewed 
3. Facilitator introduced session 
objectives. 
1 •  
4. Facilitators addressed Parking 
Lot questions from previous 
sessions. 
0 • Unclear as to whether they were sent to the 
ACTU 
5. Facilitator introduced the 
Parking Lot for Session 3. 
1 •  
6. Facilitator led Clinical Trials 
PowerPoint presentation  
1 • Did not give AZT example for DSMB slide –
better scripting on all slides? 
7. Facilitator introduced the 
“Informed Consent” activity, 
placed the corresponding posters 
on the wall and read information 
from each poster aloud.  
1 • Didn’t read introductory script; or that 
headings are the same, but content varies 
from study to study 
8. Facilitator led the “Silly Consent 
Form” activity. 
1 • Facilitator states that we want equal numbers 
of people in each study arm.   
• Confusion between “cost to participate” and 
“compensation”  
• Facilitator spoke about “fear of needles” as a 
risk 
• Did not read summary text 
9. Facilitator distributed the “Key 
Questions to Ask Clinical Trial 
Staff” handout. 
0 • Went directly into Break the Barrier 
10. Facilitator led the “Break the 
Barrier” activity. 
1 • Facilitator is threading/leading with the 
“needles” example throughout the session. 
•  Did not offer an example prior to exercise 
11. Facilitator concluded session by 
reiterating session activities  
1 •  
12. Facilitator gave information 
about the upcoming session  
0 •  
 
IMPLEMENTATION SCORE 
 
75% 
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Appendix E: Facilitator Debriefing Guide 
 
Session __ 
 
1. How do you feel about the session?  Did it go well?  Why or why not? 
            
             
 
2. What types of activities worked well?  What did not work well?   
            
             
 
3. In what way did the session flow logically? 
            
             
 
4. Did the participants seem to easily understand the content of the session?  
Probe: What did not they understand?  What were some indicators that they did 
understand the content? 
            
             
 
 
5. Did the participants seem to easily understand the activities in the session?  
Probe: What did not they understand? 
 
            
             
 
6. How engaged were the participants?  
Probe: What were some indicators that the participants were engaged? 
 
            
             
 
7. How did their participation and involvement change as you progressed through the 
session? 
            
             
 
8. How well do you think the participants related to the session?   
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9. What interesting points/questions were raised for you (with the process or feedback 
from the participants)? 
 
            
             
 
 
10. How well was the match between the amount of time allotted to teach the session and 
the amount of materials that you needed to cover? 
 
             
             
 
11. How well was the session objectives met? 
 
            
             
 
12. Was there anything unusual or awkward about the session? 
 
            
             
 
13. What was challenging about teaching this session? 
            
             
 
 
14. What revisions/changes would you make to this session? 
 
            
             
 
15. What revisions/changes would you recommend for the remaining sessions? 
 
            
             
 
16. Were there any interruptions during the session? 
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17. Were there other people (besides participants) present during the data collection 
event?  If so, who and what was their role?  
            
             
 
18. Were there problems with the layout of the room? Briefly describe the setting. 
 
            
             
 
19. Were there any other logistical problems (e.g., food, etc.)? 
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Appendix F: Facilitator Debriefing Interview Codebook 
 
Concept Code  Code Name Code comment 
Barriers to 
Implementation  
IMPLEMENTATION 
BARRIERS 
 Apply this general code to any 
information that is important to 
capture related to barriers to 
implementation, but does not fit 
into any of the sub-topical codes 
below.   
 IMPTIME Delayed start/Late 
arrival 
Apply this code to any information 
that reflects a late start to the 
sessions.   This could be due to late 
arrival or logistical problems. 
 IMPMALFUNCT Malfunctioning 
equipment 
Apply this code when the 
facilitator references 
implementation barriers related to 
malfunctioning audiovisual 
equipment (projector, DVD, 
volume problems, etc.) 
 IMPFORECAST Forecasting Apply this code when the 
facilitator references 
implementation barriers related to 
participant inquiries that are 
beyond the scope of the current 
session (and will be covered in 
subsequent sessions). 
 IMPCONFLAT Care vs. Clinical 
Trials 
Apply this code when the 
facilitator references 
implementation barriers related to 
participant conflation with clinical 
trials.   
 
An example statement could be, “I 
was in a clinical trial--I went to the 
doctor and he switched my 
medication because I was getting 
sick.” 
 IMPINTERRUPT Interruptions  Apply this code when the 
facilitator references 
implementation barriers related to 
interruptions (i.e. participants 
entering the room, a disruptive 
participant, or cell phones ringing). 
 IMPINCORRECT Incorrect 
Information 
Apply this code when the 
facilitator references 
implementation barriers related to 
his/her provision of incorrect 
information (i.e. handouts, 
duplicates of session materials (i.e., 
support slips”),) or delivery of 
session content(i.e. not fully 
reading instructions for and 
exercise.  
 
This does not apply to the omission 
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of information; instead use 
“IMPOMISSION” 
 IMPOMISSION Omission of 
session content 
Apply this code when the 
facilitator references 
implementation barriers related to 
his/her omission of session 
information.   This includes 
omission of scripted text in the 
session plan. 
 
This does not apply to the 
provision of incorrect information; 
instead use “IMPINCORRECT”. 
Modification / 
Future 
Application 
MODIFICATION  Apply this general code to any 
information that is important to 
capture related to facilitator 
recommendations for modification 
of current session content, but does 
not fit into any of the sub-topical 
codes below.   
 MODNONE No modifications Apply this code when the 
facilitator states that no 
modifications were needed to the 
activity and/or session. 
 
This includes the facilitator stating 
that the perfect amount of time was 
used for the session. 
 MODRESTRUCT Restructure 
activity   
Apply this code when the 
facilitator states that an activity 
should be restructured.   
 
Examples include: giving feedback 
during role-plays, removing a 
picture from an exercise, making a 
PPT presentation into a handout, or 
condensing session activities. 
 
If a specific activity is mentioned, 
apply the appropriate code from 
“SPECIFIC” 
 MODEDIT  Apply this code if the facilitator 
makes any reference to scripting 
that text in the lesson plan needs to 
be edited.   
 
This code applies specifically to 
wording in the curriculum (i.e. 
adding more or less text to the 
introduction of an exercise, or 
shuffling/condensing session 
objectives within a lesson plan). 
 
 MODREMOVE Remove activity Apply this code when the 
facilitator states that an activity 
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should be removed from a session 
completely, or when the activity is 
described as not being useful.     
 MODMORE More Time Apply this code when the 
facilitator states more time was 
needed for a specific session or 
session activity or more time with 
the ACTU expert.  Double code 
with “ACTU” if this is the case. 
 MODLESS Less Time  Apply this code when the 
facilitator states less time was 
needed for a specific session or 
session activity. 
 MODLIVE Real PLWHA Apply this code when facilitator 
states an in-person testimonial 
from a PLWHA (currently or 
previously) enrolled in a clinical 
trial would be beneficial. 
 MODINTERACT Interactive 
exercises 
Apply this code when the 
facilitator suggests an activity 
should be made more interactive 
for session participants.   
 MODMATERIAL Provision of 
session materials 
Apply this code when the 
facilitator states that provision of 
existing session materials would be 
helpful for session participants (i.e. 
PPT presentations, informed 
consent form, etc.) 
MISC.    
 ENGAGEMENT  Apply this code when the 
facilitator references participant 
engagement or disengagement, 
including verbal and non-verbal 
indicators of engagement.  Apply 
this code to illustrate 
disengagement as well. 
 INTERESTING  Apply this code when the 
facilitator references interesting 
points made by participants, or 
interactions among participants 
that were surprising or unusual. 
 
If this relates to their 
comprehension of session specific 
materials, double code with the 
appropriate “KNOWLEDGE” 
code. 
 CHALLENGE  Apply this code when the 
facilitator references challenges 
related to group management.     
 ILL EQUIPPED  Apply this code when the 
facilitator references feeling ill-
equipped to answer participant 
questions.  This is a function of 
insufficient training, not a lack of 
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preparation.      
 LAYOUT  Apply this code when the 
facilitator references the layout of 
the room and how it may have 
contributed to participant 
engagement.  Can double code 
with “ENGAGEMENT” when 
applicable.   
 LOGISTICALGEN  Apply this code when the 
facilitator references logistical 
problems (i.e. incentives, food, 
meeting space, transportation, etc.).  
If this is stated within the context 
of the late arrival of participants 
and it affected the start time of the 
session, double code with 
“IMPTIME”. 
 
This does not apply to 
malfunctioning AV equipment, 
instead use “IMPMALFUNCT”. 
 RELATE  Apply this code when the 
facilitator references how well 
participants related to the session 
content.  
 TRUST  Apply this code when the 
facilitator references participant 
concerns related 
skepticism/mistrust of the medical 
establishment in general or clinical 
trials research.  
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Appendix G:  Client Focus Group Discussion Guide 
Recruiting 
 
I’m going to start by asking you some questions about how you got involved with this series and what your 
experiences were before the sessions started. 
 
How did you first hear about the Project EAST’s Client Intervention Series? 
 
What were your reasons for wanting to participate in the sessions? 
 
What did [recruitment source] tell you about the program? 
 
Did you think you received enough information about Project EAST to feel comfortable 
starting the sessions? 
 
Did you think you received enough information about the series to feel comfortable 
participating? 
 
What did you expect the sessions to be like? 
 
Intervention Series 
 
Now I have some questions about the sessions themselves.  Please think about the 6 sessions that made up 
the series. 
 
How would you describe the sessions to a friend/colleague who is also living with HIV?   
 
Probe: What did you do at the sessions? 
 
How were the sessions similar to what you expected? 
 
How were they different from what you expected? 
 
What did you like about the sessions? 
 
What was most memorable about the sessions? 
 
What was the most important part of the sessions? 
 
What new skills or information did you learn from the sessions? 
 
What skills do you feel you need more help with? 
 
What information do you feel you still need to be effective in being informed about HIV 
trial opportunities? 
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What information do you feel you still need to be effective in being referred to HIV/AIDS 
clinical trials?   
 
What information do you feel you still need to locate HIV trial opportunities? 
 
What information do you feel you still need to be supported in your decision to participate 
in a clinical trial? 
 
What would you have liked to get out of the sessions that you didn’t get? 
 
How do you feel about the amount of information you got?  What about the length of the 
sessions? 
 
What would you do to improve the sessions? 
 
Future Application 
 
These last few questions ask about how you feel about incorporating what you’ve learned into your personal 
lives. 
 
How prepared do you feel about locating HIV trial opportunities?  
 
Before going through this series, did you know about your role as a potential participant of a 
HIV trial? 
 
Now that you have gone through the series, do you think you consider HIV trial 
opportunities and tell others about trial participation? 
 
How comfortable are you talking with your service provider about HIV trials? 
 
How comfortable are you talking with referral services about HIV trials? 
 
What fears do you have about communicating with your service provider about HIV trials? 
 
What fears do you have about communicating with referral services about HIV trials? 
 
What do you think will be most difficult about participation in HIV trials? 
 
What do you think will be most rewarding about participating in HIV trials? 
 
 
Thank you so much for your time and thoughtful comments!  The information you have provided will greatly 
help us with future sessions. 
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Appendix H: Service Provider Focus Group Discussion Guide 
 
 Recruiting 
 
I’m going to start by asking you some questions about how you got involved with this series and what your 
experiences were before the sessions started. 
 
How did you first hear about the Project EAST’s Service provider Intervention Series? 
 
What were your reasons for wanting to participate in the sessions? 
 
What did [invitation source] tell you about the program? 
 
Did you think you received enough information about Project EAST to feel comfortable 
starting the sessions?  Why or Why not? 
 
Did you think you received enough information about the series to feel comfortable 
participating?  Why or Why not? 
 
What did you expect the sessions to be like? 
 
Intervention: Series 
 
Now I have some questions about the sessions themselves.  Please think about the 4 sessions that made up 
the series. 
 
How would you describe the intervention series to a colleague?   
Probe: What did you do at the trainings? 
 
How were the sessions similar to what you expected? 
 
How were they different from what you expected? 
 
What did you like about the sessions? 
 
What was most memorable about the sessions? 
 
What was the most important part of the sessions? 
 
What new skills or information did you learn from the sessions? 
 
What skills do you feel you need more help with? 
 
What information do you feel you still need to be effective in informing your clients/patients 
about HIV/AIDS clinical trial opportunities? 
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What information do you feel you still need to be effective in referring your patients/clients 
to HIV/AIDS clinical trials?   
 
What information do you feel you still need to locate HIV/AIDS-related clinical trial 
opportunities for your patients/clients? 
 
What information do you feel you still need to support your clients/patients as they decide 
on participating in a clinical trial? 
 
What would you have liked to get out of the sessions that you did not get? 
 
How do you feel about the amount of information you got?  What about the length of the 
sessions? 
 
What would you do to improve the sessions? 
 
Future Application 
 
These last few questions ask about how you feel about incorporating what you’ve learned into your practice as 
a service provider. 
 
How prepared do you feel to fulfill the key roles of a service provider relating to HIV/AIDS 
clinical trials?  
 
Before going through this series, did you know about your role as a service provider relating 
to HIV/AIDS clinical trials (inform your clients/patients about clinical trials, refer them to 
available opportunities, and support them through their decision to enroll and participate in 
clinical trials)?  Tell me more about how you saw your role. 
 
Now that you have gone through the series, how do you foresee your future interactions 
with clients/patients with respect to HIV/AIDS-related clinical trials? 
 
How comfortable are you talking with your clients/patients about HIV/AIDS-related 
clinical trials? 
 
What fears do you have about communicating with your patients/clients about clinical trials? 
 
What do you think will be most difficult about fulfilling your role as a service provider 
relating to HIV/AIDS clinical trials? 
 
What do you think will be most rewarding about fulfilling your role? 
 
Have you informed your clients/patients about HIV/AIDS clinical trials, referred them, and 
supported them through the decision-making process to participate since the end of the 
series?  If so, please describe how the process went. 
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Appendix I: Service Provider and Client Focus Group Discussion Codebook 
Concept Code  Code Name Code comment 
Recruitment 
  
RECRUIT     Apply this general code to 
capture information that is 
important to capture related to 
participant recruitment.   
Motivators for 
Participation  
MOTIVATORS  Apply this general code to any 
information that is important to 
capture related to participant 
motivators for participation, and 
does not fit within any of the 
sub-topical codes below.   
 MOTCTKNOW Clinical trial 
knowledge 
Apply this code when 
participants reference motivators 
related to learning more about 
clinical trials knowledge.  This 
includes correct and incorrect 
references regarding clinical trial 
characteristics (definition, 
phases, key terms, and 
availability).   
 MOTPROG Project EAST Apply this code when 
participants reference motivators 
related to learning more about 
“the program” or “classes”.  This 
includes correct and incorrect 
references regarding the sessions 
and general references about the 
project (i.e. wanted to learn more 
about why the project is taking 
place.) 
 MOTLIVEHIV Living with HIV Apply this code when 
participants reference motivators 
related to learning more about 
living with HIV.  This includes 
references to symptoms, 
treatment regimens, and side of 
effects medication. 
 MOTINCENTIVE Incentives Apply this code when 
participants reference motivators 
related to financial incentives 
(gift cards, gas card) or 
transportation. 
 
Do not apply if participants 
reference incentives as part of 
their “most memorable” or 
“liked” part of the intervention 
session.  Instead, use 
“SATINCENTIVE”. 
 MOTALTERN Alternative  Apply this code when 
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participants reference motivators 
related to a “break” or 
“alternative” to their regular 
routine.  This includes avoiding 
boredom, or being given the 
opportunity to convene with 
other people living with HIV. 
 MOTPROVIDREC Service provider 
Recommendation 
Apply this code when 
participants state their local 
service provider (physician, 
nurse, case manager, peer 
coordinator, etc.) suggested they 
participate in the sessions to gain 
more information about clinical 
trials opportunities. 
 MOTGOAL Organizational goal Apply this code when 
participants state the intervention 
sessions fit with their 
organizational goal or that they 
received administrative 
persuasion (i.e. mandatory, or 
“clear your calendars”) to 
participate. 
 MOTPREVUNC Previous 
relationship with 
UNC 
Apply this code when 
participants state previous 
relationships/collaborations with 
UNC served as motivators for 
participation. 
Satisfaction with 
Session 
*SATISFACTION  Apply this general code to any 
information that is important to 
capture related to participant 
satisfaction with the 
intervention sessions, but does 
not fit into any of the sub-topical 
codes below.   
 
*If a session activity is 
mentioned in context of 
participants “liking” and 
activity or an activity being 
identified as being the “most 
memorable” activity in the 
session, double code with 
corresponding activity from 
“SPECIFIC”. 
 
 SATAWARE 
 
Awareness Apply this code when 
participants make any reference 
about the sessions raising 
awareness or increasing 
knowledge about clinical trials.  
Also apply this code for any 
reference to the sessions being 
“informational” or 
“informative”. 
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 SATFACIL Facilitator 
characteristics 
Apply this code when 
participants make any reference 
about characteristics of the 
facilitators.  This includes 
facilitator knowledge of content 
or interpersonal interactions. 
 SATINCENTIVE Incentive Apply this code when 
participants make any reference 
to incentives being their “most 
memorable” or “liked” part of 
the intervention session. 
 SATAURS Audience response 
system 
Apply this code when 
participants make any reference 
about the audience response 
system (“Turning Point”), 
“survey”, or “clickers”. 
 SATGROUP Other 
PLWHA/Group 
Setting 
Apply this code when 
participants reference being 
happy, comfortable, or “feeling 
safe” with other PLWHA in a 
group setting. 
 SATQSANS Questions answered  Apply this code when 
participants give any general 
reference regarding their 
questions being answered 
directly, or in a timely fashion.   
  SATQSANS.ACTU Apply this sub-code when 
participants specifically 
reference ACTU experts 
answering questions or receiving 
“Parking Lot” responses (from 
ACTU experts, or in general). 
 SATGENACT Interactive activities  Apply this code when 
participants make any reference 
about “liking” or “being satisfied 
with” the intervention sessions in 
general.   
Do not apply this code if 
participants reference a specific 
activity; instead use 
“SATSPECACT” with the 
relevant sub-codes. 
 
Modifications MODIFICATION  Apply this general code to any 
information that is important to 
capture related to participant 
recommendations for 
modification of current session 
content—or skills they still need 
help with as it related to CT 
participation and referral 
 MODNONE No modifications Apply this code if participants 
state that no modifications were 
needed to the activity and/or 
session. 
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 MODLIVE Real PLWHA Apply this code if participants 
state that an in-person 
testimonial from a PLWHA 
(currently or previously) 
enrolled in a clinical trial would 
be beneficial. 
 MODOUTCOMES Clinical Trial 
Outcomes  
Apply this code if participants 
state that provision of statistics 
on clinical trial outcomes 
(survivorship, mortality, illness, 
injured by research) would be 
beneficial during the sessions. 
 
Also apply if participants 
mention outcomes being 
beneficial to the medical 
community. 
 MODINTERACT Interactive exercises Apply this code if participants 
desired more interactive 
activities.   
 MODFDBK Feedback on 
activities 
Apply this code if participants 
desired feedback on activities 
(i.e. role-plays--where 
demonstration of skills are being 
assessed)   
 MODMATERIAL Provision of session 
materials 
Apply this code if participants 
desired copies of existing session 
materials (i.e. PPT presentations, 
informed consent form, etc.). 
 MODREMOVE Remove activity Apply this code if participants 
state that an activity should be 
removed from a session, or if the 
activity is described as not being 
applicable or useful.     
 MODRESTRUCT Restructure activity   Apply this general code if 
participants state that an activity 
should be restructured, but not 
removed from a session.   
Examples include: removing a 
picture from an exercise, making 
a PPT presentation into a 
handout, providing more context 
to the introduction of an 
exercise, or condensing session 
activities. 
 MODFGGUIDE Focus group 
discussion guide 
Apply this code if participants 
state the questions asked as part 
of their focus group discussion 
are redundant, or if 
questions/statement/complaints 
are made in reference to the 
discussion and timing.  
 MODACCESS Accessible Apply this code if participants 
state the intervention study needs 
to be made accessible to the 
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broader community.  
 MODREFERRAL Referral  Apply this code if participants 
suggest ways to streamline the 
referral process. 
 
An example includes setting up 
satellite clinics (where trials can 
be offered) in rural areas. 
 MODSTAFF Project staff Apply this code if participants 
suggest changes to staff for the 
sessions.  This includes the 
rotation of staff in roles of 
facilitators or note takers. 
MISC.    
 ROLECONSIDER CLIENTS ONLY 
Consideration of 
participation (before 
or during) 
Apply this code if participants 
reference considering 
participation in clinical trials, 
thoughts/inquiries about 
participation (prior to beginning 
the series or during the sessions). 
 SPROLE SERVICE 
PROVIDERS 
ONLY 
Service provider 
role in the referral 
process 
Apply this code if participants 
reference their roles as service 
providers as it relates to 
awareness about and referral to a 
clinical trial. 
 
This includes lack of knowledge 
about their role prior to 
participating in the series, or if 
they don’t think the roles are 
practical with their population. 
 TELLOTHERS Tell other PLWHA 
about clinical trials 
General information about what 
participants would tell other 
PLWHA about clinical trials 
and/or clinical trials 
opportunities. 
 
This should not be confused 
the probe for the question 
“What did your during the 
sessions”, as this probe is used 
to assess participant 
knowledge.  If this is the case, 
use the appropriate 
“KNOWLEDGE” code.   
 PREVEXPER  Apply this code if participants 
reference previous participation 
in clinical trials.    Also include 
and contextual information to 
describe their experience(s). 
Specific Session 
Activities 
SPECIFIC   
 CTBAS Clinical Trials 
Basics 
Apply this code to capture the 
facilitator’s thoughts related to 
participant knowledge of clinical 
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trial basics (definition, phases, 
types, and key terms (blinding, 
randomization, placebo)), or 
regimen changes for a potential 
participant. 
Includes PPT presentations, 
handouts, or other associated 
activities (i.e. randomization 
activity (CLIENTS only)). 
 TYPE Types of Trials Includes “Types of Clinical 
Trials” handout, THE CARD, 
vignettes (SERVICE 
PROVIDERS only), or posters 
(CLIENTS only)). Associated 
terms may include “naïve”, 
“failing” “HIV negative” or 
“suppressed”.   
 VIDEO Testimonial Video Includes participant testimonial 
video.  Associated terms may 
include “Glow” or “his story”, or 
“other people”. 
 
This should be a function of 
participant feedback and/or 
engagement, not malfunctioning 
AV equipment; instead use 
“IMPMALFUNCT”.  
 INFCONS Informed Consent This includes the Jeopardy 
game, consent form (SERVICE 
PROVIDERS only), “silly” 
consent form and/or posters 
(CLIENTS only) or PPT 
presentations (SERVICE 
PROVIDERS and CLIENTS).  
Associated terms may include 
“IRB”, “DSMB”, “participant 
rights”, “bells”, “candy” or 
“teams”. 
 REFERRAL Referral to 
Participation 
Includes handouts (SERVICE 
PROVIDERS and CLIENTS) or 
posters (CLIENTS only)). 
Associated terms may include 
“steps” or “walking around the 
room” 
 COMM Communication Includes skits or role plays.  
Associated terms may include 
“communication” or “talking 
with” family, local health care 
service provider or clinical trial 
staff (aka “referral source”) as it 
relates to trial participation. 
 SUPP Support Includes handouts and/or 
posters/slips (CLIENTS only)). 
Associated terms may include 
“help”, “love”, “trust”, “care”, 
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“advice”, or “childcare”. 
 LOCATE Locating trials Includes homework, internet 
exercise, and sample clinical 
trial advertisements.  Associated 
terms may include “internet”, 
“find”, “brochure” or “flyer”.  
 CONFID Confidentiality Includes discussion and handout.  
Associated terms may include 
“private”, “privacy”. 
 BREAK Break the Barrier Includes brainstorm activity 
(participants generate barriers to 
clinical trial participation).  
Associated terms may include 
“bells” or “teams”. 
 ACTU “Ask the Expert” This includes the “Ask the 
Expert” discussion and the 
homework that details questions 
to ask the expert. 
 EAST Project EAST This includes the Project EAST 
brochure or PowerPoint 
presentation. Associated terms 
may include “classes”, or 
“program”. 
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Appendix J: Satisfaction Survey 
 
Project EAST 
Service provider Curriculum 
 
Response options 
1 = Strongly Agree 
2 = Agree 
3 = Disagree 
4 = Strongly Disagree 
5 = Not Applicable 
 
Satisfaction 
 
_____ 1. The facilitator did a good job teaching the series. 
 
_____ 2. The facilitator did a good job teaching me new skills. 
 
_____ 3. The facilitator was knowledgeable about the material. 
 
_____ 4. Material was clearly explained during the session 
 
_____ 5. The session activities were appropriate for the material. 
 
_____ 6. I was comfortable asking questions during the sessions 
 
 _____7. The facilitator did a good job answering my questions. 
 
_____ 8. I think other service providers would find this series helpful  
 
_____ 9. I learned relevant information for my professional practice through these sessions. 
 
_____ 10. The information presented was what I expected. 
 
_____ 11. I was satisfied with the series.   
 
_____ 12. Overall, I liked participating in the program.   
 
 
 
 
Thank you for completing this survey! 
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Appendix K: Client Attendance Log, by Session and Group
 
1 2 3 4 5 6 total #
LT8 1 1 1 1 1 1 6 1.00
AL3 1 1 1 1 1 1 6 1.00
MN2 1 1 0 0 1 1 4 0.67
AR1 1 1 1 1 1 1 6 1.00
EE5 1 1 1 1 1 1 6 1.00
DC7 1 1 1 1 1 1 6 1.00
RW8 1 1 1 1 1 1 6 1.00
IG6 1 1 0 0 0 0 2 0.33
RI0 1 1 1 1 1 1 6 1.00
AB3 1 1 1 1 1 1 6 1.00
DR2 1 1 1 1 1 1 6 1.00
UB8 1 1 1 1 1 1 6 1.00
MM5 1 1 1 1 1 1 6 1.00
0.92
1 2 3 4 5 6 total #
BC1 1 1 0 0 0 0 2 0.33
AT1 1 1 1 1 1 1 6 1.00
OR3 1 1 1 1 1 0 5 0.83
AP1 1 1 1 1 1 1 6 1.00
EK3 1 1 1 1 1 1 6 1.00
BW2 1 1 1 1 1 1 6 1.00
IM5 1 1 1 1 1 1 6 1.00
AM6 1 1 1 1 1 1 6 1.00
AH6 1 1 1 1 1 1 6 1.00
LM1 1 1 0 0 0 0 2 0.33
NK0 1 1 1 1 1 1 6 1.00
0.86
1 2 3 4 5 6 total #
LI4 1 1 1 1 1 1 6 1.00
BJ5 1 1 0 0 0 0 2 0.33
JO3 1 1 1 1 1 1 6 1.00
DG4 1 1 1 1 1 1 6 1.00
0.83
1 2 3 4 5 6 total #
BP97 1 1 1 1 1 1 6 1.00
LB59 1 1 1 1 1 1 6 1.00
LA40 1 1 1 1 1 1 6 1.00
LL68 1 1 0 0 0 0 2 0.33
LL55 1 1 0 0 1 1 4 0.67
AL73 1 1 1 1 1 1 6 1.00
0.83
CL2
CL3
CL4
Session Number
 AVERAGE
 AVERAGE
 AVERAGE
 AVERAGE
CL1
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Appendix L: Provider Attendance Log, by Group 
SP1  
ID Session 1 
Session 
2 
Session 
3 
Session 
4 
total # 
attended  
AAAA1 1 1 1 1 4 1 
AAAA2 1 1 1 1 4 1 
AAAA3 1 1 1 1 4 1 
AAAA4  1 1 1 1 4 1 
AAAA5 1 1 1 1 4 1 
AVERAGE 1 
SP2 
BBBB1 1 1 1 1 4 1 
BBBB2 1 1 1 0 3 .75 
BBBB3 1 1 1 1 4 1 
BBBB4 1 1 1 1 4 1 
BBBB5 1 1 1 1 4 1 
BBBB6 1 1 1 1 4 1 
AVERAGE .96 
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Appendix M:  Sample Fidelity Comparison by Data Source (Client Series) 
 
Implementation Checklist Only Facilitator Debriefing Interviews only Both 
• Did not ask participants what questions they have after the CT brainstorm.  
• Did not follow scripting after the randomization exercise (creating comparable 
groups)  
• Did not forecast upcoming information for session 3.  
• Facilitator gives too much info about trends in clinical trial participation when 
reading the EAST brochure; this information is captured as part of the PowerPoint 
presentation later in the session; this information shouldn’t be introduced this early. 
• Asked participant to volunteer to 
read CT definition; not 
accounting for potential literacy 
issues. 
• Used analogy to 
elicit participant 
responses for CT 
brainstorm that was 
not scripted  
• The facilitator did not introduce the Parking Lot. 
• Facilitator did not present the session 3 recap PPT presentation; read it verbally 
• Did not write participant feedback on the video on a flipchart.  
• Did not use the coin reference—this is VERY important concept! Instead used,” luck 
of the draw”  
• Went over time (72+ minutes) 
• Two participants made it to step 8; script calls for one. 
• Speakers were not working 
well/static  
• Still unclear as to what went 
wrong 
• Had participants read  “Referral 
to Participation” Handout  
• Selected four 
participants instead 
of two; integrated 
with types of trials 
activity  
 
• Facilitator did not read objectives at the beginning; read at the end of the entire 
activity  
• No responses during recap, facilitator reframes question as “Who is eligible for”  
• Did not summarize “silly consent” exercise at all; also did a test run questions before 
part 1 began; should have been done before part 2. 
• Facilitator did not summarize the “silly consent” at all. 
• Posters were placed ~ 20 feet 
away from participants, much 
further away than they were at 
other sites 
• Posters not put up in 
time  
• Did not follow the 
script for Break the 
Barrier  
• Did not say: “Remember your participation is voluntary” or that the circles 
correspond to the pictures on the poster.  
• Asked participant to read four rows homework assignment; she read everything.  
• Facilitator gave several hints to 
see if participants would associate 
pictures on slips with posters. 
• Duplicate support 
slips 
 
• Did not have participants name places first—jumped directly into what they 
found and information from the ad; engages in dialogue about trials not being on 
on TV 
• Framing his inquiry around “has anyone disclosed their information”; this isn’t 
the focus of this activity (e.g., “what do you tell people if they ask why you’re 
going….” 
• Facilitator uses “privacy” and 
“confidentiality” 
interchangeably during this 
session.; unsure to what the 
difference is 
• No Internet for 
locating trials 
activity; walked 
through website 
links very slowly for 
participants.  
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Appendix N: Sample Visual Display of Client Satisfaction, Select Sessions  
Session 
# 
Client Group 
CL1 CL2 CL3 CL4 
1 
• Facilitators were 
personable; “broke 
down” [information] and 
provided answers to 
participant parking lot 
questions. 
• “Clickers”  
• Session was more than 
expected; great job 
• Participant thought he 
would have to talk about 
himself; was glad he didn’t 
have to (“I be happy.”) 
 
• Skit 
• Interact with other CLIENTS 
• Organization of the room (like a 
board room) 
• “Clickers” (audience response 
system) 
• New information (“Learning 
things I didn’t know about” 
• “All of it” 
• Participants questions were 
answered; received a lot of 
information  
• Randomization activity 
3 
• “Clickers” from previous 
week (ARS) 
• Facilitators were great 
• Break the Barrier 
activity (“the thing we 
did competing for the 
candy… that was 
challenging”) 
• “All of it” 
• Interactive activity from 
previous week  
• How to overcome barriers 
(“Break the Barriers” 
activity)  
• Everyone’s participation in 
activities (“I won’t forget 
how everybody 
participated”) 
• Comfortable; around people 
who have the same problem 
• That you all make it fun and like 
down to earth so that, you know, 
you can relate all different types 
of situations from n-, not having 
family support to having family 
support 
• Receiving “vital information” 
• Feeling comfortable (“I felt 
comfortable with [the people], 
you know, I do, you know.” 
 
Appendix O: Sample Visual Display of Service Provider Satisfaction, Select Sessions 
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        Appendix O: Sample Visual Display of Service Provider Satisfaction, All Sessions 
  
Session 
# 
Service Provider Group 
SP1 SP2 
1 
• Comprehensiveness and detail of “Referral to Participation” activity; 
visual representation of the process 
• Defining the different types of trials and what different trials look at. 
• Honesty and upfront nature of the clinical trial participant video; 
participants worked issues with the CT team. 
• Video is an excellent tool for clients as it shows someone who has 
been through trial and is still alive 
• Facilitators were informative; kept participants attention 
• Knowing what research is being offered at UNC (The CARD) 
• Use of different media (paper, internet, skit)  
• Interactive 
• More information on how people get involved; never paid 
attention 
• Sessions flowed together; well integrated 
• Most memorable was testimonial video 
• How to reach out and where to go to get more information  
• RTP handout very helpful 
• Types of Trials new to everyone except for physician 
2 
• Informed consent activity (Jeopardy) allowed service provider to 
look through an ICF to find major components (“Don’t do away with 
Jeopardy!) 
• Understanding the informed consent process, and that participation is 
voluntary  
• Jeopardy; good way to learn informed consent 
• Scavenger Hunt made them more aware; “they are everywhere 
now” 
• Service provider/Patient role-play was helpful; allow them to 
feel more equipped give more detailed information; got easier 
as they went through  
3 
• Learning where to go to find clinical trials (where the rubber meets 
the road); having facilitator navigate service providers through the 
website. 
• Don’t recall the four service provider roles handout 
• Circles of Connections more local in content; local HIV service 
providers 
4 
• “Breaking the Barrier”—what service provider thinks is a barrier 
may not be perceived by someone else at a barrier; challenged 
service provider to think outside the box 
• Opportunity to have a candid conversation with ACTU doctor; “real 
time responses” 
• Most memorable overall: presenters and testimonial video. 
• “Were we uneducated; now that we are educated, those barriers 
have been removed.”  
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Appendix P: Client Satisfaction Compared to Facilitator Perceived Engagement, Select Sessions 
 CL3 CL4 
Session 
# 
Facilitator Perspective 
(Engagement) 
Client Perspective 
(Satisfaction) 
Facilitator Perspective 
(Engagement) 
Client Perspective 
(Satisfaction) 
3 
• First 30 minutes less lively as 
compared to the rest of the session 
activities; participant really 
wanted a copy of the presentation 
slides; facetiously said “Here’s a 
handout” when handouts were 
passed out. 
• “Pretty lively group” 
• Not as engaged and lively during 
the ICF activity; observer states 
they were glancing off, but still 
paying attention to the facilitator 
• Participants looked “drained and 
disengaged” after the ICF activity; 
facilitator took a five minute 
break (and a few other five minute 
breaks over course of the day) 
•  
• That you all make it fun 
and like down to earth 
so that, you know, you 
can relate all different 
types of situations from 
n-, not having family 
support to having family 
support 
• Female participant that was 
disengaged the previous week 
was very active during this 
session (taking notes, 
answering facilitator 
questions); couldn’t quite 
finish her responses, but 
spoke anyway 
• Older male participant is 
“checked out”; very quiet and 
doodling during the session 
but, made 2 or 3 
comments! 
• Dominant female very 
engaged; first to answer every 
question 
• Receiving “vital information” 
• Feeling comfortable (“I felt 
comfortable with [the 
people], you know, I do, you 
know.” 
 
6 
• Expert ask participant to pass her 
a note? 
• Participant looked “paralyzed”; 
very still and didn’t say anything.  
Expert tried to make her look 
comfortable be asking if she had 
anything to ask 
• Small group, pretty engaged;  
body language is somewhat 
deceiving because the participant 
with back turned and head down 
is still engaged in dialogue 
• Flow of entire series; 
doctor came in an 
“nipped everything in the 
bud” 
• Doctor explanation of 
how medication dosages 
are determined 
• Interaction in session 
activities; get the “full 
view” on what’s going on 
instead of just being told.  
• Very engaged; attentive.  
Male participant still 
doodling, but engaged 
otherwise 
• Doctor answered all 
participant questions 
(honestly and clearly)  
• Being able to talk their 
disease in a space with other 
clients 
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Appendix Q:  Service Provider Satisfaction Compared to Facilitator Perceived Engagement, Session 1 
Session # Facilitator  SP1 Facilitator SP2 
1 
• Participants are 
attentive and engaged; 
seem comfortable 
asking questions 
• Participants sitting 
forward during the skit; 
gave insightful 
feedback  
• Participants more 
attentive with the 
“Referral 101” exercise; 
very quick responses 
with the client 
vignettes. 
• Nodding in affirmation; 
smiling 
• One service provider 
looked fatigued; had 8 
patients that morning 
• People getting fidgety 
and restless towards the 
end of the session 
 
• Comprehensiveness and detail 
of “Referral to Participation” 
activity; visual representation 
of the process 
• Defining the different types of 
trials and what different trials 
look at. 
• Honesty and upfront nature of 
the clinical trial participant 
video; participants worked 
issues with the CT team. 
• Video is an excellent tool for 
clients as it shows someone 
who has been through  trial 
and is still alive 
• Facilitators were informative; 
kept participants attention 
• Knowing what research is 
being offered at UNC (The 
CARD) 
• Starting with the basics and 
building from there (not 
assuming that SERVICE 
PROVIDERS know the 
information 
• Use of different media (paper, 
internet, skit)  
• Participants spread out across 
the room; no table for them sit 
around 
• More engaged and attentive at 
the beginning and end of the 
session 
• Participants some nodding off; 
no questions about Project 
EAST 
• Facilitator states, “I felt like I 
had one cheerleader in the 
crowd for a while.” 
• One question during the CT 
PPT presentation 
• More attentive with the 
“Referral 101” exercise; read 
TOT handout very quick 
responses with the client 
vignettes. 
• Pretty active during the CT 
barriers brainstorm.  Physician 
shared info about Guatemala; 
WWII  
• Participants read handouts that 
are passed out; somewhat 
engaged 
• Two participants (MD and NP) 
ask questions about RTP. 
• Interactive 
• More information 
on how people get 
involved; never 
paid attention 
• Sessions flowed 
together; well 
integrated 
• Most memorable 
was testimonial 
video 
• How to reach out 
and where to go to 
get more 
information  
• RTP handout very 
helpful 
• Types of Trials 
new to everyone 
except for 
physician 
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